Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,insulin-like growth factor I binding (GO:0031994),-0.8643250220582619,-2.0672874960954286,0.0,0.001050704156118662,0.001,9/13,11.23%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.8560638631022085,2.0237466497842895,0.0,0.06588436788653476,0.056,7/23,2.40%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,inward rectifier potassium channel activity (GO:0005242),0.8261897806171439,2.0216158994882134,0.0,0.03628414463316407,0.062,3/24,1.14%,ABCC9;KCNJ8;KCNJ12
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.7245034562370046,-2.0078114168186367,0.0,0.005778872858652641,0.01,8/25,6.08%,MICAL3;POR;MICAL2;CYP26B1;NOS3;FMO1;FMO2;CYP27A1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.8633588858755029,2.0044310608330136,0.0,0.03787555448549582,0.093,7/21,2.40%,PDE8B;PDE4D;PDE4C;PDE3A;PDE5A;PDE7B;PDE9A
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.9272265674920831,1.9875634495647088,0.0,0.04081966271230958,0.125,5/12,2.13%,PDE8B;PDE4D;PDE4C;PDE3A;PDE7B
prerank,cyclic nucleotide binding (GO:0030551),0.8273477270690025,1.9775618526389667,0.0,0.04296806601295745,0.159,7/21,6.50%,PDE4D;RAPGEF2;RAPGEF4;PDE5A;SLC19A1;PDE4B;POPDC3
prerank,store-operated calcium channel activity (GO:0015279),0.9331405234714166,1.9723535119112572,0.0,0.039785246308293935,0.18,5/10,3.58%,TRPC3;TRPC4;TRPC6;TRPC1;STIM2
prerank,retinoid binding (GO:0005501),-0.7508706079733747,-1.9621589271285858,0.0,0.00980657212377418,0.025,7/22,9.57%,ALDH1A2;PTGDS;RBP1;CYP26B1;RBP4;ABCA4;CRABP2
prerank,cation channel activity (GO:0005261),0.6495427488406437,1.9589741371989269,0.0016051364365971107,0.04474135127698426,0.229,15/94,6.61%,ABCC9;TRPC3;ANO1;TRPC6;CACNB2;TRPC1;KCNG1;TRPV2;KCNQ4;UNC80;SLC24A4;SLC24A2;TMEM38B;RYR2;CHRNA7
prerank,calcium channel activity (GO:0005262),0.6532538856043358,1.9499145069188202,0.001692047377326565,0.04738422835317808,0.271,12/84,4.84%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;TRPC1;TRPV2;CACNG7;CACNA2D1;STIM2;SLC24A4;SLC24A2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.915772522800628,1.9481383795708922,0.0,0.044029005914511955,0.279,6/11,3.68%,TRPC3;TRPC4;TRPC6;TRPC1;ITPR2;ITPR1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.7627068838624329,-1.9082146262559263,0.0,0.02390351955169956,0.078,6/15,13.12%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.8142416463392911,-1.9068381159272756,0.0,0.01933295647258338,0.079,7/12,6.22%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,glutamate receptor activity (GO:0008066),0.8413185702329528,1.8887440525147368,0.00199203187250996,0.11200342540710907,0.597,7/19,5.93%,GRM3;GRM7;GRIK1;GRM5;GRID1;GRIA2;GRM1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.7346346618883303,1.8717196026423855,0.009380863039399626,0.12925141473392657,0.678,8/31,8.54%,ABCC9;SLC12A2;KCNG1;KCNQ4;SLC12A6;TMEM38B;TMEM38A;PKD2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.6817243169674958,1.8688569484083901,0.0035335689045936395,0.12349340454094439,0.697,16/55,8.54%,TRPC3;CACNB2;ATP2A3;TRPC1;ITPR2;TRPV2;ATP2C1;ITPR1;ATP2B3;SLC24A4;SLC24A2;ATP2A2;RYR2;CHRNA7;CACNA1D;PKD2
prerank,cAMP binding (GO:0030552),0.8699325344710915,1.863740877002618,0.002173913043478261,0.11972298735234298,0.712,5/11,6.50%,PDE4D;RAPGEF2;RAPGEF4;PDE4B;POPDC3
prerank,glucuronosyltransferase activity (GO:0015020),-0.7264126935881091,-1.8475077584630095,0.0,0.04465492663504314,0.203,4/19,5.44%,EXT1;LARGE1;CSGALNACT1;CHSY1
prerank,intracellular chloride channel activity (GO:0061778),0.8245335048351736,1.844487781995771,0.00847457627118644,0.13342380201949455,0.801,2/16,0.26%,ANO1;ANO4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.8245335048351736,1.844487781995771,0.00847457627118644,0.13342380201949455,0.801,2/16,0.26%,ANO1;ANO4
prerank,ion gated channel activity (GO:0022839),0.7566616262505999,1.8302049300744965,0.01160541586073501,0.14913499578663983,0.847,2/24,0.26%,ANO1;ANO4
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.7932462527929482,1.8098326476797864,0.02032520325203252,0.1752984758515558,0.905,7/13,7.43%,PIP5K1B;PIK3CD;PIP4K2A;PIK3CA;PIP4K2C;PIK3C2A;PIKFYVE
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.6942487358648595,-1.8018399277390924,0.001937984496124031,0.07520039745934995,0.357,9/18,11.72%,TGFBR3;SMAD3;SMAD6;TGFBR2;TGFBR1;SMAD7;FKBP1A;USP15;TGFB1
prerank,I-SMAD binding (GO:0070411),-0.7575119545267077,-1.7931211662704056,0.0,0.07525668518199917,0.393,6/13,6.30%,SMAD3;SMAD6;TGFBR1;SMAD9;SMAD7;SMURF1
prerank,calcium activated cation channel activity (GO:0005227),0.7671904904919651,1.7831706810052608,0.013409961685823755,0.21950846563162707,0.955,2/17,2.27%,ANO1;KCNMB1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.7533871297818929,-1.7768031703284033,0.001869158878504673,0.08487354683314081,0.467,6/13,13.12%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1;ALDH3A2
prerank,cGMP binding (GO:0030553),0.8348581505437747,1.7725719009916843,0.011160714285714286,0.2310224555106028,0.967,2/11,1.66%,RAPGEF2;PDE5A
prerank,insulin-like growth factor binding (GO:0005520),-0.6966851314587619,-1.7670920859605552,0.007889546351084813,0.08636788163295402,0.508,9/15,11.23%,IGFBP2;IGFBP5;ITGA6;IGF1R;IGFBP6;IGFBP4;IGFBP3;ITGB4;ITGB3
prerank,anion channel activity (GO:0005253),0.6106854043131641,1.7608227529138811,0.0070921985815602835,0.2445837802048678,0.974,7/61,6.03%,ANO1;ANO4;SLC1A4;GPR89A;GPR89B;GABRG2;GABRA2
prerank,voltage-gated chloride channel activity (GO:0005247),0.818992104053938,1.7606411551340144,0.026143790849673203,0.23339162205768316,0.974,1/10,0.04%,ANO1
prerank,voltage-gated anion channel activity (GO:0008308),0.7716741822477314,1.7606380509477109,0.01882845188284519,0.22278291196415212,0.974,3/15,4.82%,ANO1;GPR89A;GPR89B
prerank,leak channel activity (GO:0022840),-0.6749454301632427,-1.7475841151646938,0.003861003861003861,0.10373315577680609,0.6,3/18,2.73%,KCNK2;NALCN;KCNK5
prerank,chloride channel activity (GO:0005254),0.6023081054081256,1.7339562303580391,0.014035087719298246,0.26685867471622277,0.985,7/59,6.30%,ANO1;ANO4;SLC1A4;TTYH2;GABRG2;GABRA2;TTYH1
prerank,cholesterol transfer activity (GO:0120020),-0.6840544834826536,-1.7294356869207994,0.009784735812133072,0.12100609531299926,0.679,7/16,18.09%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5
prerank,potassium channel activity (GO:0005267),0.5836275869840735,1.7288995222165422,0.0030581039755351682,0.2673170699454269,0.988,23/89,12.63%,ABCC9;KCNG1;KCNMB1;KCNQ4;KCNV2;GRIK1;KCND2;KCNH4;KCNH8;TMEM38B;KCNQ5;HCN2;KCNA4;TMEM38A;KCNE5;KCNQ3;PKD2;HCN3;KCNG2;KCNC4;GRIK5;GRIK2;KCNMA1
prerank,transforming growth factor beta binding (GO:0050431),-0.6465091059449976,-1.7264356942166557,0.008213552361396304,0.1154158103798038,0.693,10/23,15.51%,TGFBR3;TGFBR2;THBS1;TGFBR1;ACVR1;LTBP4;ACVRL1;TWSG1;LTBP1;CD109
prerank,MAP-kinase scaffold activity (GO:0005078),-0.7572504201118576,-1.7208605335376612,0.003898635477582846,0.11377625004827799,0.713,4/11,2.84%,AKAP13;SH3RF1;IQGAP1;KSR1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.6675807975193238,-1.720766116763014,0.003780718336483932,0.10626121365546735,0.713,7/18,6.22%,TGFBR3;TGFBR2;BMPR2;TGFBR1;ACVR1;LTBP4;ACVRL1
prerank,potassium channel regulator activity (GO:0015459),0.6380079593627489,1.7149234917995844,0.014084507042253521,0.2866065487655402,0.993,6/49,5.58%,ABCC9;NEDD4L;KCNMB1;KCNE4;DPP10;KCNAB3
prerank,G protein-coupled receptor activity (GO:0004930),0.5019114742865382,1.708230939759064,0.0027472527472527475,0.29008953285158195,0.994,25/239,6.47%,GRM3;PDGFRB;CYSLTR2;P2RY14;S1PR3;PTH1R;ADGRL3;RORB;ADORA2A;GPR61;ADCYAP1R1;GPR152;FFAR2;GIPR;OPN1MW;OPN1MW3;GRM5;GPR87;XPR1;TAS1R1;CXCR2;GRM1;GPR45;TRHR;OPRK1
prerank,sterol transfer activity (GO:0120015),-0.662863619553065,-1.7008395157497145,0.007920792079207921,0.12424576646103179,0.795,9/17,24.61%,ABCA1;PLTP;GRAMD1C;GRAMD1A;NPC2;STARD4;STARD5;OSBP;GRAMD1B
prerank,P-type ion transporter activity (GO:0015662),0.7751987273780017,1.6911027145918993,0.0367965367965368,0.3193782750312912,0.996,5/12,6.32%,ATP2A3;ATP2C1;ATP7A;ATP2B3;ATP2A2
prerank,diacylglycerol kinase activity (GO:0004143),0.7965751682627809,1.6828631426381035,0.037037037037037035,0.3270006230144833,0.998,3/11,1.90%,DGKB;DGKH;DGKG
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.6177886995934512,1.6715437571261593,0.025906735751295335,0.34064951032188334,0.998,6/48,3.48%,ABCC9;TRPC6;SLC12A2;TRPC1;TRPV2;UNC80
prerank,high voltage-gated calcium channel activity (GO:0008331),0.7988057732227462,1.6703697375673507,0.03225806451612903,0.33187261060526474,0.998,4/10,9.59%,CACNA1C;CACNB2;CACNA1D;CACNA1A
prerank,metalloendopeptidase activity (GO:0004222),-0.4894327506841366,-1.6673456028085427,0.0,0.16953420589608764,0.904,22/76,14.11%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;THSD4;ADAMTS2;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ADAMTS1;ADAMTS15;ADAMTSL1;ADAMTSL4;MMP14;IDE;MMP19;ADAMTS14;ADAMTS3;SPG7;ADAM33
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.40069467078384197,-1.6663563798784249,0.0,0.16175006758915625,0.907,74/254,18.38%,NFIB;SMAD3;ZBTB16;MECOM;NFAT5;FOXO1;FOXO3;NFIA;NR3C1;ERG;HOXB3;ESR1;MLXIP;ELF1;MEOX2;ELF4;KLF4;PLAGL1;TFDP2;FOXC2;LEF1;NFATC1;TCF4;HOXA5;AR;GLIS2;GTF2I;PRRX1;SIX1;IRF1;HLF;PRDM16;IRF2;FOXC1;HINFP;NR2C2;PGR;STAT3;KLF10;TFCP2;RREB1;HIF1A;NR4A2;ATF6;FOSL2;TFCP2L1;NFYC;CEBPG;ELK3;MEF2A;ZIC3;PPARA;RELA;MDM2;SOX17;ZNF585A;ZNF585B;CLOCK;HSF2;HOXC4;MEIS2;HOXB7;HHEX;CREB3;SOX18;NKRF;CREB3L1;MEIS1;ATF1;NFYB;SOX12;KLF15;MAFF;PLAG1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.6609894817020745,1.6647836219065975,0.03903345724907063,0.3341344660276433,0.999,5/27,3.90%,SLC12A2;ATP2A3;ITPR2;ITPR1;ATP2B3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.6603656067225581,1.6619142890956147,0.02564102564102564,0.329451678367405,0.999,6/34,4.99%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;OGT
prerank,filamin binding (GO:0031005),-0.7291463962965667,-1.6599121979463614,0.009107468123861567,0.16446285054194215,0.921,3/11,5.31%,NEBL;DPYSL3;SYNPO2
prerank,chemokine binding (GO:0019956),0.6469629251420523,1.6578486596396305,0.02091254752851711,0.32858273241962616,1.0,8/30,8.04%,ITGA4;CCRL2;ACKR3;FGF2;ITGB1;CXCR2;ACKR2;CCR9
prerank,semaphorin receptor activity (GO:0017154),-0.7293251783575819,-1.648585443656026,0.009727626459143969,0.1776215375918598,0.943,4/11,2.18%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,calcium channel regulator activity (GO:0005246),0.6335072995460037,1.6474839899712086,0.03411131059245961,0.3412450785120562,1.0,7/37,3.68%,REM1;PRKG1;RRAD;NRXN1;CACNG7;STIM2;ITPR1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6386860210129769,-1.6412148051835163,0.011131725417439703,0.1813215172273348,0.954,7/18,5.58%,PDLIM5;BAIAP2L1;STXBP6;ANXA2;BAIAP2;ANXA1;CNN3
prerank,frizzled binding (GO:0005109),-0.5512735114866459,-1.6367249794822538,0.006355932203389831,0.1810076705313513,0.96,16/34,18.25%,WNT4;WNT6;LRP6;RNF43;WNT9A;SDCBP;WNT5A;FZD7;ZNRF3;MYOC;WNT5B;CCDC88C;WNT16;SFRP1;WNT11;FZD1
prerank,phospholipase C activity (GO:0004629),0.6759590627876935,1.63283726011837,0.04448742746615087,0.36502395127198145,1.0,3/25,0.50%,PLCL1;EDNRA;PLCE1
prerank,gap junction channel activity (GO:0005243),0.6856364772358967,1.632822026929553,0.04780876494023904,0.3549374440650596,1.0,4/22,5.96%,GJD3;GJC1;GJA4;GJC2
prerank,wide pore channel activity (GO:0022829),0.682793131985572,1.6302475458216374,0.04435483870967742,0.35099619570104157,1.0,4/23,5.96%,GJD3;GJC1;GJA4;GJC2
prerank,exopeptidase activity (GO:0008238),0.5860703143362124,1.6289606047760963,0.02422145328719723,0.34507628687482145,1.0,9/50,5.39%,ACE2;ENPEP;FAP;NAALAD2;CPM;METAP2;ANPEP;GGH;DPP10
prerank,flavin adenine dinucleotide binding (GO:0050660),-0.5006131488764644,-1.6237741016453127,0.0049261083743842365,0.19707555345634384,0.975,21/53,21.54%,MICAL3;AOX1;DDO;POR;MICAL2;XDH;NOS3;DPYD;PRODH;AIFM1;ACOX1;ACADL;PPOX;NOS1;ACOX3;SQOR;ILVBL;QSOX1;CYB5R3;CYBB;GCDH
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.6298279842365899,-1.6233926841581519,0.01717557251908397,0.1894332034802271,0.975,5/18,16.13%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.5862068173135965,-1.6208789535828056,0.01639344262295082,0.1868992552903876,0.98,8/24,10.47%,PLA2G4A;OSBPL8;CERT1;SESTD1;ARFIP2;GOLPH3;DAB2IP;GSDMD
prerank,NAD binding (GO:0051287),-0.579569706703326,-1.60935591951761,0.019880715705765408,0.20116943419841152,0.984,11/26,19.53%,ALDH1A1;CRYL1;PARP9;SORD;ME1;NNT;BDH2;SIRT2;HSD17B8;SIRT3;NUDT6
prerank,SH2 domain binding (GO:0042169),0.6559624108390303,1.6075896399237075,0.04690431519699812,0.38321149244148717,1.0,4/31,3.86%,DLC1;PTK2;AFAP1L2;PAG1
prerank,LRR domain binding (GO:0030275),-0.6693307032415948,-1.6052518709839825,0.013435700575815739,0.20169628300603795,0.987,4/14,9.10%,ROBO1;PAWR;ERC1;PMF1
prerank,ion channel activity (GO:0005216),0.5438430752509548,1.6020750924382106,0.011075949367088608,0.38633065575205744,1.0,10/80,6.61%,ABCC9;TRPC6;TRPC1;TRPV2;CHRNA3;UNC80;GRIK1;GRID1;GRIA2;CHRNA7
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.4515928498701084,-1.5884198574219301,0.010471204188481676,0.2281529024714809,0.997,24/78,12.30%,CTSH;CASP12;USP47;CAPN2;CTSC;CFLAR;USP46;CASP4;USP12;USP8;USP15;CAPNS1;USP18;CAPN5;CAPN1;CTSB;USP34;CASP8;USP5;USP11;USP35;GPAA1;CTSS;USP49
prerank,GTPase regulator activity (GO:0030695),0.4760028023871635,1.583569811953016,0.007936507936507936,0.41896775478217047,1.0,31/212,4.75%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;TBC1D1;RGS6;ARHGAP10;RAPGEF2;ARHGAP32;ARHGEF6;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;WAS;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;WASL;RIMS1;RGS11;RTKN;ASAP2;SYDE1;RIN2;TBC1D30
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.6834902269919928,-1.5693199830734483,0.02666666666666667,0.2618064907625328,0.998,7/12,14.28%,SULF1;ARSB;SULF2;ARSI;ARSK;ARSG;GALNS
prerank,solute:anion antiporter activity (GO:0140323),-0.6399639708350592,-1.56928697078758,0.032015065913371,0.2530796077371151,0.998,3/14,2.89%,SLC7A11;SLC26A7;SLC26A2
prerank,GTPase activator activity (GO:0005096),0.45060028239784555,1.5664346681291035,0.008827238335435058,0.45141477182713396,1.0,39/313,4.75%,DLC1;RGS5;STARD8;CHN1;ARHGAP42;RAPGEF5;TBC1D1;RGS6;PLCE1;ARHGEF17;ARHGAP10;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;ARHGAP32;FARP1;ARHGEF6;RASGRP2;PREX2;ARHGAP1;RASGRP3;SIPA1;NF1;AGAP2;RGS3;STARD13;SH3BP1;GRTP1;GARNL3;CYTH3;RGS11;RALGPS1;ASAP2;EPS8L1;SYDE1;RIN2;TBC1D30
prerank,carboxylic acid binding (GO:0031406),0.6055744976262355,1.5651476453027642,0.04690431519699812,0.44424761170812754,1.0,3/38,2.46%,GRM7;UBR1;SESN3
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7539825800610445,1.5627535278844191,0.07659574468085106,0.44029247037216857,1.0,4/11,9.81%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,phosphatidic acid binding (GO:0070300),0.6814743723134578,1.5612424890183316,0.07184466019417475,0.4339880761298858,1.0,3/19,1.86%,PITPNC1;RAPGEF2;MARK1
prerank,potassium ion leak channel activity (GO:0022841),-0.6336447309977988,-1.5592040045645237,0.03136531365313653,0.2694886692032091,0.998,2/15,2.73%,KCNK2;KCNK5
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.5275227799937793,1.5502059562757324,0.034071550255536626,0.4522855992059565,1.0,8/73,6.47%,EDNRA;CYSLTR2;PTH1R;ADCYAP1R1;GIPR;SORCS1;NPSR1;OPRK1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6212092056107277,1.5461713812529585,0.05222437137330754,0.4525766461326965,1.0,11/28,14.99%,CHRNA3;GRIK1;GABRG2;GRID1;GABRA2;CHRNA7;GABRA5;GABRA4;GRIK5;GRIK2;CHRNB2
prerank,phospholipase inhibitor activity (GO:0004859),-0.7026309397967478,-1.543775909750356,0.04189435336976321,0.2987611598913658,1.0,4/10,4.07%,ANXA4;ANXA5;ANXA2;ANXA1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.7022964552216,1.5418686000397122,0.07855626326963906,0.452895351350464,1.0,4/14,9.65%,PTEN;MTMR12;MTMR14;MTMR7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6145215365546844,1.5384384517676197,0.056530214424951264,0.4520708224193197,1.0,4/27,5.41%,ANO1;XPR1;SLC22A8;SLC26A1
prerank,FAD binding (GO:0071949),-0.5528215685498005,-1.5107859769105536,0.03260869565217391,0.3779351010038945,1.0,8/24,19.23%,MICAL3;DDO;MICAL2;PRODH;AIFM1;SQOR;QSOX1;CYB5R3
prerank,bHLH transcription factor binding (GO:0043425),-0.5887062413356782,-1.508527130991245,0.03244274809160305,0.37284546010504876,1.0,7/19,16.40%,SMAD3;FHL2;BHLHE40;LMO2;BHLHE41;USF1;USF2
prerank,AMP binding (GO:0016208),-0.6552734431369582,-1.5020130458513095,0.05827067669172932,0.38167578973979055,1.0,2/11,2.76%,PRKAG2;MPPED2
prerank,leucine zipper domain binding (GO:0043522),-0.6679978841887393,-1.4968525295865984,0.053406998158379376,0.3859002875611375,1.0,3/10,9.10%,PAWR;ERC1;PMF1
prerank,amino acid:sodium symporter activity (GO:0005283),-0.668364355862122,-1.4962058628107415,0.0575139146567718,0.37768554801022175,1.0,4/11,8.45%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,nucleotide diphosphatase activity (GO:0004551),-0.6128134129187717,-1.4931544144706679,0.04805914972273567,0.37568203603116473,1.0,8/14,20.55%,FHIT;ENPP1;NUDT4;NUDT3;NUDT12;NUDT13;NUDT6;CILP
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.5351977472353682,-1.4920688295066291,0.046,0.3692012757807729,1.0,7/24,14.75%,DAPK1;CAMK1D;PHKA2;PTK2B;CAMK2A;MKNK2;MAPKAPK3
prerank,C-C chemokine receptor activity (GO:0016493),0.6160822300828104,1.4902463252892084,0.08870967741935484,0.5649059381019087,1.0,5/21,8.04%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.5243781679478074,-1.4900708036576535,0.03418803418803419,0.3654349054980707,1.0,13/29,20.86%,PTPRJ;NFATC1;ACE;MAPK14;DUSP1;DUSP16;GCH1;DUSP7;MAPKAPK3;DUSP10;TPR;ATF7;CDK5RAP3
prerank,ephrin receptor activity (GO:0005003),-0.5915748524497444,-1.4826053451852315,0.054878048780487805,0.36799662229775043,1.0,6/17,12.69%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5915748524497444,-1.4826053451852315,0.054878048780487805,0.36799662229775043,1.0,6/17,12.69%,EPHA4;EPHA3;EPHA7;EPHB4;EPHA8;EPHB2
prerank,muscle alpha-actinin binding (GO:0051371),-0.5873071744673866,-1.4734011670431233,0.052123552123552123,0.3848265059235537,1.0,5/15,6.04%,PDLIM5;SYNPO2;PALLD;PDLIM7;PDLIM2
prerank,voltage-gated calcium channel activity (GO:0005245),0.5591873024237971,1.4710272503058852,0.07265774378585087,0.6056531448597648,1.0,8/37,9.59%,CACNA1C;CACNB2;CACNA1H;CACNG7;CACNA2D1;CACNA1D;PKD2;CACNA1A
prerank,poly(A) binding (GO:0008143),0.6256780725341513,1.466297469185759,0.100418410041841,0.6068963888009644,1.0,9/21,13.69%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;HNRNPU
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6139572661116975,-1.4632285312489135,0.07567567567567568,0.40583448030083324,1.0,4/13,3.19%,BMP6;CDH5;BMP7;BMP4
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.6567215747336995,-1.4630993000448322,0.07719298245614035,0.39716617101285423,1.0,3/10,8.45%,SLC6A13;SLC6A12;SLC6A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.5425547426224818,-1.463069992146119,0.0513347022587269,0.38860064800101735,1.0,13/22,32.19%,DUSP1;DUSP12;DUSP16;DUSP7;DUSP10;DUSP23;MTMR3;DUSP15;PPM1F;DUSP8;DUSP4;CDKN3;DUSP18
prerank,cytochrome-c oxidase activity (GO:0004129),0.657082666878062,1.4626335944575548,0.11713665943600868,0.6055704833935173,1.0,2/15,1.22%,COX4I2;NDUFA4L2
prerank,R-SMAD binding (GO:0070412),-0.5775164470987537,-1.458146777187943,0.060784313725490195,0.3943046788429992,1.0,5/18,6.30%,LDLRAD4;SMAD3;SMAD6;DDX5;SMURF1
prerank,voltage-gated cation channel activity (GO:0022843),0.47989176681514034,1.4557527540766797,0.047987616099071206,0.6130287574498856,1.0,22/97,11.67%,CACNA1C;CACNB2;KCNG1;KCNQ4;KCNV2;CACNG7;CACNA2D1;KCND2;KCNH4;KCNH8;KCNQ5;HCN2;CACNA1D;KCNA4;KCNE5;KCNQ3;PKD2;HCN3;CACNA1A;GRIN2B;KCNG2;KCNC4
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6115923788636999,1.4532052821337442,0.12260536398467432,0.6086187839257573,1.0,7/21,16.50%,CHRNA3;GRM5;GRM1;CHRNA7;CHRFAM7A;CHRNB2;GRIA1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.6031028935475689,1.45225853662006,0.094,0.6003082143326163,1.0,2/25,0.86%,ART3;PARP8
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.65382795308427,1.4486251833036363,0.12083333333333333,0.5996934874065746,1.0,5/16,13.08%,PTEN;MTMR12;MTMR14;MTMR7;SACM1L
prerank,triglyceride lipase activity (GO:0004806),0.6112421091257073,1.4466280495030674,0.13026819923371646,0.5945397455907837,1.0,3/20,6.99%,CEL;LIPC;LIPH
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.5890882606531415,-1.4415235573588425,0.06451612903225806,0.43098571103792366,1.0,4/14,9.40%,CAPN2;CAPNS1;CAPN5;CAPN1
prerank,death domain binding (GO:0070513),-0.630093478416664,-1.4407621715980687,0.058823529411764705,0.4244415931880163,1.0,9/11,30.28%,DAP;MCL1;IRGM;DAPL1;RIPK1;BCL2L1;CRADD;RACK1;TRADD
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.6080152792494868,-1.4405475376353818,0.08171206225680934,0.41664622606729423,1.0,7/12,18.37%,TAF1;STAT1;H3-3A;RELA;HDAC1;POU2F1;TBPL1
prerank,adrenergic receptor binding (GO:0031690),0.6272703024069722,1.4395689230402193,0.11063829787234042,0.6029609173049928,1.0,3/16,5.90%,PDE4D;RAPGEF2;UCHL1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.47757921667138326,-1.4351181136873048,0.05045871559633028,0.42304233611256087,1.0,16/35,25.20%,FOXP1;NR3C1;TAF1;STAT1;KLF10;H3-3A;RELA;HDAC1;POU2F1;TBPL1;PARK7;AGO1;UBTF;PIH1D1;SMARCA4;TP53
prerank,voltage-gated potassium channel activity (GO:0005249),0.49319507395993717,1.4322977923444802,0.06542056074766354,0.6117379472363276,1.0,21/80,12.63%,KCNJ8;KCNJ12;KCNG1;KCNQ4;KCNV2;KCNE4;KCND2;KCNH4;KCNH8;KCNQ5;HCN2;KCNA4;KCNE5;KCNQ3;PKD2;HCN3;KCNJ3;KCNJ6;KCNG2;KCNC4;KCNMA1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.598430118269559,-1.4322759241074092,0.07692307692307693,0.4232519222734156,1.0,2/14,1.38%,SLC7A11;SLC1A3
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.6185175943512692,-1.4298031440641625,0.08396946564885496,0.4220262278387562,1.0,6/12,11.23%,CDH5;ITGA5;VEGFD;VEGFC;DAB2IP;ITGB3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.6190583919685705,1.4284512706239785,0.12761506276150628,0.6120562292067939,1.0,8/19,12.53%,GRIK1;GABRG2;GRID1;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2
prerank,C-C chemokine binding (GO:0019957),0.5891239150977812,1.4280801451603828,0.10860655737704918,0.6031546011940736,1.0,5/22,8.04%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,alpha-tubulin binding (GO:0043014),0.5643227377851238,1.4261147912615941,0.12992125984251968,0.5987338553001309,1.0,3/31,6.31%,DLEC1;ARL4C;SNCA
prerank,chloride channel inhibitor activity (GO:0019869),-0.6487748094005307,-1.4240298579405695,0.07115384615384615,0.43047738425869037,1.0,4/10,10.31%,WNK4;STX7;WNK1;STX1A
prerank,voltage-gated sodium channel activity (GO:0005248),0.5952429269035643,1.4236025473326035,0.13827655310621242,0.5958984460498381,1.0,10/22,13.43%,CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;PKD2;HCN3;SCN9A;SCN2B;SCN1A
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6090476012328627,1.4222490453868735,0.11513859275053305,0.5908733399108335,1.0,4/19,4.15%,AFAP1L2;NRG1;GRM5;NRG3
prerank,BMP receptor binding (GO:0070700),-0.6139592523266564,-1.4190271826547751,0.09107468123861566,0.43672995841870427,1.0,4/12,3.19%,BMP6;CDH5;BMP7;BMP4
prerank,voltage-gated ion channel activity (GO:0005244),0.6331870254265876,1.4189235997285632,0.14747474747474748,0.589617350288916,1.0,5/14,8.54%,CACNA1H;KCND2;GPR89A;GPR89B;PKD2
prerank,amino acid binding (GO:0016597),0.5751145861967025,1.4110279146039568,0.11264822134387352,0.6004555639548711,1.0,1/31,0.09%,GRM7
prerank,carboxypeptidase activity (GO:0004180),0.5385919600662574,1.408844952130109,0.1171875,0.5973965360964908,1.0,3/35,0.98%,ACE2;NAALAD2;CPM
prerank,sequence-specific mRNA binding (GO:1990825),0.6796955978954627,1.4083742285922656,0.16593886462882096,0.5899287130861115,1.0,5/10,16.28%,RBM24;DHFR;SSB;LARP6;FMR1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.6258821343802282,-1.4071934078912123,0.09481216457960644,0.46300404393821826,1.0,6/10,23.24%,CXADR;CD47;CD200;SIRPA;DSG2;DSP
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.651122191990275,1.4064970402945178,0.1394335511982571,0.5857570446756886,1.0,4/10,12.11%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,beta-tubulin binding (GO:0048487),0.561342752306637,1.4046931309920652,0.11706349206349206,0.5814070203042806,1.0,3/31,6.84%,DLEC1;FGF13;APPL1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.5719870378887242,1.401730839690982,0.14314115308151093,0.5805595758793946,1.0,2/25,3.24%,ADAP2;NCF1
prerank,cAMP response element binding (GO:0035497),-0.6272408435717196,-1.4011123793647653,0.0931899641577061,0.4714527981910684,1.0,7/10,27.84%,CREB5;CREB3L2;CREB3L1;ATF7;NR4A3;ATF2;JUN
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.6160403356987927,-1.3988366878981446,0.08771929824561403,0.46990026044072375,1.0,5/11,15.82%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,phosphatidylglycerol binding (GO:1901611),0.6493039609557376,1.395649485417559,0.13846153846153847,0.5873479562392211,1.0,1/13,0.15%,PITPNC1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6452194206144386,1.395360417847248,0.14937759336099585,0.5800817944980526,1.0,4/14,9.81%,KCNJ8;KCNE4;KCNE5;KCNJ3
prerank,mannosyltransferase activity (GO:0000030),-0.5168187019370223,-1.3906750163147361,0.0931174089068826,0.48569244830210623,1.0,3/21,4.80%,TMTC1;TMTC4;TMTC2
prerank,death receptor activity (GO:0005035),-0.6066238123165781,-1.3899147250027755,0.09074074074074075,0.4799266350431342,1.0,9/11,35.30%,TNFRSF1B;TNFRSF19;TNFRSF1A;TNFRSF11A;EDA2R;FAS;TNFRSF14;TNFRSF10B;TNFRSF25
prerank,phosphatidylinositol kinase activity (GO:0052742),0.6097345257985282,1.3844029755430416,0.1593625498007968,0.599248562715228,1.0,4/15,7.43%,PIK3CD;PIK3CA;PIK3C2A;PIKFYVE
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),-0.3054286358389637,-1.3810996384613943,0.0,0.4985677344074536,1.0,174/732,16.40%,NFIB;FOXP2;PBX1;PKNOX2;FOXN3;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;NFIA;ZIC2;NR3C1;HIVEP3;ERG;HOXB3;RARB;ESR1;MLXIP;ZIC5;ELF1;MEOX2;ZBTB7C;MAFG;ELF4;FOXD1;PRRX2;NR3C2;DNMT3A;TBX15;KLF4;PLAGL1;FOXC2;SMAD9;LEF1;NFATC1;KLF2;TCF4;TCF7L2;THRB;HOXA5;SKI;MXI1;ZNF23;HOXA3;TEAD4;ZNF697;GTF2IRD1;ARNT2;AR;CREM;RARG;HIF3A;STAT2;GLIS2;FOXP4;SOX13;THRAP3;PRRX1;BHLHE40;SIX1;IRF1;HLF;TEAD1;PRDM16;HOXC6;IRF2;FOXC1;BPTF;HIVEP1;GLIS1;STAT1;HINFP;NR2C2;PGR;STAT3;KLF10;H3-3A;TBX1;ZNF219;ZBTB18;IRF9;TFCP2;FOXL1;RREB1;MKX;HIF1A;NLRC5;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;FOSL2;IKZF1;HOXB9;ZKSCAN7;ZKSCAN3;TGIF1;TFCP2L1;ZFHX2;SIX5;ESRRG;GATA2;NFYC;PRDM5;CEBPG;FOXQ1;ZSCAN25;PATZ1;ELK3;BACH2;NSD1;MEF2A;LRRFIP1;ZIC3;AHR;PPARA;RELA;ZSCAN22;HDAC1;GLI3;ATOH8;USF1;CHD2;ZGPAT;DACH2;SOX17;GATA6;RFX2;TAL1;ZNF585A;ZNF585B;CLOCK;ZNF568;ZBTB4;KCNIP3;SARS1;HDAC5;HSF2;MAZ;HOXC4;MEIS2;HOXB7;SOX7;HOXB5;JUND;POU2F1;SREBF1;HHEX;CREB3;SOX18;NKRF;HMGB2;KDM6B;NKX6-1;MNT;USF2
prerank,vinculin binding (GO:0017166),0.6582760294924004,1.380693182534616,0.1696035242290749,0.5995678497866536,1.0,3/11,4.03%,UTRN;DMD;CORO2B
prerank,adenyl ribonucleotide binding (GO:0032559),0.4001796595476099,1.3777632286071735,0.03768844221105527,0.5984155733296646,1.0,49/291,10.58%,MYO1B;PDE4D;KCNJ8;MAP3K20;RAPGEF2;RAPGEF4;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;SLC19A1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;SYN1;PDE4B;POPDC3;SIK1;MCM6;LIG4;PAPOLA;HSPA14;MAP4K4;PEX1;STK3;MYO6;NEK6;MARK2;GCK;MAP4K1;COQ8A;ABCF3;DARS2;BRSK1;DYRK3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6169891896317767,-1.3760488437853644,0.11538461538461539,0.5067105527088386,1.0,5/10,15.82%,CASP12;CFLAR;CASP4;CASP8;CASP6
prerank,sodium channel activity (GO:0005272),0.5291889128320986,1.3749655745039298,0.1265597147950089,0.5972438759658599,1.0,14/37,13.43%,CACNA1H;GRIK1;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;PKD2;HCN3;SCN9A;ASIC3;GRIK5;GRIK2;SCN1A
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),-0.30332281899495306,-1.3724908440965262,0.0,0.5094414151238199,1.0,175/731,16.40%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;KLF3;SKIL;FOXO3;NFIA;ZIC2;NR3C1;HIVEP3;ERG;HOXB3;RARB;ESR1;MLXIP;ZIC5;ELF1;MEOX2;ZBTB7C;MAFG;ELF4;FOXD1;PRRX2;NR3C2;DNMT3A;TBX15;KLF4;PLAGL1;FOXC2;SMAD9;LEF1;NFATC1;KLF2;TCF4;TCF7L2;TRIM24;THRB;HOXA5;SKI;MXI1;ZNF23;CREB3L2;HOXA3;TEAD4;ZNF697;GTF2IRD1;ARNT2;AR;CREM;RARG;HIF3A;STAT2;GLIS2;FOXP4;SOX13;THRAP3;PRRX1;BHLHE40;SIX1;IRF1;HLF;TEAD1;PRDM16;HOXC6;IRF2;FOXC1;BPTF;HIVEP1;GLIS1;STAT1;HINFP;NR2C2;PGR;STAT3;KLF10;H3-3A;TBX1;ZNF219;ZBTB18;IRF9;TFCP2;FOXL1;RREB1;MKX;HIF1A;NLRC5;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;FOSL2;IKZF1;HOXB9;ZKSCAN7;ZKSCAN3;TGIF1;TFCP2L1;ZFHX2;SIX5;ESRRG;GATA2;NFYC;PRDM5;CEBPG;FOXQ1;ZSCAN25;PATZ1;ELK3;BACH2;NSD1;MEF2A;LRRFIP1;ZIC3;AHR;PPARA;RELA;ZSCAN22;HDAC1;GLI3;ATOH8;USF1;CHD2;ZGPAT;DACH2;SOX17;GATA6;RFX2;TAL1;ZNF585A;ZNF585B;CLOCK;ZNF568;ZBTB4;KCNIP3;SARS1;HDAC5;HSF2;MAZ;HOXC4;MEIS2;HOXB7;SOX7;HOXB5;JUND;POU2F1;SREBF1;HHEX;CREB3;SOX18;NKRF;KDM6B;CREB3L1;NKX6-1;MNT;USF2
prerank,lysophospholipase activity (GO:0004622),-0.5263157851857262,-1.3668235993849633,0.11155378486055777,0.5186374218116352,1.0,11/20,25.32%,PLA2G4A;ASPG;PNPLA7;PLA2G6;LYPLA1;MGLL;ABHD16A;LYPLAL1;ENPP2;GDPD3;LYPLA2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6140734914006865,-1.3664177142877858,0.11194029850746269,0.5118060767850627,1.0,4/11,19.22%,SLC25A20;SLC22A4;SLC22A5;SLC25A29
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.4896131066645213,1.3622013513433664,0.11986863711001643,0.6211212220365318,1.0,4/55,3.17%,SLC38A11;SLC16A12;SLC16A3;SLC19A1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.607073702531624,1.3616836353171509,0.16424116424116425,0.6146701198892487,1.0,2/15,4.11%,P2RY14;GPR87
prerank,phospholipase activator activity (GO:0016004),0.6370719011814108,1.3559916220179848,0.1887966804979253,0.6208973950530814,1.0,3/10,12.36%,ARHGAP6;STX4;SRC
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5728104228600515,1.355148540466854,0.1603960396039604,0.6152118784993443,1.0,2/23,0.50%,EDNRA;PLCE1
prerank,dipeptidyl-peptidase activity (GO:0008239),0.6505886187480142,1.3512858546109703,0.17920353982300885,0.616980012942683,1.0,3/10,5.39%,FAP;NAALAD2;DPP10
prerank,protease binding (GO:0002020),-0.3723995460902306,-1.350299022636358,0.04177545691906005,0.5532912567561227,1.0,25/99,11.32%,TIMP3;COL1A2;FN1;COL3A1;COL1A1;VWF;LCOR;CCBE1;F3;DPP4;SLC2A13;ANXA2;TIMP2;ITGA3;CFLAR;RNF139;BDKRB2;AMFR;CST3;ADAMTSL4;ECM1;PSAP;BRCA2;ITGB3;ATP9A
prerank,peptidase inhibitor activity (GO:0030414),-0.46751675550327987,-1.34890927157133,0.08488612836438923,0.5490791734057121,1.0,6/33,7.68%,RECK;CAST;TIMP2;ITIH2;SERPIND1;CST3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.40861174810398376,-1.3485597713200888,0.07194244604316546,0.5418234108596618,1.0,20/53,22.02%,SLC7A11;SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A5;SLC7A7;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC17A6;SLC7A1;SLC66A1;SLC25A22;SLC22A2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.4183443989265471,-1.3483588473916988,0.08064516129032258,0.5346865946926751,1.0,20/54,19.89%,HDAC4;HDAC8;TGM2;HDAC9;ACER2;ASPA;NAAA;ACER3;UPB1;GLS;ASPG;ASRGL1;HINT1;HDAC1;HDAC5;NIT2;SIRT7;SIRT2;NIT1;NGLY1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.615375799477242,1.3415413155355567,0.1953781512605042,0.6324035408901786,1.0,4/12,12.51%,OPN1MW;OPN1MW3;RRH;OPN3
prerank,poly-purine tract binding (GO:0070717),0.5484892185842691,1.3409225491036563,0.15495867768595042,0.6267496227610287,1.0,10/27,13.69%,RBPMS;RBMS3;ELAVL4;HNRNPDL;DDX3X;RBMS1;KHDRBS2;PABPC4;DAZAP1;HNRNPU
prerank,Tat protein binding (GO:0030957),-0.5994021352868413,-1.3389089305911124,0.1417624521072797,0.5565579914960552,1.0,6/10,27.15%,MDFIC;ACTB;GABARAPL1;SMARCA4;DLL1;CTDP1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.5304961707058485,1.3373499599557586,0.1641509433962264,0.6280443467930106,1.0,4/35,4.86%,PLCL1;PLCE1;PLD6;GPCPD1
prerank,sialyltransferase activity (GO:0008373),-0.5055954757324559,-1.3355930689328799,0.12815533980582525,0.558456658302112,1.0,9/20,11.81%,ST3GAL4;ST3GAL6;ST3GAL1;ST3GAL2;ST6GALNAC3;ST3GAL3;ST6GALNAC2;ST8SIA2;ST6GALNAC6
prerank,GTPase inhibitor activity (GO:0005095),-0.5581932110621588,-1.3351047240578577,0.12897196261682242,0.5521450340403569,1.0,6/13,21.26%,IQGAP1;SLIT2;CPEB2;IQGAP2;RHOH;PDE6D
prerank,syntaxin-1 binding (GO:0017075),-0.48782300455517547,-1.3316193519730042,0.13,0.5544839302782922,1.0,3/22,4.10%,DAPK1;UNC13B;LRRK2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.3962954586485505,-1.3309816909427938,0.09828009828009827,0.5488509345238768,1.0,24/60,13.56%,EPHA4;EPHA3;FLT1;EGFR;EFEMP1;NRP2;PDGFRA;EPHA7;NTRK3;NRP1;TEK;FGFR2;IGF1R;EPHB4;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;FLT4;EPHB2;MET;RET
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6068359912612291,1.3309713250125141,0.1877637130801688,0.6362895599236803,1.0,7/13,10.38%,PRKAR1B;PKIA;PRKAR2B;RYR2;PRKAR2A;CSK;PRKAR1A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6174977290407676,1.3301626549908507,0.18736383442265794,0.6309469875220866,1.0,3/10,9.84%,APOBEC1;ADARB2;DCTD
prerank,iron ion binding (GO:0005506),-0.4117566170271654,-1.3300251613157024,0.0815347721822542,0.5444748937006907,1.0,25/48,35.52%,KDM7A;AOX1;AGMO;EGLN2;EGLN3;FTL;KDM3A;DNAJC24;ISCA2;FTO;TYW5;FTH1;DOHH;TET2;EGLN1;CYP2R1;TET1;CDO1;HIF1AN;RIOX1;ACP5;JMJD6;PHYH;HAAO;ALOX5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6406574073390673,1.3299940164093522,0.20081967213114754,0.6243190255745369,1.0,3/10,7.18%,PIK3CD;PIK3CA;PIK3C2A
prerank,actin monomer binding (GO:0003785),-0.4907203219172386,-1.3279706751450717,0.12398373983739837,0.5431863986039767,1.0,7/22,12.93%,MTSS1;LIMA1;NOS3;PRKCE;TMSB4X;PFN1;TWF1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5022067740536632,1.324554249905442,0.1710758377425044,0.6300709887351895,1.0,4/38,5.12%,SERPINB8;SERPINI1;WFDC3;SERPINA10
prerank,delayed rectifier potassium channel activity (GO:0005251),0.53562643414057,1.324455383543453,0.1691449814126394,0.6233779735848113,1.0,10/32,13.84%,KCNG1;KCNQ4;KCNE4;KCNQ5;KCNA4;KCNE5;KCNQ3;KCNG2;KCNC4;KCNS3
prerank,neuropeptide receptor binding (GO:0071855),0.6011056178621961,1.3228473021681586,0.19913419913419914,0.6200374955749013,1.0,2/14,3.65%,UCN2;NMU
prerank,cholesterol binding (GO:0015485),-0.4109220997908991,-1.3208306110160277,0.08351648351648351,0.5566958111321175,1.0,18/47,18.63%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL1A;STARD3;PTCH1;STARD4;OSBP2;STARD5;ERLIN2;CD81
prerank,metalloexopeptidase activity (GO:0008235),0.4835520415634867,1.32067335564272,0.1519434628975265,0.6185245402194971,1.0,6/51,3.11%,ACE2;ENPEP;CPM;METAP2;ANPEP;MMP15
prerank,tropomyosin binding (GO:0005523),0.591206175312681,1.3180916581747377,0.18255578093306288,0.6177243570638222,1.0,4/16,5.47%,CALD1;SMTNL2;TMOD1;TMOD3
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.39535002251428497,-1.3109308991033157,0.09382716049382717,0.5794633420994421,1.0,24/60,13.56%,EPHA4;EPHA3;FLT1;EGFR;PDGFRA;EPHA7;NTRK3;TEK;TGFBR2;FGFR2;IGF1R;EPHB4;ACVR1;ACVRL1;DDR1;TIE1;KIT;EPHA8;KDR;FGFR4;FLT4;EPHB2;MET;RET
prerank,serine-type peptidase activity (GO:0008236),0.43540884304105865,1.310487624091041,0.13406940063091483,0.6284594768636702,1.0,6/96,3.01%,TMPRSS4;FAP;NAALAD2;TMPRSS7;RHBDD3;RHBDF1
prerank,"DNA binding, bending (GO:0008301)",-0.5499612593713602,-1.3103647239638916,0.14953271028037382,0.5736844692407894,1.0,7/14,21.81%,FOXD1;LEF1;FOXC1;FOXL1;HHEX;HMGB2;TOP2A
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.41154461740901027,1.309976617115462,0.11128048780487805,0.6231364203036538,1.0,16/147,4.69%,RAPGEF5;PLCE1;ARHGEF17;DOCK10;KALRN;RAPGEF2;DENND2A;RAPGEF4;FARP1;ARHGEF6;RASGRP2;PREX2;CYTH3;RALGPS1;EPS8L1;RIN2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.447610426364918,1.3086366526392117,0.15474209650582363,0.6199017157159181,1.0,17/74,13.00%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;ADK;CLP1;PIK3C2A;XYLB;GK;NMRK1;COASY;DGKD;FAM20A;PAPSS1;CHKB;IPMK
prerank,ligand-gated channel activity (GO:0022834),0.524971547703973,1.305755184897499,0.17472118959107807,0.6198314030567577,1.0,14/29,22.61%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA4;GRIA1;GRID2;GRIN1;CNGB1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5690232742547718,1.3036817166403056,0.2012072434607646,0.6121994560935038,1.0,1/16,0.17%,PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5690232742547718,1.3036817166403056,0.2012072434607646,0.6121994560935038,1.0,1/16,0.17%,PTPRK
prerank,protein tyrosine kinase binding (GO:1990782),-0.3807445376960602,-1.3031748399687786,0.08737864077669903,0.587448693685944,1.0,10/71,4.95%,EPHA4;CDH5;PTPN14;TJP2;DOCK4;NEDD9;BMPR2;ANGPT1;ACVR1;GAS6
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.5642509172744858,-1.303079150470604,0.17086330935251798,0.5804945887711882,1.0,5/11,18.86%,SGMS1;SGMS2;PTDSS2;PIGN;PTDSS1
prerank,ligand-gated ion channel activity (GO:0015276),0.5192259016574453,1.3014511319057784,0.18382352941176472,0.6108650352975239,1.0,14/30,22.61%,CHRNA3;GRIK1;GRID1;GRIA2;GRIN2B;GRIK5;GRIK2;CHRNB2;GRIN2A;GRIA4;GRIA1;GRID2;GRIN1;CNGB1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5852137052868813,-1.299433968509227,0.17926186291739896,0.5842555781285688,1.0,7/10,28.74%,USP15;IDE;DNAJB2;ANKRD13D;ANKRD13A;DNAJC2;LAPTM5
prerank,FMN binding (GO:0010181),-0.575987345295364,-1.2977287620314808,0.15779467680608364,0.5820014888862107,1.0,2/11,3.11%,POR;NOS3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),-0.28420626631231144,-1.2930059598656147,0.0,0.5880065675593117,1.0,203/831,18.67%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;AEBP1;SMAD3;ZBTB16;MECOM;NFAT5;FOXP1;ZKSCAN2;HDAC4;CUX1;GLI2;NFIX;CREB5;ZFHX4;GLIS3;HOXB6;IKZF2;FOXO1;PBX3;OSR1;KLF3;SKIL;FOXO3;NFIA;ZIC2;NR3C1;HIVEP3;ERG;HOXB3;RARB;ESR1;MLXIP;ZIC5;ELF1;MEOX2;ZBTB7C;MAFG;ELF4;FOXD1;PRRX2;NR3C2;DNMT3A;TBX15;KLF4;PLAGL1;TFDP2;FOXC2;SMAD9;LEF1;NFATC1;KLF2;TAF1;TCF4;TCF7L2;ETV6;THRB;HOXA5;SKI;MXI1;ZNF23;HOXA3;TEAD4;ZNF697;GTF2IRD1;ARNT2;AR;CREM;RARG;HIF3A;STAT2;GLIS2;FOXP4;SOX13;THRAP3;PRRX1;BHLHE40;SIX1;IRF1;HLF;TEAD1;PRDM16;HOXC6;IRF2;FOXC1;BPTF;HIVEP1;GLIS1;STAT1;HINFP;NR2C2;PGR;STAT3;KLF10;H3-3A;TBX1;ZNF219;ZBTB8A;ZBTB18;IRF9;TFCP2;FOXL1;RREB1;LHX6;MKX;HIF1A;TWIST2;NLRC5;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;FOSL2;IKZF1;HOXB9;ZKSCAN7;ZKSCAN3;TGIF1;TFCP2L1;ZFHX2;SIX5;ESRRG;GATA2;NFYC;PRDM5;CEBPG;FOXQ1;ZSCAN25;PATZ1;ELK3;BACH2;NSD1;MEF2A;LRRFIP1;ZIC3;PPARA;RELA;ZSCAN22;HDAC1;GLI3;ATOH8;USF1;CHD2;ZGPAT;DACH2;SOX17;GATA6;RFX2;TAL1;ZNF585A;ZNF585B;CLOCK;ZNF568;ZBTB4;KCNIP3;SARS1;HDAC5;HSF2;MAZ;ENO1;HOXC4;MEIS2;HOXB7;SOX7;HOXB5;JUND;POU2F1;SREBF1;HHEX;CREB3;SOX18;NKRF;KDM6B;NKX6-1;ZNF436;MNT;USF2;SNAI1;ZFP69;MEIS1;JUNB;ZFP14;ATF1;NFYB;NFIL3;SOX12;KLF15;CEBPB;NR6A1;MAFF;TBPL1;PLAG1;NPAS2;NFXL1;CC2D1A;POU5F2;ZSCAN2;ATF7
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.5377267798473946,-1.2918296210485198,0.172147001934236,0.5844387353092981,1.0,6/13,19.22%,SLC7A2;SLC7A7;SLC38A5;SLC7A1;SLC66A1;SLC25A29
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5675533027088637,-1.2911962945859914,0.1493624772313297,0.5796221694718787,1.0,5/11,25.24%,LEF1;SRRM2;GATA2;MBD2;ZXDC
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5539959745775662,-1.2901439629323601,0.15018315018315018,0.575906648145684,1.0,7/12,32.48%,ENTPD1;ENTPD5;CANT1;ENTPD2;NUDT18;ENTPD3;NUDT5
prerank,ADP binding (GO:0043531),-0.45393413316791603,-1.2888000156046182,0.1522198731501057,0.573290455182245,1.0,7/25,11.09%,PRKAG2;MYO18A;ME1;MYH10;GCLC;MYO9B;ERN1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6148926577028138,1.2882338829837705,0.22077922077922077,0.6341955486230563,1.0,4/11,17.11%,SLC5A1;SLC2A9;SLC23A2;SLC23A1
prerank,low-density lipoprotein particle binding (GO:0030169),0.5745388107645139,1.2876047853043453,0.20662768031189083,0.6294381329337183,1.0,6/16,6.99%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,steroid hydroxylase activity (GO:0008395),0.5706593427262241,1.2816719558768817,0.2135306553911205,0.6368454980604232,1.0,1/16,0.54%,CYP7B1
prerank,SH3 domain binding (GO:0017124),0.4473943754440336,1.2797232640068894,0.1539708265802269,0.6355454386272106,1.0,8/62,3.59%,SGIP1;AFAP1L2;VASP;WAS;PTPN22;WIPF1;NCF1;ABI2
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5828696287269679,1.277035343249783,0.18831168831168832,0.6353508662528123,1.0,5/12,15.56%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3987138420212541,-1.2732957183851896,0.11538461538461539,0.6123007983943191,1.0,17/51,16.04%,SLCO2B1;SLC16A2;MCU;SLCO2A1;ANKH;SLCO1C1;SLC20A2;SLC22A6;TMEM241;SLC7A5;SLC22A4;SLC5A6;CLCN3;SLC5A5;MFSD2A;SLC35E4;SLC35D2
prerank,lipase activator activity (GO:0060229),0.6110141245107369,1.2730896135502687,0.22105263157894736,0.6385331247125976,1.0,1/10,1.06%,ARHGAP6
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5643348689513592,-1.2720859729232996,0.17907801418439717,0.6089998033770001,1.0,5/11,16.80%,ATP10A;ABCA3;ABCA4;ATP8A1;ATP11A
prerank,MAP kinase activity (GO:0004707),-0.5279850953603699,-1.2715870569282552,0.20153550863723607,0.6038777809798037,1.0,4/14,14.36%,MAPK4;MAPK14;MAPK6;MAPK3
prerank,lipoprotein particle binding (GO:0071813),0.5535114745777219,1.2713949084741931,0.22266401590457258,0.636502052771779,1.0,6/20,6.99%,COLEC12;SCARB1;SCARF1;LDLR;MSR1;LIPC
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.4656802880351753,-1.2667645619890195,0.17165668662674652,0.6120808537285172,1.0,10/26,9.01%,SLC6A13;SLC6A6;SLC16A2;SLC6A12;ABCG2;SLC16A1;SLC16A6;SLC16A11;SLC6A1;SLC5A6
prerank,neuropeptide receptor activity (GO:0008188),0.49883020800982275,1.2654796200261038,0.2076923076923077,0.6437851456387882,1.0,10/29,18.75%,TACR2;SORCS1;TACR1;NPSR1;GPR37;NPY1R;NTSR1;TACR3;NPY2R;SSTR2
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.41868418116047335,1.2650935482388035,0.16031746031746033,0.638878718899731,1.0,20/100,14.10%,MYO1B;ADAP2;FERMT2;ARAP2;CYTH3;SNX20;OGT;RPH3A;TTPAL;MYO10;GAP43;PLEKHA5;HIP1;PLA2G4E;ARHGAP9;PIRT;ANKFY1;ZFYVE28;RLBP1;ATG2B
prerank,G protein-coupled receptor binding (GO:0001664),-0.34028519945287167,-1.2623423270732055,0.07038123167155426,0.6178592353743805,1.0,43/132,24.73%,WNT4;WNT6;LRP6;RNF43;WNT9A;SDCBP;ARRB1;PDCD6IP;CXCL12;ACE;WNT5A;ITGB4;GNAS;GNA14;FZD7;TULP3;ZNRF3;MYOC;WNT5B;GRK2;CCL25;S1PR1;PTCH1;CCDC88C;WNT16;REEP1;SFRP1;HOMER1;GNA13;HOMER3;WNT11;FZD1;AGTR1;PPY;TAFA5;NTS;BAMBI;REEP2;CCL19;GNAI1;PENK;PRKN;PSMC5
prerank,phospholipase binding (GO:0043274),0.5858457228171206,1.2613792034713582,0.2571428571428571,0.6415188170134765,1.0,4/13,12.36%,ARHGAP6;WAS;BLNK;SRC
prerank,metallopeptidase activity (GO:0008237),-0.34852739491912205,-1.2604953927003328,0.06451612903225806,0.6166627403075581,1.0,26/113,11.73%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;THSD4;ADAMTS2;PAPPA;ADAMTS9;ADAMTS5;ADAM9;ADAM10;ACE;ADAMTS1;ADAMTS15;ADAMTSL1;RNPEP;ERAP1;ADAMTSL4;LNPEP;ADAM15;MMP14;IDE;MMP19;ADAMTS14;ADAMTS3
prerank,metallocarboxypeptidase activity (GO:0004181),0.5180092577993094,1.2597754606853289,0.2088607594936709,0.6394909983396703,1.0,2/26,0.98%,ACE2;CPM
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.32473947507005346,-1.2542370151170839,0.07476635514018691,0.6293054292525867,1.0,29/134,11.76%,ABCC4;SLC6A13;SLC13A3;SLC1A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLCO2A1;SLC26A2;GJA1;ABCG2;SLCO1C1;SLC16A1;SLC22A6;SLC7A2;SFXN2;SLC16A11;SLC6A9;SLC7A5;SLC25A17;SLC6A1;SLC5A6;SLC25A38;SLC39A8;SLC38A5;SLC25A24;SLC3A2;SLC38A6
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5683993256889187,1.251935120806864,0.2480916030534351,0.6509007128767182,1.0,1/15,0.23%,NDST3
prerank,adenylate cyclase binding (GO:0008179),0.6066354512011055,1.250207337439623,0.2516703786191537,0.6487759175890172,1.0,4/10,8.46%,CAP2;AKAP6;CAP1;AKAP12
prerank,pentosyltransferase activity (GO:0016763),0.479511071754152,1.2441251327184975,0.22181146025878004,0.657357440446735,1.0,2/36,0.86%,ART3;PARP8
prerank,chemokine receptor activity (GO:0004950),0.5089910335345669,1.242250357846063,0.22,0.6561026125852106,1.0,5/24,8.04%,CCRL2;ACKR3;CXCR2;ACKR2;CCR9
prerank,exoribonuclease activity (GO:0004532),-0.5287142645005356,-1.2402414525258794,0.22549019607843138,0.6643624268808219,1.0,4/12,23.84%,CNOT7;ZC3H12A;EXOSC5;EXOSC7
prerank,sodium:proton antiporter activity (GO:0015385),-0.5388829080043191,-1.2367655183655708,0.24242424242424243,0.6680528672624985,1.0,3/11,7.08%,SLC9A2;SLC9B2;SLC9A9
prerank,sequence-specific double-stranded DNA binding (GO:1990837),-0.27691977068020146,-1.236577517528189,0.008064516129032258,0.661782796290045,1.0,124/597,16.60%,NFIB;BNC2;PBX1;PKNOX2;MAF;SMAD3;FLI1;SMARCA2;SMAD6;NFAT5;FOXP1;HDAC4;CUX1;TBL1XR1;GLI2;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MEOX2;MAFG;ELF4;PRRX2;NR3C2;TBX15;KLF4;FOXC2;LEF1;NFATC1;KLF2;TCF4;TCF7L2;THRB;HOXA5;ZNF23;CREB3L2;ARNT2;AR;BRD7;CREM;RARG;GLIS2;SOX13;CENPC;YAP1;BHLHE40;SIX1;IRF1;HLF;TEAD1;PRDM16;KDM5B;IRF2;FOXC1;CHD3;HIVEP1;GLIS1;HINFP;NR2C2;STAT3;KLF10;TBX1;VSX1;ZBTB18;IRF9;TFCP2;LHX6;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;HOXB9;CARM1;TGIF1;TFCP2L1;ESRRG;GATA2;NFYC;PRDM5;CEBPG;FOXQ1;ELK3;BACH2;ZIC3;AHR;RELA;MBNL2;GLI3;USF1;SOX17;ZW10;GATA6;RFX2;TAL1;CLOCK;ZNF568;HDAC5;HSF2;HOXC4;MEIS2;HOXB7;SOX7;HOXB5;BEND3;JUND;SREBF1;HHEX;CREB3;SOX18;HMGB2;CREB3L1;USF2;CENPB;SNAI1
prerank,sequence-specific DNA binding (GO:0043565),-0.2814957299143185,-1.2363311457205821,0.0,0.6557455251509863,1.0,129/590,18.06%,NFIB;FOXP2;PBX1;PKNOX2;ZNF423;MAF;SMAD3;FLI1;NFAT5;FOXP1;HDAC4;CUX1;GLI2;NFIX;CREB5;HOXB6;ELF2;FOXO1;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MEOX2;MAFG;ELF4;FOXD1;PRRX2;NR3C2;TBX15;KLF4;FOXC2;LEF1;NFATC1;KLF2;TAF1;TCF4;TCF7L2;THRB;HOXA5;ZNF23;ARNT2;CREM;RARG;GLIS2;SOX13;BHLHE40;SIX1;HLF;TEAD1;TET3;PRDM16;KDM5B;IRF2;FOXC1;BPTF;HIVEP1;GLIS1;NR2C2;KLF10;TBX1;VSX1;ZBTB18;IRF9;TFCP2;SMG6;FOXL1;UPF3A;LHX6;HIF1A;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;HOXB9;ZKSCAN3;TGIF1;TFCP2L1;ESRRG;GATA2;PRDM5;CEBPG;FOXQ1;ELK3;BACH2;MEF2A;ZIC3;AHR;PPARA;MBNL2;GLI3;USF1;ZGPAT;GATA6;RFX2;CLOCK;ZBTB4;HSF2;HOXC4;SLTM;MEIS2;HOXB7;SOX7;HOXB5;JUND;POU2F1;SREBF1;HHEX;CREB3;SOX18;CREB3L1;USF2;CENPB;SNAI1;SMG5;JUNB;MYRF;FBXL19;CSRNP3;SOX12;KLF15;CEBPB;NR6A1;MAFF
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5616592222156107,-1.2352159021770746,0.21296296296296297,0.652476773908128,1.0,3/10,10.84%,MECOM;PRDM16;EHMT1
prerank,ubiquitin-specific protease binding (GO:1990381),0.530848404585256,1.2329327363697418,0.2399193548387097,0.6714933469223436,1.0,3/19,6.39%,PTEN;DERL3;SART3
prerank,transcription coactivator binding (GO:0001223),-0.4713477486890421,-1.232225445947259,0.18110236220472442,0.6548071525023075,1.0,12/20,20.20%,SMAD3;VGLL4;ESR1;THRB;AR;PGR;AHR;RELA;RPL23;CDK9;CIT;TEAD2
prerank,ATP binding (GO:0005524),0.36140837366647316,1.2317584212114554,0.1267605633802817,0.6683597703213247,1.0,41/266,10.58%,MYO1B;KCNJ8;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;AGAP2;AKT3;RPS6KA4;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;STK38L;MINK1;CLP1;SYN2;RRM1;SYN1;SIK1;MCM6;LIG4;PAPOLA;HSPA14;MAP4K4;PEX1;STK3;NEK6;MARK2;GCK;MAP4K1;ABCF3;DARS2;BRSK1;DYRK3
prerank,active ion transmembrane transporter activity (GO:0022853),0.47359658121335746,1.2308848126427865,0.20614828209764918,0.664821495705619,1.0,6/37,5.23%,SLCO3A1;COX4I2;NDUFA4L2;SLCO5A1;UQCRFS1;SLC22A8
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.43869332278892686,-1.2266177746152322,0.22334004024144868,0.665291450224743,1.0,6/27,11.23%,SLC9A2;SLC41A1;SLC8A3;SLC9B2;SLC9A9;SLC3A2
prerank,titin binding (GO:0031432),-0.5183960424142955,-1.2261782125413283,0.22033898305084745,0.6601890444241512,1.0,4/13,15.58%,ACTN2;CALM2;TRIM63;CALM1
prerank,phosphatidylinositol binding (GO:0035091),0.40487063890051955,1.225573956959889,0.19902120717781402,0.6710020501371623,1.0,12/91,6.84%,PITPNC1;PIGU;SCARB1;ITPR2;NCF1;EPB41;ITPR1;MREG;PITPNM2;RPH3A;WDFY3;APPL1
prerank,phospholipase activity (GO:0004620),0.4264305548055736,1.2203967071618786,0.20066334991708126,0.6771514682409328,1.0,7/67,7.32%,PLCL1;PLCE1;PLD6;LIPC;LIPH;PLAAT1;ABHD3
prerank,CARD domain binding (GO:0050700),-0.5153033270957049,-1.2198094663707975,0.2283464566929134,0.6740368190746997,1.0,6/14,10.57%,NOD1;CASP4;CARD14;IRGM;CARD10;MAVS
prerank,thioesterase binding (GO:0031996),0.5845168547275845,1.2194099448860896,0.25481798715203424,0.673980334542772,1.0,8/11,26.40%,TRAF5;TRAF3;TRAF6;TRAF2;ARF6;TRAF1;CDC42;HAUS7
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.3895174058583094,-1.2189137728947745,0.1515837104072398,0.6707895466786513,1.0,8/49,4.07%,ANXA3;PLA2G4A;CPNE8;ESYT2;ANXA4;ANXA5;ANXA2;ANXA1
prerank,5'-nucleotidase activity (GO:0008253),-0.5177795323280118,-1.2178461148689783,0.2632612966601179,0.6676035435730944,1.0,9/13,38.22%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,kinesin binding (GO:0019894),0.5010435434142969,1.2177628546760324,0.25889328063241107,0.6717457431315689,1.0,6/27,8.53%,CLSTN1;TOR1B;AP1G1;AP1AR;SNCA;NEK6
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.5579645268225951,1.2173178251329746,0.26429980276134124,0.6673448876249004,1.0,3/12,7.18%,PIK3CD;PIK3CA;PIK3C2A
prerank,cadherin binding (GO:0045296),0.34681003721816545,1.2159046639380804,0.1258023106546855,0.6651991332516197,1.0,34/315,7.23%,NOTCH3;TRPC4;MYO1B;CALD1;COBLL1;CDH2;CDH4;CEMIP2;PHLDB2;VCL;MPRIP;ARHGAP1;TNKS1BP1;VASP;MYH9;EFHD2;CD46;CDC42EP1;SPTBN1;CTNNA3;EPS8L1;ITGB1;TMOD3;CDH8;ANK3;CHMP2B;DDX3X;PDLIM1;YWHAZ;CDH19;CDH20;CDH7;CDH22;WASF2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5588666048995503,1.2147173701673275,0.2692307692307692,0.6625342340943264,1.0,4/12,10.81%,PIK3R1;SH2B3;IRS1;BLNK
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.549632472808073,-1.2144246747795493,0.25665399239543724,0.6714686934148982,1.0,6/10,28.74%,IDE;PML;DNAJB2;ANKRD13D;ANKRD13A;LAPTM5
prerank,DNA binding (GO:0003677),-0.26919899120056145,-1.2136465373472751,0.010869565217391304,0.6674792726587526,1.0,179/694,22.27%,NFIB;TSHZ2;FOXP2;PBX1;ZNF423;SMAD3;FLI1;SMARCA2;ZBTB16;EGFR;MECOM;HDAC4;DENND4A;CUX1;GLI2;FOXO1;FOXO3;APP;ZIC2;ERG;NUPR1;RARB;MEOX2;FOXD1;DNMT3A;PLAGL1;FOXC2;LEF1;KLF2;TAF1;TCF4;TCF7L2;THRB;HOXA5;HDGFL3;DDX60;SSBP2;QRICH1;CREM;RARG;SOX13;CENPC;THRAP3;SIX1;PDS5B;IRF1;HLF;TEAD1;PRDM16;KDM5B;INO80;IRF2;ZNF292;SSBP1;FOXC1;CHD3;BPTF;STAT1;HINFP;NR2C2;PGR;STAT3;TBX1;ZNF219;ERCC5;POLR2A;RTF1;ZBTB18;RC3H2;TFCP2;AIFM1;FOXL1;DCLRE1C;REXO4;RAD51B;PCBP2;HIF1A;TRIM16;NHEJ1;KLF12;NR4A2;SAMHD1;ATF6;IKZF1;ZKSCAN3;ZC3H12A;BRCA2;NABP1;NFYC;PRDM5;CEBPG;PATZ1;DNASE1L1;MEF2A;LRRFIP1;XRCC4;ZIC3;AHR;PPARA;RELA;RPS27;USF1;TDG;CHD2;CALR;SPHK1;ZGPAT;EZH1;RFX2;CLOCK;ZBTB4;RPL7;RPA1;SLTM;MEIS2;RAD50;DDB1;APLP2;TAF4B;RPS15;CDK9;POU2F1;CEBPZ;SREBF1;HHEX;GTF3C2;HMGB2;SPO11;USF2;CENPB;GTF3C5;XRN1;TSHZ1;MEIS1;JUNB;MYRF;DEDD;NFYB;PSIP1;CSRNP3;SOX12;CEBPB;NR6A1;MAFF;HMGN1;PPARGC1A;NPAS2;SMARCAD1;PARK7;MCMDC2;RFC3;SIRT3;GTF3C1;POU2F2;NFATC2;E2F1;YAF2;POLRMT;CTCF;HP1BP3;THAP1;TOP3A;FOXD2;DEDD2;CHRAC1;NR5A2;DNMT1;SMC1A;RAD52;GLI1;ZMYND11;RAD51C;TOP2A;RFC1;SP7;NEIL3;ZNF513;NR4A3;HDGFL2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5873400982234237,1.2132294106383756,0.2748414376321353,0.6604225579314406,1.0,3/10,10.01%,NCF2;NCF1;NOX3
prerank,lipase activity (GO:0016298),0.4569504512752234,1.21284032581692,0.23063063063063063,0.6560238995332472,1.0,5/43,7.32%,CEL;PLA1A;LIPC;LIPH;ABHD3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.30052731357460016,-1.2115228270350304,0.057971014492753624,0.6676019976175245,1.0,49/188,18.30%,BNC2;PBX1;SMAD3;FLI1;SMARCA2;SMAD6;HDAC4;TBL1XR1;FOXO3;KLF4;FOXC2;TCF7L2;CREB3L2;AR;BRD7;GLIS2;SOX13;YAP1;SIX1;IRF1;PRDM16;FOXC1;CHD3;HINFP;STAT3;VSX1;FOXK1;ATF6;CARM1;NFYC;PRDM5;AHR;RELA;SOX17;GATA6;TAL1;ZNF568;HDAC5;SOX7;JUND;HHEX;SOX18;HMGB2;CREB3L1;NFYB;SOX12;KLF15;CEBPB;BASP1
prerank,protein kinase C activity (GO:0004697),-0.4915851713890741,-1.2114844972323497,0.2300380228136882,0.6616570626758157,1.0,6/14,10.88%,PRKCH;PRKCE;PRKCZ;PRKCB;PRKCD;PRKCG
prerank,metalloaminopeptidase activity (GO:0070006),0.5405194630738078,1.2113530632432465,0.2781065088757396,0.6539732245265835,1.0,3/16,3.11%,ENPEP;ANPEP;MMP15
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.40709915385368123,-1.2105564095179555,0.2145922746781116,0.6523840867914988,1.0,16/34,25.84%,NDUFV3;NDUFS4;NDUFB8;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFA10;NDUFB4;NDUFB7;NDUFS1;NDUFS7;NDUFS8;NDUFB10;NDUFA3
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.40709915385368123,-1.2105564095179555,0.2145922746781116,0.6523840867914988,1.0,16/34,25.84%,NDUFV3;NDUFS4;NDUFB8;NDUFC1;NDUFS5;NDUFA4;NDUFB5;NDUFA13;NDUFA10;NDUFB4;NDUFB7;NDUFS1;NDUFS7;NDUFS8;NDUFB10;NDUFA3
prerank,serine-type endopeptidase activity (GO:0004252),0.41327343506860637,1.2104279051528395,0.2229299363057325,0.6508082832724972,1.0,4/80,3.01%,TMPRSS4;FAP;RHBDD3;RHBDF1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33777756912114054,1.2082381522511825,0.12186379928315412,0.6505416216662366,1.0,59/431,10.58%,MYO1B;RASL12;REM1;KCNJ8;RERG;MAP3K20;CDK6;ATP1A2;MAP3K5;SNRK;PEAK1;MARK1;MYH9;NUAK2;RND3;AGAP2;AKT3;RRAD;RPS6KA4;NOA1;HSPA4L;ABCD2;CDC42BPA;ATP7A;UBA2;RAC3;STK38L;MINK1;CLP1;RIT2;TUBA8;SYN2;ARL4C;RRM1;SYN1;SIK1;MCM6;RAP1A;LIG4;HRAS;PAPOLA;TUBB2B;HSPA14;RAB28;MAP4K4;PEX1;STK3;NEK6;RAB38;MARK2;GCK;RNF112;MAP4K1;ABCF3;TUBG2;DARS2;ARL5C;BRSK1;DYRK3
prerank,transmitter-gated ion channel activity (GO:0022824),0.47970541889236185,1.2071069596452524,0.25430210325047803,0.6478991192899932,1.0,11/29,16.33%,GRIK1;GABRG2;GRID1;GRIA2;GABRA2;GABRA5;GABRA4;GRIK5;GRIK2;GABRB3;GRIA4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.42073705599972555,1.202498103162995,0.2332155477031802,0.6525905150395688,1.0,4/72,2.28%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.3844489765091545,-1.2018389453248506,0.19831223628691982,0.6716789037658741,1.0,10/42,7.21%,PDLIM5;BAIAP2L1;STXBP6;BSG;ANXA2;BAIAP2;ANXA1;PALLD;CNN3;CD47
prerank,actin binding (GO:0003779),0.36738740347096854,1.1992689618960717,0.2034383954154728,0.6546110037058622,1.0,26/170,6.57%,EPS8;CALD1;CAP2;UTRN;DMD;SYNE1;PTK2;VCL;MYH9;FERMT2;SPEF1;SSH2;CORO7;NCALD;TMOD1;ADCY8;CORO2B;FMN2;EPS8L1;ACTN4;ITGB1;SPTB;RUSC1;SNCA;PDLIM1;SMTN
prerank,GDP binding (GO:0019003),0.4257628433287817,1.1986002079907916,0.24561403508771928,0.6513110055643107,1.0,8/63,7.86%,RASL12;RERG;RAB8B;RIT2;RAB3B;RAP1A;HRAS;RAB28
prerank,GABA-A receptor activity (GO:0004890),0.5035761936601696,1.198301023821529,0.2540650406504065,0.647202983857262,1.0,5/18,15.56%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3
prerank,symporter activity (GO:0015293),-0.5386827983910063,-1.197928676361212,0.2641165755919854,0.6769852778528769,1.0,3/10,12.93%,SLC5A6;SLC5A5;MFSD2A
prerank,syntaxin binding (GO:0019905),-0.3509630037567339,-1.1952667216134927,0.19672131147540983,0.6784716515583975,1.0,19/61,21.35%,DAPK1;UNC13B;ABCA1;RAB11A;LRRK2;STX7;SNAP23;STXBP4;STX6;SCFD2;SNAP47;NAPA;BLOC1S6;UNC13C;SYT9;VPS52;TMED9;PTPN2;VAMP8
prerank,protein tyrosine phosphatase activity (GO:0004725),0.40938971203375946,1.1935238784133408,0.210016155088853,0.6523827871874868,1.0,6/71,2.76%,PTPRK;PTEN;PALD1;PTPN9;TNS2;PTPN22
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4406999520077016,1.1926590104567902,0.2535211267605634,0.6494612799098612,1.0,2/47,1.79%,SLC38A11;SLC1A5
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.34718372028704275,-1.1922640585467417,0.1717171717171717,0.6811461425872706,1.0,11/70,11.17%,GXYLT2;EXT1;LARGE1;B4GALT1;CSGALNACT1;CHSY1;HEXA;HEXB;B3GALNT1;POGLUT1;POGLUT2
prerank,NADP binding (GO:0050661),-0.40225371956970263,-1.1903550552807265,0.21263157894736842,0.6806138229750194,1.0,13/32,27.41%,GMDS;LBR;NOS3;DPYD;ME1;NNT;PGD;NOS1;NOX1;DECR1;ME3;GRHPR;MTRR
prerank,MAP kinase phosphatase activity (GO:0033549),-0.5101819024100119,-1.189817278873554,0.2446183953033268,0.6765021039077572,1.0,6/12,29.59%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,aminopeptidase activity (GO:0004177),0.4979451337013789,1.1851309631152913,0.2781065088757396,0.6607808482683298,1.0,4/26,3.11%,ENPEP;METAP2;ANPEP;MMP15
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5191194815541256,1.1850569176471295,0.2982107355864811,0.6562519542486931,1.0,4/22,3.66%,RBMS3;CPEB1;RBM24;ELAVL4
prerank,calcium ion binding (GO:0005509),0.33843625169393154,1.184998293473774,0.15945611866501855,0.651672176594627,1.0,58/323,11.39%,ASPN;CASQ2;ADGRL3;CDH2;CDH4;RAPGEF2;AIF1L;DYSF;RASGRP2;CEMIP2;SLIT1;SLIT3;ITPR2;RASGRP3;CIB3;EFHD2;NRXN1;PVALB;STIM2;ITPR1;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;RPH3A;SLC25A13;CDH8;SNCA;ATP2A2;RYR2;PADI2;CDH19;CDH20;CDH7;CDH22;AOAH;STIM1;SYT1;PKD2;RYR3;LETM1;BNIP2;HPCA;CDH10;PLA2G4E;CDH18;PGS1;KCNIP1;SYT2;SPOCK1;BAIAP3;ASAH2;BRAF;MICU3;CASQ1;CHP2
prerank,BMP binding (GO:0036122),-0.5246516444736238,-1.184944573339034,0.26171875,0.6845999785614838,1.0,3/11,6.37%,BMPR2;GREM2;NBL1
prerank,myosin binding (GO:0017022),0.41836120989739306,1.1826224487713386,0.24914089347079038,0.6519513052091219,1.0,12/55,12.88%,CALD1;DMD;RAB39B;RAB3B;ARFGEF1;KIRREL1;NKD2;CORO1A;TRAK1;STXBP5L;TRAK2;NPHS1
prerank,peptide hormone receptor binding (GO:0051428),0.5548971814211701,1.18232903497088,0.3004484304932735,0.6479330619476829,1.0,2/11,7.77%,UCN2;CCK
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5211125512982039,-1.181879188757492,0.25646123260437376,0.6877033819155997,1.0,3/11,10.31%,KCNK2;KCNQ1;KCNT1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5205407125498571,-1.179562788768418,0.26908396946564883,0.6886540810342695,1.0,3/11,12.06%,SASH1;DAB2IP;PPEF2
prerank,histone deacetylase activity (GO:0004407),-0.45397495502861285,-1.178490096694866,0.2573099415204678,0.6858945057167735,1.0,8/19,18.81%,HDAC4;HDAC8;HDAC9;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3
prerank,ligand-gated cation channel activity (GO:0099094),0.4103017212693813,1.174630378022974,0.2630718954248366,0.6590823903431974,1.0,18/75,16.50%,KCNJ8;KCNJ12;CHRNA3;GRIK1;ASIC2;GRIA2;CHRNA7;KCNJ3;GRIN2B;KCNJ6;ASIC3;GRIK5;GRIK2;P2RX5;CHRNB2;GRIN2A;GRIA4;GRIA1
prerank,chloride channel regulator activity (GO:0017081),-0.49102967461987296,-1.1744167811159085,0.29191321499013806,0.6918673310286081,1.0,4/14,10.31%,WNK4;STX7;WNK1;STX1A
prerank,manganese ion binding (GO:0030145),-0.368578981140868,-1.172484009989337,0.22650602409638554,0.691939527327822,1.0,21/48,30.25%,LARGE1;B4GALT1;XPNPEP1;MPPED2;ME1;PPM1M;MGAT1;MTPAP;MGAT2;ADCY2;FAM20C;NUDT16;MPPE1;HMGCL;XXYLT1;SOD2;ATP13A2;ABL1;ENDOU;WRN;POMGNT1
prerank,fibroblast growth factor binding (GO:0017134),-0.44405335312288124,-1.1720216650446476,0.2661122661122661,0.6878834025610145,1.0,7/21,16.01%,FGFR2;THBS1;KL;RPS19;ITGB3;FGFR4;GLG1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.5311303668745597,-1.1712680459991123,0.275,0.6792512805169637,1.0,6/10,29.59%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.5311303668745597,-1.1712680459991123,0.275,0.6792512805169637,1.0,6/10,29.59%,DUSP1;DUSP16;DUSP7;DUSP10;DUSP8;DUSP4
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4172692753103498,1.167468080614975,0.27427597955706984,0.6689979712472603,1.0,6/60,4.18%,PTEN;CTDSPL;PHLPP1;PPM1E;PPP3CA;LRRC40
prerank,histone acetyltransferase activity (GO:0004402),-0.407638355775314,-1.1626691408466272,0.26143790849673204,0.6979548615804803,1.0,15/30,26.77%,KAT6B;KAT2B;TAF1;KAT14;ARRB1;BAZ1A;TADA2A;BRCA2;CLOCK;NAA40;MCM3AP;USP22;HAT1;EPC1;ATF2
prerank,cation:chloride symporter activity (GO:0015377),0.5566199876772394,1.1625326936573397,0.31140350877192985,0.674977958751796,1.0,4/10,12.37%,SLC12A2;SLC12A6;SLC12A5;SLC12A4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3759644348814879,-1.1618830664603201,0.22466960352422907,0.6949226968673499,1.0,12/38,20.47%,PLA2G4A;SESTD1;WIPI2;ZFYVE19;PARD3;DAB2IP;SNX21;PLEKHA4;ATG2A;ZFYVE1;SNX3;BBS5
prerank,Wnt-activated receptor activity (GO:0042813),0.5229602823888401,1.1609463391783545,0.3202479338842975,0.6733937118009523,1.0,4/15,5.17%,ROR1;FZD6;RYK;TSPAN12
prerank,double-stranded DNA binding (GO:0003690),-0.2613435374206291,-1.1590573524857888,0.029197080291970802,0.6975382422281924,1.0,95/531,15.14%,NFIB;PBX1;PKNOX2;MAF;FLI1;EGFR;NFAT5;FOXP1;CUX1;GLI2;NFIX;CREB5;HOXB6;ELF2;OSR1;KLF3;FOXO3;NR3C1;ERG;RARB;ESR1;ZIC5;ELF1;MEOX2;MAFG;ELF4;PRRX2;NR3C2;TBX15;KLF4;FOXC2;LEF1;NFATC1;KLF2;TCF4;THRB;HOXA5;ZNF23;HDGFL3;DDX60;ARNT2;CREM;RARG;GLIS2;BHLHE40;SIX1;HLF;TEAD1;KDM5B;IRF2;HIVEP1;GLIS1;STAT1;NR2C2;KLF10;TBX1;ERCC5;VSX1;ZBTB18;IRF9;TFCP2;REXO4;LHX6;RAD51B;KLF12;NR4A2;FOXK1;BHLHE41;ATF6;HOXB9;TGIF1;TFCP2L1;ESRRG;GATA2;CEBPG;FOXQ1;ELK3;BACH2;ZIC3;AHR;MBNL2;GLI3;USF1;TDG;GATA6;RFX2;CLOCK;HSF2;HOXC4;MEIS2;RAD50;HOXB7;SOX7;HOXB5;JUND
prerank,disordered domain specific binding (GO:0097718),-0.4300225169127835,-1.1574254044471688,0.2644787644787645,0.6966088348642597,1.0,9/23,21.18%,FN1;CALM2;MDM2;HSP90AB1;CALM1;PPIL1;TEAD2;NUMA1;DFFB
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.5018949148394325,-1.1531749409413483,0.29678638941398866,0.7030404786429438,1.0,5/12,8.86%,IGF1;SOCS2;IGF2;ARRB1;GNAS
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3868123526162125,1.1528954285720718,0.2746710526315789,0.6857793658929899,1.0,4/91,2.28%,MYO1B;ADAP2;MARK1;LDLRAP1
prerank,hexosyltransferase activity (GO:0016758),-0.31322604582867425,-1.152726311268442,0.20738636363636365,0.6989315646626335,1.0,11/101,6.85%,TMTC1;EXT1;LARGE1;B4GALT1;TMTC4;CSGALNACT1;TMTC2;A4GALT;CHSY1;HEXA;HEXB
prerank,pyrophosphatase activity (GO:0016462),-0.3634370519283945,-1.1524409954583046,0.21678321678321677,0.6946095401039387,1.0,26/50,32.91%,ENTPD1;ENPP1;ENPP3;NUDT4;ALPL;NUDT3;PLPP1;ENTPD5;LHPP;ENTPD2;DOLPP1;NUDT6;CILP;PLPP4;NUDT16;PPA1;NUDT1;CILP2;BNIPL;TRPM2;DXO;ENTPD3;NUDT5;FITM2;NUDT10;NUDT9
prerank,receptor ligand activity (GO:0048018),-0.2793049173028405,-1.1513391824025425,0.14181818181818182,0.692663094682167,1.0,29/245,7.82%,BMP6;IGF1;WNT4;EPHA7;SEMA3D;BMP7;SEMA6A;TGFA;SEMA3C;IL15;WNT6;DPP4;BMP4;SEMA7A;CSF1;WNT9A;VEGFD;TNFRSF11B;VEGFC;GAS6;IGF2;IL16;FGF1;GREM2;CCL15;NBL1;WNT5A;OSGIN2;SEMA3E
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.48275689330286364,-1.1505572467191885,0.2970873786407767,0.6899263422772702,1.0,4/14,5.88%,TIMP3;RECK;TIMP2;SPOCK2
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.502182674949424,-1.150530827631855,0.3042671614100185,0.6849900854287466,1.0,6/11,32.90%,NUDT4;NUDT3;NUDT16;NUDT1;NUDT5;NUDT10
prerank,ATPase binding (GO:0051117),-0.3348712909034033,-1.1504005953068428,0.22163588390501318,0.6804223066656266,1.0,19/71,12.09%,ABCA1;EGFR;ATP1B3;TMTC4;SNTA1;PTPN3;CAV1;SLC2A13;ESR1;EZR;ATP6V0A4;AR;PGR;ATP6V1G1;TOR1AIP1;NOP58;CHMP4A;ATP6V0A1;TCIRG1
prerank,sterol binding (GO:0032934),-0.3455654650033769,-1.149628996624916,0.23623853211009174,0.6778780382187725,1.0,20/56,18.63%,ABCA1;OSBPL8;CAV1;APOD;OSBPL10;GRAMD1C;GRAMD1A;PROM1;SIDT1;NPC2;OSBPL9;OSBPL1A;INSIG2;STARD3;PTCH1;STARD4;OSBP2;STARD5;ERLIN2;CD81
prerank,transcription cis-regulatory region binding (GO:0000976),-0.2635019736172735,-1.1488848025940317,0.0855614973262032,0.6748672794750166,1.0,92/406,18.66%,BNC2;PBX1;FOXN3;AEBP1;SMAD3;FLI1;SMARCA2;SMAD6;FOXP1;HDAC4;CUX1;TBL1XR1;OSR1;FOXO3;NR3C1;MLXIP;KLF4;PLAGL1;TFDP2;FOXC2;LEF1;TCF7L2;ETV6;MXI1;CREB3L2;AR;BRD7;CREM;HIF3A;GLIS2;SOX13;YAP1;SIX1;IRF1;TEAD1;PRDM16;IRF2;FOXC1;CHD3;HINFP;NR2C2;STAT3;KLF10;ZBTB8A;VSX1;TFCP2;RREB1;LHX6;HIF1A;TWIST2;FOXK1;ATF6;FOSL2;CARM1;NFYC;PRDM5;ELK3;MEF2A;AHR;RELA;HDAC1;GLI3;SOX17;GATA6;TAL1;ZNF568;ZBTB4;HDAC5;HSF2;ENO1;SOX7;JUND;SREBF1;HHEX;CREB3;SOX18;HMGB2;CREB3L1;ZNF436;MNT;SNAI1;ZFP69;ATF1;NFYB;NFIL3;SOX12;KLF15;CEBPB;BASP1;NFXL1;PARK7;ZSCAN2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.4629593336439071,-1.1470075284057484,0.28932038834951457,0.6749172065519385,1.0,1/15,1.13%,PLA2G4A
prerank,MAP kinase kinase activity (GO:0004708),-0.4628134123928437,-1.146654575701201,0.2900763358778626,0.6712149726337477,1.0,5/15,14.75%,LRRK2;MAP2K6;MAPK14;MAP2K5;MAPKAPK3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.38288625119906994,1.146183612093764,0.26232114467408585,0.6953392994386202,1.0,11/85,10.50%,NDST3;CEL;PON2;LIPC;AOAH;PLAAT1;ABHD3;MRPL58;ACHE;GDPD1;PLA2G4E
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5376401456871646,1.1433036401549854,0.32421052631578945,0.6967701584661181,1.0,3/11,14.99%,CHRNA3;CHRNA7;CHRNB2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5127897538598087,1.1395581259647167,0.3305613305613306,0.6999526409183625,1.0,3/17,5.06%,PITPNC1;PITPNM2;ATP8B2
prerank,cysteine-type peptidase activity (GO:0008234),-0.3314536556323475,-1.13838623867307,0.20833333333333334,0.6884243021215519,1.0,18/73,12.30%,CTSH;USP47;CAPN2;CTSC;USP46;CASP4;USP12;USP8;USP15;USP18;CTSB;USP34;CASP8;USP5;USP11;USP35;CTSS;USP49
prerank,phospholipid transfer activity (GO:0120014),0.4878826378781439,1.1365042528512614,0.3413173652694611,0.7016358522104158,1.0,3/21,6.76%,PITPNC1;PITPNM2;PRELID3A
prerank,WW domain binding (GO:0050699),0.46737080198248404,1.136104134130844,0.2940038684719536,0.6977302466687954,1.0,2/26,3.14%,RAPGEF2;NDFIP2
prerank,tubulin binding (GO:0015631),0.3284966767402626,1.1357564569336747,0.22179487179487178,0.6939497668545778,1.0,41/295,11.62%,DLEC1;SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;NCALD;SVBP;FGF13;IFT81;NAV3;CLASP2;MAPRE2;GAS8;ARL4C;DDX3X;TPPP;SNCA;KIF26B;APPL1;MAP4K4;HOOK3;FAM161A;TTLL11;CLIP2;TTLL12;KIF3A;NUSAP1;MACO1;BRSK1;UXT;TPGS1;ARHGEF7;TOGARAM2;PAK1;KIF5C;KIF20A;CCDC66;KIF3C
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3920853729159525,-1.135669879067131,0.2605042016806723,0.6907358308550643,1.0,17/32,35.59%,KDM7A;TET3;EGLN2;TMLHE;EGLN3;FTO;TYW5;PHYHD1;ALKBH5;TET2;EGLN1;JMJD7;TET1;HIF1AN;RIOX1;PHYH;KDM4A
prerank,transcription coregulator binding (GO:0001221),-0.35535890641438,-1.134522968122251,0.2553699284009546,0.6888706296936326,1.0,19/50,20.36%,SMAD3;ZBTB16;LCOR;VGLL4;ESR1;THRB;AR;LMO2;PGR;USP11;EHMT1;AHR;RELA;RPL23;CDK9;CIT;EZH2;TEAD2;CTCF
prerank,guanyl ribonucleotide binding (GO:0032561),0.3392020735736377,1.1341281529652063,0.24507042253521127,0.6929593992352054,1.0,22/196,9.08%,RASL12;REM1;RERG;RAPGEF2;PDE5A;RND3;AGAP2;RRAD;RAB8B;NOA1;SLC19A1;RAC3;RIT2;TUBA8;ARL4C;RAB3B;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5204619079681712,-1.133270209907752,0.33458646616541354,0.6874987584806295,1.0,1/10,0.95%,KDM7A
prerank,general transcription initiation factor binding (GO:0140296),-0.40730821025405595,-1.127809917274548,0.2935222672064777,0.6976103784842272,1.0,11/25,26.11%,ESR1;TAF1;AR;AHR;RELA;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4295955860140815,-1.1273449394086625,0.3157894736842105,0.6941604795741252,1.0,4/20,8.00%,TJP2;DLG1;MAGI3;CMPK1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.48666297777094203,1.1272009050010778,0.3192307692307692,0.7032746177810254,1.0,7/20,13.13%,USP25;SENP5;OTUD5;DESI2;SENP1;OTUB1;USP50
prerank,NAD+ binding (GO:0070403),-0.49410683781558506,-1.1251680494827183,0.31645569620253167,0.6952911348264694,1.0,4/12,18.81%,CRYL1;PARP9;SIRT2;SIRT3
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.39384762066727036,-1.1247557752536197,0.3037974683544304,0.691608499029174,1.0,16/29,34.52%,ACER2;ACER3;CTBS;PGGHG;ADPRS;GANAB;GAA;NEU3;HEXD;MOGS;ENGASE;GLA;HPSE;HYAL3;LCT;GALC
prerank,calcium-release channel activity (GO:0015278),0.4884792713029052,1.1237415297260993,0.3493975903614458,0.7062089015276141,1.0,6/17,11.81%,ITPR2;ITPR1;RYR2;PKD2;RYR3;RASA3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4530669253503127,1.121173458612477,0.34833659491193736,0.7074562137469552,1.0,11/26,22.36%,PABIR1;PTN;PPP1R14A;PPP1R11;SET;MGAT5;CABIN1;SAG;LMTK2;BOD1L1;STYXL1
prerank,protein kinase activator activity (GO:0030295),0.39520121969184985,1.1209906608018338,0.31239092495637,0.7033491068488595,1.0,16/60,12.41%,GPRC5C;AFAP1L2;RGCC;AGAP2;NRG1;GRM5;FGF13;SPDYA;SPRY2;DDX3X;CDKN1A;STK3;MARK2;ETAA1;FAM20A;CAB39L
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3403410688961473,1.1182096960589565,0.28751753155680226,0.7047061215472333,1.0,17/173,5.31%,TBX2;HEY2;HEYL;ZEB1;PRDM1;TRPS1;ZBTB34;TBX3;ZFHX3;NR2F1;ZEB2;HESX1;NKX6-3;SCRT2;PPARD;ZBTB45;SREBF2
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.464499664841473,-1.1176869963100795,0.3253968253968254,0.7061497342741071,1.0,2/14,2.89%,SLC26A7;SLC26A2
prerank,proton transmembrane transporter activity (GO:0015078),0.4211084240603582,1.116089905857425,0.3242258652094718,0.704397538775013,1.0,6/39,12.28%,COX4I2;NDUFA4L2;UQCRFS1;ATP6V1B2;COX4I1;COX5A
prerank,transition metal ion binding (GO:0046914),-0.2594713670642621,-1.1132434698820413,0.15544041450777202,0.713220746184285,1.0,105/397,20.47%,SMAD3;LARGE1;KDM7A;B4GALT1;HDAC4;GLI2;MOXD1;AOX1;PAM;AGMO;PAPPA;EEA1;XPNPEP1;ENPP1;MYRIP;SHANK3;MPPED2;NPEPPS;NOS3;SEC23A;SEC24D;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;TNFSF10;ATOX1;LACC1;ACE;ENPP3;TET3;TES;KDM5B;SORD;ACER3;CHD3;SEC24A;RNPEP;ME1;ERAP1;PPM1M;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;MGAT1;DPP3;ZMYND8;SAMHD1;IDE;FTL;MTPAP;KDM3A;DNAJC24;MGAT2;GCH1;ADAMTS3;NSD1;RNF125;NUDT12;MDM2;RPS27;PLA2G15;CALR;ADH1A;ADAM33;MSRB3;GDA;ISCA2;TYW5;SMPDL3A;NOS1;PLSCR3;TIMM13;FBXL19;TRIM8;SIRT2;FTH1;ZCCHC4;PARK7;TIMM8B;SIRT3;MT3;PIAS4;ZFYVE1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CALB1;ZDHHC15;GLO1;TIMM9;ADCY2;CTCF;ENPP2;FNTB;THAP1
prerank,omega peptidase activity (GO:0008242),0.36872171610666205,1.112591152035032,0.3056426332288401,0.7073875734720304,1.0,10/89,6.70%,GGT5;GGT1;USP25;JOSD2;GGH;USP40;OTUD5;UCHL1;PAN2;DESI2
prerank,potassium ion antiporter activity (GO:0022821),-0.4634991688024319,-1.1123941438458997,0.34600760456273766,0.7107429891611572,1.0,3/15,7.08%,SLC24A3;SLC9A2;SLC9A9
prerank,MAP kinase kinase kinase activity (GO:0004709),0.541236284055871,1.1120333367934998,0.350561797752809,0.7041900727312376,1.0,2/11,1.26%,MAP3K20;MAP3K5
prerank,cation transmembrane transporter activity (GO:0008324),-0.35437812716701983,-1.1119299338416677,0.3049645390070922,0.7073354024499353,1.0,27/48,33.79%,SLC6A6;SLC41A1;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC39A1;SLC7A1;SLC66A1;SLC22A2;SLC36A1;SLC1A1;SLC38A1;MFSD12;PKD1L3;SLC6A7;SLC7A3;SLC36A2;SLC22A3;SFXN3;OCA2;MMGT1;SLC38A9
prerank,endopeptidase regulator activity (GO:0061135),-0.36656122461458135,-1.1116682914412293,0.28043478260869564,0.7034430431531986,1.0,6/40,11.28%,RECK;CAST;ITIH2;SERPIND1;CST3;PSME2
prerank,endopeptidase activity (GO:0004175),-0.2705413895110603,-1.111076379870616,0.1888412017167382,0.7004963785446495,1.0,52/257,14.62%,ADAMTS10;TRABD2B;ADAMTSL3;ADAMTS12;ADAMTS6;THSD4;ADAMTS2;CTSH;PCSK5;ADAMTS9;F3;HTRA3;ADAMTS5;DPP4;USP47;ADAM9;CTSC;USP46;ADAM10;ACE;ADAMTS1;CASP4;USP12;ADAMTS15;USP8;ADAMTSL1;KLK2;ADAMTSL4;USP15;PIK3IP1;USP18;CTSB;MMP14;IDE;USP34;CASP8;MMP19;USP5;USP11;USP35;RHBDF2;ADAMTS14;ADAMTS3;CTSS;USP49;PSMB4;PREP;SPG7;ADAM33;PSMB1;RHBDL3;SFRP1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4153881097590536,-1.110387240258939,0.3245967741935484,0.6977077139617516,1.0,5/20,20.37%,AGPAT4;LPGAT1;PLA2G15;AGPAT2;DGAT2
prerank,ionotropic glutamate receptor activity (GO:0004970),0.49377077545416354,1.1101785114977245,0.3776908023483366,0.7036515699270983,1.0,8/17,16.50%,GRIK1;GRIA2;GRIN2B;GRIK5;GRIK2;GRIN2A;GRIA4;GRIA1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.46853370015413964,1.1098607059943073,0.3403361344537815,0.7000930222377867,1.0,4/22,6.32%,ATP2A3;ATP2C1;ATP6V0E2;ATP2A2
prerank,neurexin family protein binding (GO:0042043),0.5374254382572132,1.1097612940624113,0.36323851203501095,0.6960826694099107,1.0,1/10,0.55%,CEL
prerank,metal ion binding (GO:0046872),0.3067485454030591,1.1078003696181433,0.2468427095292767,0.6959397284052102,1.0,77/477,11.39%,ASPN;CASQ2;MAP3K20;ADGRL3;CDH2;CDH4;RAPGEF2;AIF1L;DYSF;MAP3K5;RASGRP2;SNRK;CEMIP2;SLIT1;SLIT3;MARK1;ITPR2;RASGRP3;NUAK2;CIB3;EFHD2;NRXN1;PVALB;STIM2;CDC42BPA;ITPR1;UBA2;STK38L;AGRN;PPP3CA;DNER;PITPNM2;ASTN2;SPARCL1;RPH3A;SLC25A13;CDH8;TPPP;SNCA;ATP2A2;RYR2;PADI2;SIK1;CDH19;CDH20;CDH7;CDH22;AOAH;PAPOLA;STIM1;MTHFD2;STK3;SYT1;NEK6;PKD2;RYR3;MARK2;LETM1;BNIP2;HPCA;CDH10;PLA2G4E;CDH18;BRSK1;DYRK3;ABL2;PGS1;KCNIP1;SYT2;SPOCK1;BAIAP3;ASAH2;RPE;BRAF;MICU3;CASQ1;CHP2
prerank,pre-mRNA binding (GO:0036002),-0.3869952939004454,-1.1039975894334964,0.3237704918032787,0.7099235581420745,1.0,2/28,3.78%,CELF2;DDX5
prerank,nucleotidase activity (GO:0008252),-0.4522942416107978,-1.1033337843044926,0.34563106796116505,0.7070379904387428,1.0,9/15,38.22%,NT5E;NT5DC3;NT5C1A;NT5C2;NT5C;ACP3;NT5C3B;NT5DC2;NT5C3A
prerank,DNA polymerase binding (GO:0070182),-0.4212304358839369,-1.1028640931619231,0.3546511627906977,0.7037222423624254,1.0,8/18,23.46%,SMG6;FANCI;CDK2AP1;HSP90AB1;NAT10;ACD;SMARCA4;RAD51
prerank,protein kinase regulator activity (GO:0019887),0.3647288236062769,1.102511547725427,0.3125,0.7028234268558589,1.0,20/95,10.49%,GPRC5C;RGCC;SPRY4;PRKAR1B;AGAP2;FGF13;SPDYA;HEXIM1;CXCL10;PRKAR2B;SNCA;TAOK3;CDKN1A;PRKAR2A;CCNC;MARK2;ANKRD54;PRKAR1A;CCNYL1;PRKRIP1
prerank,metal ion:proton antiporter activity (GO:0051139),-0.46554981963991326,-1.101651774886853,0.3592592592592593,0.7024055175344819,1.0,3/13,7.08%,SLC9A2;SLC9B2;SLC9A9
prerank,anion transmembrane transporter activity (GO:0008509),-0.4783640105316485,-1.1007199711361404,0.35390199637023595,0.7001970326312255,1.0,4/12,10.17%,SLCO2B1;ABCG2;SLC22A6;SLC39A8
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.47442098355220996,-1.0985629025768495,0.3614678899082569,0.7013224630770203,1.0,3/12,7.08%,SLC9A2;SLC9B2;SLC9A9
prerank,sulfotransferase activity (GO:0008146),-0.3733246359136074,-1.097615498704313,0.34080717488789236,0.6991987687683547,1.0,11/33,19.65%,UST;CHST11;HS3ST3A1;HS6ST1;SULT1A1;CHST15;HS3ST1;CHST8;GAL3ST2;TPST1;TPST2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4897024753940974,1.0955879234444987,0.3565217391304348,0.7130212968795815,1.0,3/15,8.04%,CCRL2;ACKR2;CCR9
prerank,endopeptidase inhibitor activity (GO:0004866),0.374465632795471,1.093419156807234,0.32524271844660196,0.7133485301842676,1.0,13/82,11.58%,SERPINB8;SERPINI1;COL4A3;ROCK1;WFDC3;SERPINA10;PSMF1;BIN1;BIRC6;SERPINA2;SPOCK3;SPOCK1;PTTG1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.44201548892976084,-1.0923423062770483,0.3575525812619503,0.7081109221842135,1.0,2/15,5.81%,PLA2G4A;SESTD1
prerank,kinase activity (GO:0016301),0.35294471639663216,1.0919479848026006,0.33183183183183185,0.7121698686540082,1.0,19/109,10.51%,DGKB;PIK3CD;DGKH;DGKG;PIK3CA;STK39;ITPKB;NEK1;PIK3C2A;MAP4K4;MTOR;GK;LYN;SEPHS2;PRKD3;NMRK1;COQ8A;COASY;DGKD
prerank,myosin II binding (GO:0045159),-0.48296684410750557,-1.0893364932910579,0.36151079136690645,0.711535588614936,1.0,4/10,14.83%,GSN;SHROOM4;TRIOBP;LLGL2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.4923987207130104,1.086579541810668,0.3702127659574468,0.7189878684240532,1.0,5/13,17.02%,GABRG2;GABRA2;GABRA5;GABRA4;GLRB
prerank,chemorepellent activity (GO:0045499),-0.3883588795095636,-1.0863745541518839,0.3463917525773196,0.7144222013858096,1.0,6/25,3.51%,EPHA7;SEMA3D;SEMA6A;SEMA3C;DPP4;SEMA7A
prerank,nuclear receptor coactivator activity (GO:0030374),0.4019555512416682,1.0847268401116625,0.34111310592459604,0.7187450816191853,1.0,16/52,9.52%,PKN1;NCOA7;ETS1;NCOA3;FGF2;PPARGC1B;TACC1;MED13;ACTN4;ELK1;RBM14;NCOA6;SS18;CCAR2;MED1;CNOT9
prerank,ferrous iron binding (GO:0008198),-0.4030675477627066,-1.0843466657728489,0.3465346534653465,0.7151667872152917,1.0,13/21,35.51%,EGLN2;EGLN3;FTL;DNAJC24;FTO;FTH1;TET2;EGLN1;CDO1;HIF1AN;ACP5;PHYH;HAAO
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4413414011834639,-1.0837444760648542,0.3861003861003861,0.7124333725076544,1.0,3/15,10.17%,SLC26A7;SLC26A2;SLC39A8
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.4649065740272347,-1.0837244872213663,0.39626168224299063,0.7082920328649561,1.0,2/12,2.93%,AOX1;XDH
prerank,hyaluronic acid binding (GO:0005540),-0.4828537698877091,-1.0830268029168373,0.3562386980108499,0.7058089807555239,1.0,4/10,25.11%,CEMIP;LAYN;LYVE1;CD44
prerank,rRNA binding (GO:0019843),-0.3506413567413307,-1.080494404911937,0.34309623430962344,0.707710336596856,1.0,18/42,25.69%,RPS14;CAVIN1;RPS13;RPS9;RPL12;RPL11;RPS5;MDM2;MRPS7;MRPS6;MRPS18A;RPL23;RPLP0;RCC1L;UTP23;FASTKD5;RRS1;RPS3
prerank,kinase activator activity (GO:0019209),0.42470869937578143,1.080354531439196,0.3704414587332054,0.7237677132203029,1.0,5/30,4.40%,GPRC5C;RGCC;AGAP2;FGF13;SPDYA
prerank,nucleotidyltransferase activity (GO:0016779),-0.41628247314438244,-1.0778149386368934,0.3609467455621302,0.7101666877165037,1.0,7/19,20.27%,REV1;PAPSS2;TUT4;TUT7;MTPAP;PNPT1;TENT4B
prerank,monocarboxylic acid binding (GO:0033293),-0.42308597715491725,-1.0766447384806268,0.36654135338345867,0.7091649200837681,1.0,5/18,28.00%,CYP26B1;PSAP;RARA;RXRA;PYGL
prerank,protein phosphatase activator activity (GO:0072542),-0.45264246805209407,-1.074863296756265,0.379110251450677,0.7097176353275353,1.0,5/13,18.96%,IGFBP3;PTPA;CALM2;CALM1;PPP2R5C
prerank,platelet-derived growth factor binding (GO:0048407),-0.4730678944423048,-1.0744277245993554,0.398576512455516,0.7067537626492268,1.0,6/11,2.37%,COL1A2;COL3A1;COL1A1;PDGFRA;COL5A1;COL6A1
prerank,protein phosphatase binding (GO:0019903),0.3428759609640408,1.0734804605612303,0.3476968796433878,0.7339818676989269,1.0,17/117,10.63%,ITGA1;SMTNL2;MAP3K5;PTK2;PIK3R1;AKAP11;JAK1;ADCY8;MYO16;ROS1;ANKLE2;TRAF3;PTPRT;PPP1R16A;STRN;KIF3A;SMG7
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.3460094729595575,-1.0724170233442956,0.3613636363636364,0.7078065579602529,1.0,12/44,20.46%,MECOM;SMYD3;SETD7;SETD1B;KMT5A;PRDM16;EHMT1;NSD1;KMT5C;EZH2;SMYD5;SETDB1
prerank,E-box binding (GO:0070888),0.40447683277325447,1.0721679737722263,0.35247524752475246,0.7326109507817847,1.0,6/34,9.62%,ZEB1;TCF15;SCRT2;SREBF2;MITF;SNAI2
prerank,acetylcholine receptor activity (GO:0015464),0.45022903994777896,1.0719320510208146,0.36981132075471695,0.7290275506580126,1.0,6/22,18.63%,CHRNA3;CHRNA7;CHRFAM7A;CHRNB2;CHRM3;CHRM2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.42957730967183283,1.0708380629035295,0.3857965451055662,0.7271580759533642,1.0,11/29,10.38%,PRKAR1B;SPRED1;PKIA;SPRY2;HEXIM1;PRKAR2B;CDKN1A;PRKAR2A;INCA1;INKA2;PRKAR1A
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.4795346833283388,1.0703434635598124,0.3783231083844581,0.7241092639266182,1.0,3/15,5.53%,SLC1A5;SLC1A4;SLC25A13
prerank,ephrin receptor binding (GO:0046875),0.44872724661182034,1.069987221531712,0.36293436293436293,0.7208343973131773,1.0,5/21,12.70%,CHN1;ANKS1B;LYN;SRC;PTPN1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.48773866885527306,1.0673556012108785,0.39549180327868855,0.7221483801735723,1.0,3/14,10.01%,NCF2;NCF1;NOX3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.4908924407126107,-1.0663626705500964,0.39388489208633093,0.7186934484498403,1.0,3/10,11.23%,SLC24A3;SLC8A3;SLC3A2
prerank,SUMO binding (GO:0032183),0.4799450122572785,1.06562582167433,0.3884297520661157,0.7216011887123558,1.0,2/13,3.83%,USP25;UBA2
prerank,cardiolipin binding (GO:1901612),-0.4760256178014341,-1.065317441675829,0.4025735294117647,0.7172787472917996,1.0,2/10,10.47%,GSDME;GSDMD
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.4936202575756877,1.065316439823407,0.3874458874458874,0.7183676250797761,1.0,2/11,3.18%,PABIR1;PPP1R14A
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3918960511091983,-1.0622879578044901,0.376,0.7206954924177256,1.0,8/24,17.80%,RPS14;RPL41;RPS13;MYH10;IGF2BP2;RPL26;LARP1;RPS7
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.46037106166601094,1.0613310800160254,0.3912175648702595,0.7222994169337588,1.0,1/20,0.46%,SLC30A10
prerank,estrogen receptor binding (GO:0030331),0.4194534002795651,1.0593552700997966,0.38817005545286504,0.7223951259305181,1.0,8/32,9.69%,RERG;PPARGC1B;TACC1;ARID5A;PADI2;NCOA6;MED1;STRN
prerank,semaphorin receptor binding (GO:0030215),0.4392217829857807,1.0534843759751333,0.376,0.7306675990071979,1.0,6/23,5.09%,SEMA6D;SEMA5A;PLXNB1;SH3BP1;SEMA6C;RIT2
prerank,protein heterodimerization activity (GO:0046982),-0.2648019757819317,-1.0516372773879894,0.32989690721649484,0.743590877779116,1.0,60/178,25.20%,BMP6;EXT1;TAF1;TCF4;ITGA3;ZHX3;SDCBP;IRAK2;ARNT2;HEXA;BHLHE40;P4HB;BDKRB2;TOP2B;FZD4;ADRA1B;MCL1;HIF1A;KCNB1;NR4A2;BHLHE41;ATF6;IRAK3;ADD1;MEF2A;AHR;TCOF1;RAN;USF1;SAE1;CYBA;ATP1A1;RALGAPA2;FXR2;VAPA;UBA3;TLR4;SMC3;USF2;MICU2;LSM5;AGTR1;MICU1;IKBKG;YWHAH;CYBB;SMC1A;TOP2A;SNX2;XBP1;PAFAH1B1;BCL2L1;TRMT112;MIGA1;ABCG4;ATF3;YWHAE;NR4A1;NPAS3;TP53
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),-0.2650281233250834,-1.0504413081221706,0.2938775510204082,0.7424552675922892,1.0,40/181,15.19%,SMAD3;HDAC4;MDFIC;ANXA4;KLF4;TACC2;NFATC1;TAF1;TCF7L2;PARP9;ZFPM2;WWP2;ARNT2;AR;GTF2I;PRRX1;RERE;BHLHE40;ATN1;MAPK14;LMO2;STAT1;STAT3;IFI27;FIZ1;DTX3L;BBS7;HIF1A;BHLHE41;MEF2A;ID2;PPARA;RELA;HDAC1;ACTB;TAL1;HDAC5;HIPK2;TAF4B;ZFPM1
prerank,ligand-gated anion channel activity (GO:0099095),0.45832482746049835,1.0489438110114366,0.4094650205761317,0.7359564219345909,1.0,6/17,17.02%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GLRB
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4227386826693025,1.0470163730083786,0.4143126177024482,0.7359779600165041,1.0,8/30,16.00%,SLC30A10;ATP7A;TTYH1;SLC31A1;ATP7B;SLC39A6;SLC30A5;SLC25A37
prerank,protein phosphatase 1 binding (GO:0008157),0.44186246346072733,1.0464493383116604,0.40344168260038243,0.7332559827224727,1.0,2/21,2.07%,SMTNL2;AKAP11
prerank,lysine-acetylated histone binding (GO:0070577),-0.40398430792949885,-1.0434019205656098,0.41649484536082476,0.7525325897279443,1.0,6/20,10.30%,MLLT3;TAF1;TRIM24;BRD7;ZMYND8;CARM1
prerank,acetylation-dependent protein binding (GO:0140033),-0.40398430792949885,-1.0434019205656098,0.41649484536082476,0.7525325897279443,1.0,6/20,10.30%,MLLT3;TAF1;TRIM24;BRD7;ZMYND8;CARM1
prerank,TBP-class protein binding (GO:0017025),-0.3941214444526696,-1.0418823343173431,0.38132295719844356,0.7523041757809619,1.0,9/21,26.11%,ESR1;TAF1;AHR;YEATS2;HHEX;BRF2;PSMC2;PSMC5;TAF11
prerank,RNA binding (GO:0003723),-0.21812212465729683,-1.040286427478561,0.21739130434782608,0.7521121115803812,1.0,397/1321,26.40%,CELF2;MSI2;SAMD4A;ROCK2;DCN;AHNAK;BICC1;NSA2;FNDC3B;HOXB6;RBFOX2;STRBP;MACF1;VIM;RBMS2;MBNL1;DIAPH1;MYO18A;ANXA2;GOLGB1;LBR;EZR;ASCC3;CAST;RPS14;PLEC;CMSS1;LARP4B;DDX5;RBM47;DDX60;RBM20;TUT4;RPL9;RPS12;MOV10;LUC7L;SERPINH1;EDC3;TUT7;SRRM2;THRAP3;P4HB;RPL41;RPS20;SIDT1;CAVIN1;TES;NUDT4;HDLBP;DDX6;SSBP1;CHD3;RPL18A;NYNRIN;RARS2;RPS13;RPS19;RPS23;CPEB2;RPS4X;SRBD1;LARP1B;CCDC9;TFRC;STAT3;NOCT;TMSB4X;ZYX;TEP1;SIDT2;IFIT2;POLR2A;RPS11;ARHGEF1;NOVA2;RPL13;AFF2;RTF1;UTP14A;TPT1;MKRN2;EIF4A1;SORBS2;RC3H2;ZFR2;MYH10;ACO1;RPL18;SMG6;SON;IGF2BP2;EIF2S2;RPL34;FAM120A;RPL32;EEF1A1;DENR;REXO4;KRR1;RPS9;COL14A1;NAF1;RBM33;OAS2;PCBP2;VIRMA;RPS8;PINX1;UTP11;FAM120C;IFIT3;SAMHD1;RPL27A;IFIT1;CTNNA1;RPL12;RPL37;ZC3H12A;KARS1;FKBP4;DHX32;USO1;EIF5A;RBM10;TDRD3;ATXN2;NXF1;ANXA11;MTPAP;NOP58;ANXA7;RPS18;NDUFV3;SLC3A2;ADD1;RBM42;RPL11;PFN1;CPEB3;TRIP6;ERI3;RPS16;RPS5;PUM1;NME1;RPL24;SUCLG1;STRAP;RPS15A;RPL39;LRRFIP1;CARS1;NOVA1;ISG20L2;RPL28;SRSF10;TCOF1;HELZ;ACTN1;UTP6;CKAP4;YBX3;GRSF1;MBNL2;RPS24;RPS27;SF3B6;ELP1;EIF4G3;RAN;FNDC3A;DDX49;CHD2;FAU;TENT5A;CALR;RPL26;EIF4A2;LARP1;TXN;RPL14;MRPS7;LRRC47;RPL10;PPIA;SARS1;HSP90AB1;TUBA1B;RPL7;CS;MRPS24;SCG3;GEMIN5;BYSL;RAMAC;SNIP1;MAZ;ENO1;PRPF3;DDX24;SLTM;FXR2;NUP98;RPL10A;RBM34;RPS6;CHCHD1;SPATS2L;TYW5;RPS15;RPL23;RPL17;RPL22;EIF5B;CEBPZ;ZCCHC17;SNRPF;AGFG1;GANAB;SLIRP;G3BP1;XPOT;NKRF;SEC23IP;HMGB2;ELAVL1;RPL31;HNRNPUL2;EBNA1BP2;MRPL15;TRMT10B;TRNAU1AP;TNRC6A;PNPT1;PPHLN1;XRN1;HNRNPAB;SNRPD1;SNRPD2;RNASEL;SMG5;ELAC2;PDIA3;TRMT2A;RPL15;NOL12;TPR;RPSA;LSM5;PSIP1;TOE1;RPL38;SRSF2;RPS25;RPS7;PNLDC1;RPLP0;MRPL39;RRP8;KCTD12;SRSF6;EIF4E2;RPL27;PPARGC1A;CSDC2;PARK7;SNRNP40;ZFP36L2;HSP90B1;HMGN5;UNC50;EIF1B;PSMD4;PABPC4L;AGO1;DYNC1H1;SF3B5;TFB1M;VCP;PNO1;RCC1L;DDX55;LGALS1;UBTF;TEFM;ERH;NAT10;PTBP3;POLRMT;TENT4B;ESF1;RRP12;RPL36A;CANX;DRG2;ZC3H18;FARSA;TCF20;USP36;SAMSN1;NONO;PURG;RPP38;HNRNPL;RRP7A;DICER1;SRPK1;MRPL12;SMC1A;CCDC86;SRF;RPS26;FTSJ3;PCBP4;MRPL1;TOP2A;RBBP6;SEC61B;DZIP3;LRRC59;UTP23;NELFCD;HSPA9;TUBB4B;RPS27L;SRSF5;NUDT16;ALDOA;ASS1;RPL35A;WBP11;WRAP53;DHX34;LYAR;RDX;RPL8;DSP;APEH;RPL36;HELZ2;CSDE1;SF3A3;FIP1L1;CCDC47;RRBP1;EXOSC7;EIF3B;BRCA1;MTHFSD;SAMD4B;POLR2G;MRPS26;USP10;DHX8;FASTKD5;MEX3A;DNAJC2;YWHAE;MRPL4;S100A16;SRPK2;TRUB2;ZNF326;RRS1;HNRNPF;DNAJC21;CDK11B;SRSF11;ABCF1;RPL13A;CWC22;RACK1;NUDT1;HNRNPA0;PEG10;RPS3;CELF5;CPNE3;ZC3H12B;ZNF106;MRPL21;RPUSD4;EIF2AK4;ALKBH5;MRPL54;G3BP2;ACIN1;DDX54;FBL;ALDH6A1;RBMX2;SNRPC;NHP2;CLK3;PEBP1;PUF60
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.46482316884791675,1.0370340539415872,0.4106090373280943,0.7479509044180667,1.0,3/16,5.53%,SLC1A5;SLC1A4;SLC25A13
prerank,mechanosensitive ion channel activity (GO:0008381),-0.4364388036578978,-1.0356392816771693,0.43272727272727274,0.7598220482990731,1.0,3/12,10.93%,PIEZO2;PIEZO1;TMC6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4944388847111847,1.0344115571162142,0.4174107142857143,0.7497140146323664,1.0,2/11,3.47%,SLC19A1;SLC25A25
prerank,protein serine/threonine kinase activity (GO:0004674),0.2975886529165524,1.0336267603099867,0.38403990024937656,0.7473907176802442,1.0,61/334,12.06%,MAST4;MAP3K20;KALRN;CDK6;MAP3K5;MYLK;SNRK;PKN1;MARK1;HUNK;NUAK2;ROCK1;AKT3;RPS6KA4;LIMK1;GRK3;CDK15;CDC42BPA;STK39;STK38L;SRPK3;RPS6KB2;MINK1;CSNK1G1;RPS6KA2;TESK2;MYLK4;TESK1;TTBK1;TAOK3;SIK1;PIKFYVE;PAK6;ALPK1;RIPK2;MAP4K4;STK24;STK3;MTOR;ACVR2B;NEK6;PRKD2;GRK5;MARK2;ATR;MAP4K1;PRKD3;CSNK1E;PDIK1L;PAK5;MAPK10;NUAK1;BRSK1;DYRK3;PAK3;LATS2;BRAF;PAK1;HIPK1;NLK;FAM20A
prerank,poly-pyrimidine tract binding (GO:0008187),0.4324837807883046,1.0304143070864749,0.405982905982906,0.7499795158284666,1.0,10/23,18.27%,RBMS3;RBMS1;SSB;PABPC4;DAZAP1;HNRNPU;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.40296486077262333,1.0300373864944712,0.384321223709369,0.7468125498675914,1.0,8/35,12.36%,PTK2;PEAK1;FRK;CSK;LYN;TEC;ABL2;SRC
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.36978067845076606,-1.0299867462568688,0.42332613390928725,0.7705126552524226,1.0,8/28,14.75%,LRRK2;MAP2K6;MAPK14;MAP2K5;AKT1;PRKCG;PRKAA2;MAPKAPK3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.44453170650235707,1.0293263227744125,0.4046242774566474,0.7444664255664957,1.0,3/18,5.07%,PIK3R1;AGAP2;SOCS5
prerank,SUMO transferase activity (GO:0019789),-0.41084835268955433,-1.0281010513813158,0.42412451361867703,0.7709833607786271,1.0,5/16,24.39%,HDAC4;CBX4;MDM2;PIAS4;PIAS3
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2576238410233933,-1.026854881811295,0.371900826446281,0.7701827365006021,1.0,41/189,14.00%,SMAD3;HDAC4;FHL2;HDAC7;KLF4;TLE4;NFATC1;HDAC9;TAF1;TCF7L2;SKI;ZFPM2;WWP2;AR;CREM;GTF2I;YAP1;PRRX1;RERE;BHLHE40;ATN1;PRDM16;LMO2;STAT1;STAT3;IFI27;FIZ1;TLE2;BBS7;ZMYND8;BHLHE41;TLE1;PRDM5;MEF2A;ID2;PPARA;RELA;HDAC1;USF1;TAL1;HDAC5
prerank,O-acyltransferase activity (GO:0008374),0.40672287576888355,1.0249872444970145,0.42412451361867703,0.7493055856447814,1.0,3/30,7.28%,MBOAT2;MBOAT4;PLAAT1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4434135868883913,1.0239986236763383,0.39272030651340994,0.7477218995624261,1.0,7/21,10.15%,WASF3;AKAP1;AKAP6;ARFGEF1;RYR2;WASF2;AKAP7
prerank,retinoic acid receptor binding (GO:0042974),0.4468683293279149,1.023889410272868,0.43137254901960786,0.744104667317546,1.0,7/17,17.09%,TACC1;ACTN4;ARID5A;NCOA6;MED1;NRIP1;CNOT1
prerank,actinin binding (GO:0042805),0.4361195825349652,1.0233067172322081,0.41245136186770426,0.7415170208422608,1.0,3/21,8.54%,CACNA1C;CACNA1D;PKD2
prerank,thyroid hormone receptor binding (GO:0046966),0.40475649990520746,1.0201854158587411,0.4321223709369025,0.7440589022281563,1.0,12/28,21.65%,NCOA3;TACC1;MED13;ARID5A;NCOA6;MED1;MED4;GTF2H1;HMGN3;MED30;TAF7;MED16
prerank,sodium channel regulator activity (GO:0017080),0.39250774268364064,1.0181902533098446,0.4260700389105058,0.7444092736719137,1.0,9/37,11.99%,NEDD4L;FGF12;FXYD2;FGF13;PRSS8;SCN2B;RANGRF;FGF11;FGF14
prerank,tau-protein kinase activity (GO:0050321),0.44223761992629973,1.0151939776857604,0.42828282828282827,0.7465146051956361,1.0,9/20,18.81%,MARK1;ROCK1;TTBK1;MARK2;BRSK1;PRKAA1;CDK5;GSK3B;MARK4
prerank,DNA polymerase activity (GO:0034061),-0.3816827774199859,-1.0133326613812923,0.44509803921568625,0.8002459910719261,1.0,8/22,27.18%,REV1;POLM;POLH;POLI;POLE2;CHRAC1;POLA1;POLD1
prerank,protein kinase inhibitor activity (GO:0004860),0.38806922801141985,1.0130317535360425,0.44623655913978494,0.7469435011338417,1.0,9/42,10.49%,SPRY4;SPRED1;SPRY2;HEXIM1;SNCA;TAOK3;CDKN1A;INKA2;PRKRIP1
prerank,translation elongation factor activity (GO:0003746),-0.41879031877724665,-1.0118453559990825,0.4528301886792453,0.7997336180782559,1.0,5/14,17.23%,EEF1A1;EIF5A;EIF5AL1;EEF1B2;EEFSEC
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.47199159095632903,1.0091995282579338,0.46017699115044247,0.7506961110481664,1.0,2/12,3.47%,SLC19A1;SLC25A25
prerank,ATPase activator activity (GO:0001671),-0.38426966705700105,-1.0086959842228216,0.4598825831702544,0.8035872491003287,1.0,7/20,18.55%,ATP1B3;TOR1AIP1;DNAJB2;DNAJC24;DNAJB6;DNAJC15;DNAJC10
prerank,PDZ domain binding (GO:0030165),-0.30815651243349035,-1.0082921997882373,0.4593908629441624,0.8005986549567873,1.0,18/61,12.51%,TGFBR3;DOCK4;CXADR;FZD2;SNTG2;ARHGAP29;SYNJ2;SLC22A4;USHBP1;ERC1;FZD4;ACOX1;FZD7;SLC22A5;TBC1D10A;F11R;CLCN3;CCDC88C
prerank,DNA-directed DNA polymerase activity (GO:0003887),-0.3836296772682588,-1.006935058871356,0.4508670520231214,0.7999899797894243,1.0,8/21,27.18%,REV1;POLM;POLH;POLI;POLE2;CHRAC1;POLA1;POLD1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.4566611139978531,-1.0067699495818916,0.48565965583174,0.7963533393055897,1.0,6/10,30.37%,BRCA2;NAA40;USP22;HAT1;ATF2;NAA60
prerank,poly(U) RNA binding (GO:0008266),0.4319214789871379,1.0062944975477857,0.43803418803418803,0.7529542234498251,1.0,9/20,18.27%,RBMS3;RBMS1;SSB;PABPC4;DAZAP1;HNRNPC;DIS3L2;FMR1;MCRS1
prerank,tau protein binding (GO:0048156),0.38605042005022916,1.0051680273665826,0.43485915492957744,0.7516815854644332,1.0,12/40,15.49%,MAP2;MARK1;ROCK1;SNCA;TTBK1;BIN1;MARK2;BRSK1;EP300;DCTN1;PRKAA1;CDK5
prerank,kinase binding (GO:0019900),0.27907307472591564,1.0043665298398763,0.4507042253521127,0.749535589319535,1.0,69/434,13.59%,PTPRK;PDGFRB;CSPG4;LIMS1;UTRN;SLC12A2;IL15RA;PTK2;RGCC;BCAR1;TNS2;RND3;FERMT2;SPRED1;AGAP2;WAS;PTN;FOXM1;ATP1A4;PTPN22;DOK7;ABI2;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;SCN5A;TNIP2;SYN1;SIK1;EMP2;YWHAZ;CASP9;KIZ;CDKN1A;PPP1CC;NEK6;SHC4;RAB11FIP2;CNOT9;INKA2;MYOM1;PRKRIP1;DGKD;PDE8A;ZC3HC1;BLNK;DLG2;ARHGEF7;KIF20A;WWC1;APC;RB1;SRC;SLC12A4;PFKM;DLG3;PTPN1;TRAF6;SPRED2;ADD2;TRAF2;PPP1R12A;BCAR3;TBL2;JTB
prerank,galactosyltransferase activity (GO:0008378),-0.4396041995640228,-1.0028992257194713,0.47368421052631576,0.8021086194857135,1.0,2/11,5.10%,B4GALT1;A4GALT
prerank,protein kinase binding (GO:0019901),0.2790582320030621,1.002716269369717,0.4639905548996458,0.7489802147803496,1.0,54/479,8.95%,PTPRK;PDGFRB;CSPG4;LIMS1;UTRN;SLC12A2;PRKCSH;IL15RA;PTK2;RGCC;PKN1;BCAR1;PRKAR1B;RND3;FERMT2;SPRED1;AGAP2;WAS;PTN;FOXM1;DOK7;SH2B3;PKIA;GRM5;RAC3;ADCY6;PDCD10;NBEAL1;STK11IP;SPDYA;SPRY2;TRIB2;ITGB1;SCN5A;TNIP2;SYN1;PRKAR2B;RYR2;IRS1;SIK1;EMP2;YWHAZ;CASP9;APPL1;KIZ;CDKN1A;PPP1CC;PRKAR2A;NEK6;PRKD2;GRK5;SHC4;RAB11FIP2;CSK
prerank,nuclear export signal receptor activity (GO:0005049),-0.44604086681194655,-1.0014379599700503,0.46545454545454545,0.8017987094381275,1.0,7/11,29.39%,RAN;NUP214;XPO4;RANBP17;EIF4ENIF1;CSE1L;XPO5
prerank,potassium:proton antiporter activity (GO:0015386),-0.4503794315662373,-1.0007018819433435,0.4506283662477558,0.799765380099307,1.0,2/10,7.08%,SLC9A2;SLC9A9
prerank,zinc ion binding (GO:0008270),-0.24139637047108423,-1.0002566230329009,0.4482758620689655,0.796806750313368,1.0,81/293,20.47%,SMAD3;KDM7A;HDAC4;GLI2;PAM;PAPPA;EEA1;ENPP1;MYRIP;SHANK3;NPEPPS;SEC23A;SEC24D;TIMP2;KLF4;ARHGEF2;TRIM24;SKI;ZFPM2;TNFSF10;ACE;ENPP3;TET3;TES;KDM5B;SORD;ACER3;CHD3;SEC24A;RNPEP;ERAP1;UPB1;P2RX4;BAZ1B;DUSP12;LNPEP;DPP3;ZMYND8;SAMHD1;IDE;DNAJC24;GCH1;ADAMTS3;NSD1;RNF125;NUDT12;MDM2;RPS27;PLA2G15;CALR;ADH1A;ADAM33;MSRB3;GDA;SMPDL3A;TIMM13;FBXL19;TRIM8;SIRT2;ZCCHC4;TIMM8B;SIRT3;MT3;PIAS4;ZFYVE1;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CALB1;ZDHHC15;GLO1;TIMM9;CTCF;ENPP2;FNTB;THAP1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.4672610089365211,0.9999565685223524,0.45585215605749485,0.7507555929587743,1.0,4/11,11.81%,ITPR1;RYR2;RYR3;RASA3
prerank,tumor necrosis factor receptor binding (GO:0005164),0.4586004339604174,0.992968387227806,0.4607218683651805,0.7603437992470671,1.0,5/12,16.92%,TRAF5;TRAF3;TRAF6;TRAF2;TRIM37
prerank,CXCR chemokine receptor binding (GO:0045236),0.4606292972423198,0.9922575250961144,0.48068669527896996,0.7581431283147763,1.0,3/11,11.95%,CXCL5;CXCL10;YARS1
prerank,androgen receptor binding (GO:0050681),-0.361416998617051,-0.9895444852297598,0.4708249496981891,0.819800156197898,1.0,7/25,13.20%,FOXP1;DDX5;TMF1;PRKCB;KDM3A;NSD1;CALR
prerank,double-stranded RNA binding (GO:0003725),-0.29336300033222085,-0.9880538228990301,0.46464646464646464,0.8194556146695358,1.0,16/70,13.96%,STRBP;VIM;MBNL1;DDX60;SIDT1;TFRC;SIDT2;EIF4A1;RC3H2;ZFR2;OAS2;SLC3A2;LRRFIP1;ACTN1;HSP90AB1;TUBA1B
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.39214262300768005,0.9835109602163166,0.46167557932263814,0.7716280961641387,1.0,5/29,5.53%,SLC1A5;SLC1A4;SLC19A1;SLC26A1;SLC25A13
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.3492719282659199,-0.9832497067073507,0.4957081545064378,0.827675377364213,1.0,11/27,24.34%,RNF19A;RNF144B;RNF125;PPARA;ANKIB1;UBE3D;RNF217;RNF144A;PRKN;RNF19B;FOXL2
prerank,ankyrin binding (GO:0030506),0.4280784007937811,0.9829550962044683,0.47193347193347196,0.769036483316522,1.0,5/19,7.58%,SPTBN1;SPTB;SCN5A;KCTD6;CACNA1D
prerank,microtubule binding (GO:0008017),0.29075151552759065,0.9824843121317727,0.4738219895287958,0.7663575437301682,1.0,53/222,19.17%,SGIP1;STARD9;MAP2;MTCL1;RMDN1;SPEF1;MID2;SVBP;FGF13;NAV3;CLASP2;MAPRE2;GAS8;TPPP;KIF26B;STIM1;MAP4K4;HOOK3;FAM161A;CLIP2;KIF3A;NUSAP1;MACO1;UXT;CAMSAP3;TPGS1;TOGARAM2;KIF5C;KIF20A;CCDC66;KIF3C;APC;KIF21A;APC2;KIFC2;DCTN1;PSRC1;MAP10;CDK5;KIF7;KIF6;FMR1;DNM1;NDE1;TERF1;CLIP1;MID1;DST;EML4;MARK4;NDRG1;DRG1;KNSTRN
prerank,antiporter activity (GO:0015297),-0.3744219070832782,-0.9820761279084416,0.48380566801619435,0.8264766784881427,1.0,5/20,16.04%,TMEM241;CLCN3;ATP1A3;SLC35E4;SLC35D2
prerank,GTP binding (GO:0005525),0.2983480845973588,0.9805691068125736,0.47701149425287354,0.7665636211024828,1.0,17/172,9.08%,RASL12;REM1;RERG;RND3;AGAP2;RRAD;NOA1;RAC3;RIT2;TUBA8;ARL4C;RAP1A;HRAS;TUBB2B;RAB28;RAB38;RNF112
prerank,protein kinase C binding (GO:0005080),-0.31551399484378034,-0.980016575982599,0.4841628959276018,0.827180941716267,1.0,12/43,14.00%,PDLIM5;HDAC7;CAVIN2;ADAM9;HDAC9;PARD6G;PRKCB;TOP2B;HINT1;TRPV4;CAVIN3;HDAC5
prerank,cytokine activity (GO:0005125),-0.25594793124435455,-0.9775393852589469,0.4688427299703264,0.8292657049638479,1.0,19/131,11.96%,BMP6;WNT4;BMP7;IL15;WNT6;BMP4;CSF1;WNT9A;TNFRSF11B;IL16;CXCL12;CCL15;WNT5A;CCL14;IL33;IL18;TGFB1;WNT5B;CCL25
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.43044329478060395,-0.9768293003976589,0.5028248587570622,0.826944777789295,1.0,2/12,11.47%,KDM7A;KDM3A
prerank,methylated histone binding (GO:0035064),-0.29515315446623375,-0.9768052235016724,0.5156626506024097,0.8230296992896995,1.0,21/62,26.45%,KDM7A;TAF1;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;CHD5;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;CBX2;ZCWPW1;L3MBTL1;MBTD1
prerank,alpha-actinin binding (GO:0051393),0.4127221658209417,0.9760683185587365,0.48406374501992033,0.7717586284712089,1.0,4/24,8.54%,CACNA1C;PDLIM1;CACNA1D;PKD2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3278865404629304,-0.9747616403533396,0.511340206185567,0.8240486686611985,1.0,8/34,16.01%,IQGAP1;IGF2;CALM2;ALS2;IRGM;DBF4;CALM1;PARP16
prerank,heme binding (GO:0020037),0.3439701086897487,0.9729270849584143,0.47294938917975565,0.7738916106600005,1.0,1/65,0.12%,GUCY1B1
prerank,histone deacetylase binding (GO:0042826),0.3327474474184194,0.9725117927912943,0.5032051282051282,0.7711694742682318,1.0,5/88,3.99%,MEF2C;HEY2;PRDM1;PKN1;MIER1
prerank,magnesium ion binding (GO:0000287),0.3102357119826804,0.9720619190095195,0.49420289855072463,0.768537597974429,1.0,22/135,11.82%,MAP3K20;MAP3K5;SNRK;MARK1;NUAK2;CIB3;CDC42BPA;UBA2;STK38L;TPPP;SNCA;SIK1;PAPOLA;MTHFD2;STK3;NEK6;MARK2;BRSK1;DYRK3;ABL2;SRR;NLK
prerank,retinoic acid binding (GO:0001972),-0.4283093227814647,-0.9691221660622927,0.5397412199630314,0.8339538954176308,1.0,3/12,25.71%,CYP26B1;RARA;RXRA
prerank,protein phosphatase 2A binding (GO:0051721),-0.3559003883363138,-0.9663845673015354,0.4895397489539749,0.836788757357783,1.0,7/23,16.86%,FOXO1;CTTNBP2NL;MFHAS1;PTPA;DAB2IP;SPHK1;SMG5
prerank,cell adhesion mediator activity (GO:0098631),0.3993665112069734,0.9659222797349547,0.4901185770750988,0.7768062108013244,1.0,7/24,13.66%,JAM3;LRRC4C;ESAM;CNTN4;CNTN6;PLXNB3;DSCAM
prerank,acetyltransferase activity (GO:0016407),-0.3301785363114301,-0.9646022524269475,0.5265392781316348,0.8370246325955488,1.0,8/31,20.84%,KAT6B;KAT2B;SPHK1;PAFAH2;ELP3;NAT10;SAT1;NAA80
prerank,death receptor binding (GO:0005123),-0.3922043284296527,-0.9645514014092758,0.5009708737864078,0.8331837313852886,1.0,10/15,42.82%,DAB2IP;BID;RIPK1;EDA;NTF3;MYD88;FADD;PIDD1;FEM1B;CASP8AP2
prerank,5'-3' exonuclease activity (GO:0008409),0.42772923471195656,0.9641723333480633,0.4678714859437751,0.7766267304067487,1.0,3/14,10.61%,DCLRE1B;XRN2;TRIR
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.4571505974953175,0.9604408027803725,0.506,0.7799155597661223,1.0,2/12,6.74%,ATP2A3;BCL2L13
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.3229680114814702,-0.9562807503330009,0.5271966527196653,0.8491211629515408,1.0,12/32,22.02%,SLC6A6;SFXN2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC38A6;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,chloride transmembrane transporter activity (GO:0015108),-0.37519705285024063,-0.9525649086730182,0.5214007782101168,0.8542224789244722,1.0,2/16,2.89%,SLC26A7;SLC26A2
prerank,DNA secondary structure binding (GO:0000217),0.3779230468216518,0.9505128565952148,0.46950092421441775,0.7959604081062978,1.0,1/31,0.66%,MEF2C
prerank,peptidoglycan binding (GO:0042834),-0.43794855681877826,-0.9479899350058836,0.548828125,0.8615628149040235,1.0,2/10,9.20%,NOD1;PGLYRP1
prerank,mRNA binding (GO:0003729),-0.2255853762347128,-0.9462477636110963,0.6352459016393442,0.8617178247017611,1.0,58/249,18.73%,CELF2;SAMD4A;RBFOX2;RBMS2;RPS14;LARP4B;DDX5;RBM47;RBM20;LUC7L;EDC3;SRRM2;RPL41;HDLBP;DDX6;NYNRIN;RPS13;CPEB2;SRBD1;NOCT;NOVA2;EIF4A1;RC3H2;MYH10;ACO1;IGF2BP2;EIF2S2;DENR;PCBP2;ZC3H12A;CPEB3;RPS5;PUM1;NOVA1;YBX3;GRSF1;SF3B6;EIF4G3;CALR;RPL26;LARP1;MRPS7;AUH;RPL7;GEMIN5;SNIP1;FXR2;NUP98;G3BP1;ELAVL1;HNRNPAB;RNF40;TPR;RPS7;SRSF6;CSDC2;PARK7;TYMS
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4035650298426673,0.9460836799502863,0.48140495867768596,0.8011370331886146,1.0,1/18,1.69%,RDH5
prerank,snRNA binding (GO:0017069),0.35445670088684517,0.9449654698730436,0.5063291139240507,0.7997577165898169,1.0,19/42,25.80%,HEXIM1;NCBP2;SART3;LSM10;RBM7;LSM8;HNRNPU;COIL;PRPF31;SF3B3;LSM2;SNRPD3;LARP7;DDX21;CCNT2;EFTUD2;TUT1;HEXIM2;SNRNP35
prerank,calcium-activated potassium channel activity (GO:0015269),0.44985485205958275,0.9445599807519719,0.5231788079470199,0.7970724119770417,1.0,3/11,14.39%,KCNMB1;KCNMA1;KCNU1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.44137394066462493,0.9435161257216934,0.5121457489878543,0.7954749779581409,1.0,2/14,6.74%,ATP2A3;BCL2L13
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.42062208584766764,0.9417015818230107,0.5159235668789809,0.7956421073559182,1.0,1/13,0.19%,PDGFRB
prerank,clathrin adaptor activity (GO:0035615),-0.38940545777293994,-0.9415745961890165,0.5433962264150943,0.8689949937799937,1.0,3/15,5.02%,DAB2;STON2;AP2A2
prerank,GABA receptor activity (GO:0016917),0.384851772798122,0.9385468689157079,0.5051334702258727,0.7982928782576182,1.0,7/21,21.53%,GABRG2;GABRA2;GABRA5;GABRA4;GABRB3;GABBR2;GABRB2
prerank,amyloid-beta binding (GO:0001540),0.32726422337715433,0.937778552797785,0.5428571428571428,0.7962169449879333,1.0,13/79,10.44%,CLSTN1;APBB2;FZD6;LDLRAP1;LDLR;MSR1;GRIA2;CHRNA7;ACHE;ITM2B;CACNA1A;GRIN2B;APBA2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.4367891096735405,0.9369525233932992,0.535031847133758,0.7943367270460818,1.0,6/10,10.38%,PRKAR1B;PKIA;CXCL10;PRKAR2B;PRKAR2A;PRKAR1A
prerank,protein homodimerization activity (GO:0042803),0.2561610715903014,0.9355669966388043,0.6268656716417911,0.7936498124082985,1.0,73/589,11.55%,ANO1;TRPC6;CASQ2;FAP;PTH1R;IMPA2;RBPMS;MAP3K5;SYNE1;RBPMS2;MTCL1;RDH5;TRIM9;MYH9;DCLRE1B;ERBB4;PLD6;PIP4K2A;ECE1;MID2;ABCD2;BCL2L10;GUCY2D;ADCY8;PDCD10;CRPPA;PEX7;CARD9;ACTN4;TFAP2B;NTRK2;TPPP;PSMF1;CHRNA7;PADI2;SFPQ;APPL1;SUPV3L1;RCHY1;RIPK2;TENM4;DCK;TYR;HMGCS1;ACHE;NR2F2;STC2;PTPRT;ARNT;PKD2;CORO1A;RAB11FIP2;TARBP2;MSH3;CIP2A;ZDHHC2;TBX18;PDGFB;CNOT9;GNPTG;CR2;MYOM1;EFEMP2;HIP1;DARS2;DGKD;SETMAR;ERP29;RPE;SOX6;TMEM266;ATP5IF1;CCDC66
prerank,glutamate receptor binding (GO:0035254),-0.3736704660723362,-0.93484416732052,0.5517241379310345,0.8811281816985063,1.0,6/17,16.82%,SHANK3;GNAS;CAMK2A;SHISA7;HOMER1;HOMER3
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.33264390317377,0.9338055023227184,0.5383275261324042,0.7933745010945671,1.0,4/57,5.26%,COX4I2;NDUFA4L2;UQCRFS1;NDUFB2
prerank,phosphatase binding (GO:0019902),0.3013500216611729,0.9337838352739859,0.568215892053973,0.7900248171544791,1.0,7/105,3.84%,ITGA1;MAP3K5;PTK2;PIK3R1;SPRED1;JAK1;MYO16
prerank,ubiquitin protein ligase activity (GO:0061630),-0.2265997662707362,-0.9330210912947999,0.6440677966101694,0.881469148063822,1.0,51/228,18.07%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;ASB2;KCMF1;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF2;AMFR;SH3RF3;BIRC3;NHLRC3;MKRN2;RNF185;RC3H2;DTX3L;RNF135;MGRN1;ZNRF3;UBE4B;TRIM27;RNF125;TRIM63;MDM2;TRIM39;TRIM35;RNF181;BRAP;WWP1;DTX1;RNF115;TRIM17;NEURL2;RNFT2;ANKIB1;RNF187;ASB1;PELI1;UBE3D;UBR4;TRIM14;TRAF3IP2
prerank,U6 snRNA binding (GO:0017070),0.41519178367758985,0.932988946108306,0.5183673469387755,0.7880729308315048,1.0,5/14,18.20%,LSM3;SART3;LSM8;LSM2;LARP7
prerank,calcium channel inhibitor activity (GO:0019855),-0.40877235641388926,-0.9320001369328662,0.5586592178770949,0.8797198834007816,1.0,5/11,17.61%,FKBP1A;CALM2;MCUB;CALM1;SLC30A1
prerank,methylation-dependent protein binding (GO:0140034),-0.29093941588487165,-0.9312051862331887,0.5823389021479713,0.8776172115537269,1.0,19/57,26.45%,KDM7A;TRIM24;BPTF;ZMYND8;TDRD3;NCAPG2;MORC4;L3MBTL2;RRP8;MPHOSPH8;ZMYND11;SGF29;MSH6;PYGO1;ING4;CBX2;ZCWPW1;L3MBTL1;MBTD1
prerank,growth factor receptor binding (GO:0070851),0.3017022359015526,0.9295744584890712,0.572139303482587,0.790851126116267,1.0,11/95,9.52%,PDGFRB;GLMN;LINGO1;ERBB4;IL1B;FGF2;IL4;FGF10;IL12RB1;PDGFB;CNOT9
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.42254007949740013,0.9272734605892733,0.5234899328859061,0.7917727337206235,1.0,1/12,1.10%,CDK6
prerank,small GTPase binding (GO:0031267),0.2882921094902557,0.9245726105713028,0.5825105782792666,0.7935852752281091,1.0,32/169,12.87%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;IFT20;PEX5L;GGA3;RIC1;LZTR1;HACE1;ARHGDIB;MTSS2;KCTD13;KIF3A;BICD2;NCKAP1;RANGRF;BRAF;PAK1;DENND10;TRIP11;ANKFY1;GCC2
prerank,ubiquitin-like protein ligase activity (GO:0061659),-0.22323153633425316,-0.9238268911321817,0.7222222222222222,0.8912044382131511,1.0,54/232,19.14%,RNF220;PDZRN3;SH3RF1;SMURF2;RNF38;ZNRF1;ASB2;KCMF1;RNF43;TRIM24;RNF130;RNF19A;WWP2;RNF144B;RNF139;SMURF1;SH3RF2;AMFR;SH3RF3;BIRC3;NHLRC3;MKRN2;RNF185;RC3H2;DTX3L;RNF135;MGRN1;ZNRF3;TRIM27;RNF125;TRIM63;CBX4;MDM2;TRIM39;TRIM35;RNF181;BRAP;WWP1;DTX1;RNF115;TRIM17;NEURL2;RNFT2;ANKIB1;RNF187;ASB1;PELI1;UBE3D;UBR4;TRIM14;TRAF3IP2;TRIM41;PIAS4;IRF2BPL
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.42285063356327063,0.9232338756521864,0.5248380129589633,0.7927498312183272,1.0,5/13,13.64%,TRMT5;TRMT1;THUMPD2;TRMT11;TRMT10C
prerank,peptidase activator activity (GO:0016504),-0.3381954695456833,-0.9207324422620099,0.569937369519833,0.8948153082416637,1.0,9/22,33.03%,CAV1;PSME2;PCOLCE;PSME3;VCP;CLPX;VSIR;APH1A;PINK1
prerank,gated channel activity (GO:0022836),-0.3779941962507184,-0.9206281853101043,0.5951940850277264,0.8910765109248653,1.0,3/14,10.93%,PIEZO2;PIEZO1;TMC6
prerank,ribosomal large subunit binding (GO:0043023),0.42433837266214297,0.9199369894020004,0.5209205020920502,0.7953946012446741,1.0,4/11,11.51%,CPSF6;NMD3;MALSU1;EIF6
prerank,hexose transmembrane transporter activity (GO:0015149),0.43419932376058124,0.9187552332746554,0.5128205128205128,0.7941782292453016,1.0,3/12,8.07%,SLC5A1;SLC2A6;SLC2A3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.3049884314734675,-0.9165277825850071,0.587737843551797,0.8966086284436484,1.0,12/37,20.62%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;VARS2;EARS2;FARSA
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.28876214703698533,-0.9154342348189266,0.5868544600938967,0.8952045696657702,1.0,8/46,11.85%,EXT1;LARGE1;HEXA;HEXB;MGAT1;B3GALNT1;MGAT2;EXTL2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.3939908230662228,-0.9154303277730133,0.5844402277039848,0.8912828421854646,1.0,6/12,20.62%,CNOT7;NOCT;CNOT8;TOE1;PNLDC1;PAN3
prerank,mannose binding (GO:0005537),-0.3953877147416244,-0.9143674764328271,0.5910852713178295,0.8897995969443153,1.0,6/12,45.99%,LMAN1;CLN5;ACR;COLEC11;LMAN1L;CLEC4D
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.3781658575337488,-0.9143317156819956,0.6003898635477583,0.885990290670773,1.0,8/14,37.40%,PRORP;ELAC2;RPP38;POP1;TSEN2;TSEN34;RPP21;RPP40
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.4406496531156229,0.9142605191494805,0.5225806451612903,0.7994348752082034,1.0,2/10,4.36%,SLCO3A1;SLCO5A1
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.35865061059630027,-0.9129368633760838,0.5885608856088561,0.8815226713946588,1.0,5/16,15.58%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.35865061059630027,-0.9129368633760838,0.5885608856088561,0.8815226713946588,1.0,5/16,15.58%,ATP6V0A4;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.39680303103848363,0.9088459761557942,0.532608695652174,0.8060431960954708,1.0,6/17,15.67%,AK8;CLP1;AK7;AK5;AK4;AK3
prerank,nuclease activity (GO:0004518),-0.28233819485088135,-0.908800182747568,0.6014150943396226,0.8867943077641507,1.0,10/52,12.31%,ENPP1;RNASE4;N4BP2;ERCC5;REXO4;SAMHD1;ZC3H12A;DNASE1L1;NME1;ISG20L2
prerank,telomerase RNA binding (GO:0070034),-0.33747106468104454,-0.908462941936963,0.5943775100401606,0.883794861711641,1.0,10/22,27.27%,TEP1;SMG6;NAF1;PINX1;XRN1;SMG5;TENT4B;WRAP53;NHP2;SNRPB
prerank,microtubule plus-end binding (GO:0051010),0.3855693674338991,0.9045578448920025,0.5381679389312977,0.8106250457486415,1.0,9/20,19.17%,CLASP2;MAPRE2;STIM1;CLIP2;APC;DCTN1;CLIP1;DST;KNSTRN
prerank,adenyl nucleotide binding (GO:0030554),-0.4008497294013601,-0.9040572536756161,0.604,0.8862689556860915,1.0,6/11,28.89%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.4008497294013601,-0.9040572536756161,0.604,0.8862689556860915,1.0,6/11,28.89%,BAG3;PFN1;BAG2;BAG5;HSPH1;BAG1
prerank,mRNA methyltransferase activity (GO:0008174),0.42025340847824927,0.9002068609788699,0.542016806722689,0.8151928765290041,1.0,4/12,17.93%,TRMT61A;RNMT;TRMT10C;NSUN2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.3762721437260713,0.8997156869837468,0.564870259481038,0.809450326080715,1.0,2/21,3.49%,CDK6;CDK15
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.3762721437260713,0.8997156869837468,0.564870259481038,0.809450326080715,1.0,2/21,3.49%,CDK6;CDK15
prerank,microtubule minus-end binding (GO:0051011),-0.36978316496042696,-0.8973555125517508,0.5830188679245283,0.8973545495357738,1.0,5/13,29.04%,MACF1;TUBGCP5;NUMA1;CAMSAP1;TUBGCP6
prerank,protein tyrosine kinase activity (GO:0004713),0.2910196227497711,0.8970314493110197,0.6276595744680851,0.8109336917366599,1.0,23/108,12.74%,PDGFRB;ROR1;PTK2;PEAK1;FRK;MERTK;ERBB4;JAK1;AXL;RYK;ROS1;NTRK2;TTBK1;CSK;LYN;EPHA2;TEC;ABL2;EPHA10;HIPK1;SRC;EPHB1;FGFR3
prerank,fatty acid synthase activity (GO:0004312),-0.399527999701467,-0.8945482860476007,0.5930018416206262,0.8994204165309548,1.0,3/10,23.52%,ELOVL7;ELOVL1;OXSM
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.40943276566451425,-0.8941835194105321,0.621414913957935,0.8965012315160755,1.0,3/10,14.33%,SHANK3;GNAS;SHISA7
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.2974993236344545,-0.8873463620199642,0.6602564102564102,0.9076682969990414,1.0,14/33,25.69%,RNF19A;RNF144B;RNF185;RNF125;PPARA;ANKIB1;UBE3D;PARK7;RNF217;RNF144A;PRKN;RNF19B;FOXL2;RPS3
prerank,acylglycerol lipase activity (GO:0047372),-0.3949621547380937,-0.8843440643120316,0.6277372262773723,0.9102673001979384,1.0,3/11,13.37%,MGLL;LIPE;ABHD16A
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.3951487045919645,0.8843113388311892,0.5456349206349206,0.8312336304595022,1.0,3/15,10.57%,PIK3R1;SOCS5;SOCS6
prerank,phosphatase inhibitor activity (GO:0019212),0.3807566973944386,0.883582793525651,0.5635245901639344,0.829234022062686,1.0,9/20,22.36%,PTN;SET;MGAT5;URI1;CABIN1;SAG;LMTK2;BOD1L1;STYXL1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.41979224443473795,0.8827709155251335,0.563265306122449,0.8273644718098364,1.0,5/10,19.40%,SETMAR;SETD3;NSD2;NSD3;SETD5
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.37047733578070496,-0.8809760950951285,0.6038461538461538,0.913613314261444,1.0,5/12,20.27%,MTPAP;TENT5A;PAPOLB;TENT5C;TENT4B
prerank,transferrin receptor binding (GO:1990459),0.41702356495444026,0.8804040547571503,0.5871369294605809,0.8284349221288352,1.0,1/10,2.06%,RGMA
prerank,GTPase binding (GO:0051020),0.2688142739069151,0.8803236399976639,0.6789617486338798,0.825322761860303,1.0,34/194,12.87%,EPS8;PLCE1;RAPGEF4;TNFAIP1;PKN1;ARHGAP1;WAS;CHML;SPTBN1;ABI2;RIMS1;RTKN;TBC1D30;AP1G1;IFT20;PEX5L;GGA3;ATG16L1;RIC1;LZTR1;HACE1;ARHGDIB;MTSS2;KCTD13;KIF3A;BICD2;NCKAP1;RANGRF;BRAF;PAK1;DENND10;TRIP11;ANKFY1;GCC2
prerank,glucose transmembrane transporter activity (GO:0005355),0.3983400261951435,0.8787658642593607,0.574468085106383,0.8250545336944727,1.0,3/17,8.07%,SLC5A1;SLC2A6;SLC2A3
prerank,RNA stem-loop binding (GO:0035613),-0.3768988499217551,-0.8784554263529215,0.6284046692607004,0.9153405992814159,1.0,4/12,11.65%,RC3H2;MYH10;ZC3H12A;CPEB3
prerank,GTPase activity (GO:0003924),0.26096431382038204,0.8756503920567827,0.6904761904761905,0.8277053699259427,1.0,20/192,9.08%,RASL12;RERG;RND3;AGAP2;GNAZ;RAB8B;RAC3;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;ARHGDIB;RAB38;GNA12;RNF112
prerank,translation initiation factor activity (GO:0003743),-0.29414921975404623,-0.8733131009557333,0.6750524109014675,0.9224967182493139,1.0,16/36,29.91%,EIF4A1;EIF2S2;MTIF3;EIF4G3;EIF4A2;EIF5B;EIF2B2;EIF4E2;EIF1B;EIF3B;EIF2B5;EIF2B4;EIF2D;AGO2;EIF3H;EIF3D
prerank,palmitoyltransferase activity (GO:0016409),0.35634270798455703,0.8722658021364115,0.5817490494296578,0.8307159429171773,1.0,8/28,13.42%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;HHAT;ZDHHC23
prerank,ribosome binding (GO:0043022),0.31615431669053706,0.8678992607181705,0.605072463768116,0.8352263823585723,1.0,16/46,20.65%,CPEB1;MRPS27;YTHDF3;SRP72;EIF3C;NCLN;CPEB4;EIF6;GTPBP6;FMR1;C1QBP;NAA15;OXA1L;SEC61A2;EEF2;SRP68
prerank,copper ion binding (GO:0005507),-0.2781019332629905,-0.8668935640294702,0.6831896551724138,0.9318201972951297,1.0,5/42,7.45%,MOXD1;PAM;ATOX1;LACC1;P2RX4
prerank,nuclear receptor binding (GO:0016922),-0.23558266997075797,-0.8650503153446573,0.75,0.9318379095138556,1.0,21/111,13.81%,SMAD3;FOXP1;LCOR;ESR1;TACC2;DDX5;LEF1;TAF1;TCF7L2;TMF1;THRAP3;PRKCB;STAT1;HIF1A;NR4A2;MMS19;KDM3A;TRIP6;NSD1;CALR;PPID
prerank,hexosaminidase activity (GO:0015929),0.38991674145419175,0.8637820598996065,0.6038961038961039,0.8394205847141176,1.0,2/12,2.66%,CEMIP2;HYAL4
prerank,cytokine receptor activity (GO:0004896),0.29003667045745773,0.8606493450951174,0.6470588235294118,0.8417058875576431,1.0,10/83,8.32%,IL15RA;IL1RL2;IL17RD;GFRA2;CCRL2;IL2RA;OSMR;ACKR2;CCR9;IL12RB1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4020768197586035,0.8596605750568919,0.5944798301486199,0.8400734328488882,1.0,1/10,2.03%,DCLRE1B
prerank,histone demethylase activity (GO:0032452),-0.3130006756157587,-0.858899893204566,0.6559356136820925,0.940712021038661,1.0,6/27,17.39%,KDM7A;KDM5B;JARID2;KDM3A;KDM6B;FBXL19
prerank,MHC class II protein complex binding (GO:0023026),-0.38241926391358977,-0.8584629049923022,0.6783088235294118,0.9377661694668267,1.0,4/11,24.85%,ANXA11;HSP90AB1;CD81;YWHAE
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.26516875269438017,-0.8580752763154196,0.6801801801801802,0.93482288087637,1.0,19/49,37.16%,ZFAND6;IKBKE;OPTN;MINDY1;WDR81;PSMD4;IKBKG;VCP;BABAM2;UBXN1;DZIP3;MINDY2;ABRAXAS2;PARP10;HDAC6;AGAP3;TAB2;ZRANB3;RAD23A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.3593662592499284,0.8576987636326941,0.599624060150376,0.8403997633289525,1.0,6/21,17.02%,CHRNA3;CHRNA7;GRIK2;P2RX5;CHRNB2;GLRB
prerank,phosphatase activity (GO:0016791),-0.24860262001066175,-0.8551734700841359,0.75,0.9370894143092388,1.0,30/73,29.59%,PLPP3;PTPRJ;ALPL;NOCT;DUSP12;PPP1CB;DUSP16;PXYLP1;PLPP1;EPHX2;PGAM5;PGP;LPIN3;DUSP10;DUSP23;LHPP;CILP;PLPP4;NUDT16;INPP5K;DUSP15;NT5C;PPP5C;CILP2;PLPPR4;ACP3;PLPP2;PPP1CA;DUSP8;DUSP4
prerank,O-methyltransferase activity (GO:0008171),-0.3822386164535715,-0.85237397493503,0.6666666666666666,0.9391662587490136,1.0,4/10,32.93%,CMTR1;FTSJ3;ASMT;BCDIN3D
prerank,ribonuclease activity (GO:0004540),-0.2603550932040639,-0.84925321659413,0.7476635514018691,0.9415560077104305,1.0,19/56,29.31%,CNOT7;RNASE4;NYNRIN;SMG6;SAMHD1;ZC3H12A;ERN1;INTS11;EXOSC5;RNASEL;ELAC2;RNASE12;AGO1;DICER1;EXOSC7;ZC3H12B;RNASEK;AGO2;ENDOU
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.3411021997826601,-0.8476131206942167,0.6906614785992218,0.9410530026245867,1.0,8/16,27.29%,CD38;MACROD1;TDG;ADPRS;NEIL3;RPS3;NEIL1;NTHL1
prerank,Toll-like receptor binding (GO:0035325),-0.3761575702997482,-0.8475006197046562,0.6724470134874759,0.937621087158757,1.0,7/11,42.87%,DAB2IP;MYD88;TLR6;CD36;TLR1;TLR2;S100A9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.3775574187375165,-0.8465116527913853,0.6679035250463822,0.9357612418477358,1.0,1/10,0.43%,DPYSL3
prerank,anion:anion antiporter activity (GO:0015301),-0.3323775592084904,-0.8424958209766762,0.68389662027833,0.9401052307478434,1.0,3/17,8.46%,SLC26A7;SLC26A2;SLC25A4
prerank,N-acetyltransferase activity (GO:0008080),-0.322516062282186,-0.8420410197788716,0.6634799235181644,0.9372976090891849,1.0,7/19,31.18%,KAT2B;NAT10;SAT1;NAA80;NAT2;NAT14;NAA10
prerank,chemokine activity (GO:0008009),-0.28726683212444803,-0.8418340081748219,0.7164502164502164,0.9340393423189282,1.0,6/31,15.55%,CXCL12;CCL15;CCL14;CCL25;CCL13;CXCL16
prerank,methyl-CpG binding (GO:0008327),0.3533069390799795,0.8412992082310649,0.6235521235521235,0.8662274641411177,1.0,4/22,10.90%,CDX1;MECP2;LHX4;PRMT1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.3894800889149921,0.840357675019169,0.6297872340425532,0.8645675903616061,1.0,3/11,13.15%,PRMT1;PRMT3;PRMT7
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.4095805762947359,0.8399938281216154,0.6048034934497817,0.8618858749794388,1.0,2/10,6.70%,OTUD5;DESI2
prerank,nucleosomal DNA binding (GO:0031492),-0.32120403461572283,-0.8397663767937431,0.6821705426356589,0.9342098682920076,1.0,7/21,28.36%,H3-3A;HDAC1;ACTB;SMARCC1;MBD2;SMARCA4;SMARCD2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3796873068260873,0.8393892758787067,0.6190476190476191,0.8596531788207464,1.0,2/13,8.57%,SREBF2;ECI1
prerank,hormone activity (GO:0005179),-0.25735202766165394,-0.8386758522843767,0.7660550458715596,0.9325726796122745,1.0,10/54,23.50%,IGF1;METRNL;CCL25;PTHLH;EDN3;PPY;AGT;AGRP;GNRH1;PENK
prerank,cytokine receptor binding (GO:0005126),0.2811225683768837,0.8380389270104416,0.6738768718801996,0.8587044149892767,1.0,11/83,8.66%,IL34;SPRED1;IL1B;CCRL2;SH2B3;JAK1;PXDN;IL4;OSMR;IL12RB1;IL22
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.2856279882977202,-0.8371187757226614,0.7293577981651376,0.9319061498080806,1.0,9/33,17.83%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;PNPT1;XRN1;TOE1;PNLDC1
prerank,motor activity (GO:0003774),0.2999380049217907,0.8351741856169115,0.6688102893890675,0.860620143333353,1.0,14/60,16.05%,STARD9;MYH9;KIF26B;MYO6;DYNC1I2;KIF3A;KIF5C;KIF20A;KIF3C;APPBP2;KIF21A;KIFC2;KIF7;KIF6
prerank,phosphate ion binding (GO:0042301),0.40135920742838604,0.8337376861062152,0.6255506607929515,0.8600881432663333,1.0,2/10,7.68%,RPH3A;MTHFD2
prerank,chemoattractant activity (GO:0042056),-0.30288757435454156,-0.8334143055107416,0.7130977130977131,0.9350785750911305,1.0,4/26,6.29%,BMP4;VEGFD;VEGFC;CCL15
prerank,deubiquitinase activity (GO:0101005),-0.2337044049466231,-0.8329618596531975,0.8432432432432433,0.9323421331782529,1.0,15/88,13.65%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP5;USP11;USP35;MINDY1;USP49;MPND
prerank,histone methyltransferase activity (GO:0042054),-0.28250656654206907,-0.8328211390067937,0.7390396659707724,0.9290811701079416,1.0,5/32,10.84%,SMYD3;SETD7;KMT5A;CARM1;EHMT1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.33448463222060953,-0.8318793893008456,0.6988636363636364,0.9272880494488295,1.0,5/16,16.68%,SLC22A4;SLC25A17;SLC22A5;SLC22A2;SLC25A26
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3765275844918081,0.8309195429695597,0.6241900647948164,0.8618495990096722,1.0,1/14,1.69%,RDH5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.2426415721688737,0.8303527791109612,0.7957559681697612,0.8596336281672147,1.0,25/248,9.08%,RASL12;RERG;MYH9;RND3;AGAP2;GNAZ;RAB8B;ABCD2;TOR1B;RAC3;ATAD1;RIT2;DNAJC27;RAB3B;DDX3X;TPPP;RAP1A;HRAS;GNG5;RAB28;MYO6;ARHGDIB;RAB38;GNA12;RNF112
prerank,channel activity (GO:0015267),-0.266053546097149,-0.8271909278106047,0.7473233404710921,0.9323695880397038,1.0,7/41,15.17%,PDPN;MCUB;TRPV4;MPV17;CHRNB1;TMEM120B;AQP11
prerank,hormone receptor binding (GO:0051427),0.3756439665424479,0.8220553459066036,0.6307339449541285,0.8707948072794071,1.0,4/14,13.94%,JAK1;CCK;NCOA6;JAK2
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.23210229983737957,-0.817605964372834,0.8449197860962567,0.9461925419681023,1.0,14/83,13.65%,USP53;USP47;USP46;USP12;USP8;USP15;USP18;USP34;ZC3H12A;USP5;USP11;USP35;USP49;MPND
prerank,water transmembrane transporter activity (GO:0005372),-0.36023740088945033,-0.8154163345627217,0.7068345323741008,0.9464844972302202,1.0,1/11,1.42%,PDPN
prerank,transcription corepressor binding (GO:0001222),0.328175959939649,0.8139907441682487,0.675146771037182,0.8817019062155592,1.0,4/27,8.53%,RORA;PER2;CNOT2;NEK6
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.3547215486283118,-0.8128784313235812,0.7320143884892086,0.9473953300027418,1.0,6/11,27.29%,APEX2;NEIL3;RPS3;APLF;NEIL1;NTHL1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3071697338316758,0.8100314894754137,0.6779026217228464,0.8851071838262129,1.0,5/38,6.72%,PIK3R1;NCK2;LDLRAP1;SH2B3;IRS1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3193680492382809,0.8055186909094245,0.6990825688073394,0.8893344212954384,1.0,7/31,11.10%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,phospholipase A2 activity (GO:0004623),-0.2811948067301473,-0.8035210634619739,0.7514910536779325,0.9595575163238054,1.0,3/26,13.04%,PLA2G4A;PLA2G6;PLA2G15
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.3300706162940471,-0.8024772228312963,0.722753346080306,0.9577420396933588,1.0,1/13,2.48%,AGPAT4
prerank,receptor tyrosine kinase binding (GO:0030971),0.2863186787785568,0.8013801924080479,0.712784588441331,0.8929962015090495,1.0,10/56,10.81%,PIK3R1;NRG1;SH2B3;NRG3;PITPNM2;SOCS5;IRS1;SHC4;CBLB;BLNK
prerank,glutathione transferase activity (GO:0004364),-0.2968444724612817,-0.7978820094000982,0.7565392354124748,0.9621166619559073,1.0,5/23,14.25%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2
prerank,solute:sodium symporter activity (GO:0015370),-0.28311179439357226,-0.7977140066171914,0.776595744680851,0.9588195003561091,1.0,3/27,9.01%,SLC4A10;SLC20A2;SLC5A6
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.3188130120490829,-0.7931838883503088,0.7455621301775148,0.9627786247476955,1.0,7/16,35.52%,PIR;ALOX12;CDO1;HGD;ALOXE3;HAAO;ALOX5
prerank,microtubule motor activity (GO:0003777),0.29215745895554085,0.7928450911314107,0.7248322147651006,0.9041283713225684,1.0,12/51,16.05%,STARD9;KIF26B;DYNC1I2;KIF3A;KIF5C;KIF20A;KIF3C;APPBP2;KIF21A;KIFC2;KIF7;KIF6
prerank,deoxyribonuclease activity (GO:0004536),-0.33254211701641334,-0.7888980211056144,0.7532956685499058,0.966044146332199,1.0,6/14,26.12%,ERCC5;DNASE1L1;NME1;DFFB;RPS3;APLF
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.2720354704289725,-0.7879816420165813,0.7701863354037267,0.9640400977344542,1.0,4/30,8.31%,CAST;GAS6;CST3;BIRC3
prerank,phosphatase activator activity (GO:0019211),-0.3275558433026423,-0.7878380758652166,0.7693726937269373,0.9607836047650554,1.0,4/14,18.96%,CALM2;FRS2;CALM1;PPP2R5C
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.382929867273204,0.7877917414433561,0.6652360515021459,0.9091477444408694,1.0,3/10,8.79%,HEXIM1;CDKN1A;INCA1
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.3564777596024301,0.7873841379398736,0.6695278969957081,0.9065506295278959,1.0,2/14,4.42%,BLVRB;DHFR
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2448538720085413,-0.7873219975901495,0.8292682926829268,0.9580380967671608,1.0,14/49,17.10%,MPPED2;PTPRJ;DUSP12;PPP1CB;SAMHD1;DUSP16;PXYLP1;EPHX2;PGAM5;PGP;DUSP10;SMPDL3A;DUSP23;LHPP
prerank,retinoid X receptor binding (GO:0046965),0.36763140633922575,0.7863328337669514,0.6687898089171974,0.9049885807995512,1.0,3/11,7.97%,TACC1;ARID5A;NCOA6
prerank,ATPase regulator activity (GO:0060590),-0.2575899499078862,-0.7848709993098328,0.801762114537445,0.9587204678993131,1.0,12/38,21.74%,ATP1B3;FNIP1;BAG3;TOR1AIP1;DNAJB2;DNAJC24;PFN1;DNAJB6;DNAJC15;DNAJC10;BAG2;PLN
prerank,alkali metal ion binding (GO:0031420),0.3639643609588343,0.7840987290765865,0.703125,0.9054258151562149,1.0,1/13,1.25%,ATP1A2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.32896056131760304,0.7839237195315024,0.6924564796905223,0.9024687054264389,1.0,6/24,13.42%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC17;ZDHHC21;ZDHHC23
prerank,lipid phosphatase activity (GO:0042577),-0.3200269710136447,-0.7817143199879968,0.782608695652174,0.9601222003167035,1.0,6/14,26.97%,PLPP3;PLPP1;EPHX2;INPP5K;PLPPR4;PLPP2
prerank,alanine transmembrane transporter activity (GO:0022858),-0.3406565290157159,-0.7799281068241505,0.7504725897920604,0.9593826343930886,1.0,3/12,11.23%,SLC6A6;SLC38A5;SLC3A2
prerank,receptor antagonist activity (GO:0048019),-0.30510004535105184,-0.7796814514314176,0.7626459143968871,0.956349432538701,1.0,1/17,1.83%,DKK3
prerank,DNA replication origin binding (GO:0003688),0.3202971402986909,0.7777629540599214,0.6963249516441006,0.9095686081110113,1.0,6/23,16.94%,KAT7;MCM6;MCM7;MCM2;ORC4;DDX11
prerank,phosphatidate phosphatase activity (GO:0008195),-0.3361315576010578,-0.7772576350314796,0.7514231499051234,0.9566642777782748,1.0,6/13,26.97%,PLPP3;PLPP1;LPIN3;PLPP4;PLPPR4;PLPP2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.3689321926859531,0.7770728431315695,0.7017937219730942,0.9075017494600032,1.0,2/10,8.57%,HADHB;ECI1
prerank,NF-kappaB binding (GO:0051059),-0.28212397214213697,-0.7749322128572159,0.7991543340380549,0.956769724696645,1.0,7/24,22.56%,ANXA4;RELA;HDAC1;TAF4B;NFKBIA;CDK5RAP3;SETD6
prerank,1-phosphatidylinositol binding (GO:0005545),0.3441624960418811,0.7730350248985371,0.721030042918455,0.9106809258633574,1.0,3/15,5.75%,SCARB1;EPB41;WDFY3
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.27422935222168543,-0.7610411456722596,0.7879377431906615,0.9740027527219997,1.0,4/22,12.56%,APOE;HSPG2;MESD;AP2A1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.22298863807671496,-0.7593318125861138,0.8958837772397095,0.9730438933347725,1.0,12/75,16.33%,ABCC4;DHRS3;CRYL1;SORD;ME1;DHDH;BDH1;PGD;ADH1A;BDH2;AKR1A1;HSD17B7
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.28078312803034017,-0.7579226160855602,0.8148893360160966,0.971707311934939,1.0,8/22,36.92%,IKBKE;OPTN;WDR81;IKBKG;MINDY2;PARP10;TAB2;ZRANB3
prerank,exonuclease activity (GO:0004527),-0.23974274774456197,-0.7568856500117536,0.8548009367681498,0.9697306188094478,1.0,10/46,15.41%,ENPP1;CNOT7;ENPP3;DCLRE1C;REXO4;ZC3H12A;ISG20L2;APEX2;RAD50;EXOSC5
prerank,endopeptidase activator activity (GO:0061133),-0.33947277335448633,-0.7567994944903524,0.7741312741312741,0.9664733122122358,1.0,4/10,30.55%,PSME2;PSME3;VSIR;APH1A
prerank,ubiquitin protein ligase binding (GO:0031625),0.22232502157582434,0.7564169014680091,0.9139072847682119,0.9333803052434974,1.0,41/254,13.27%,GLMN;VCL;FZD6;USP25;PTPN22;PRR5L;CUL3;RBX1;ABI2;JAK1;TRAF5;TRIB2;FAF2;SCN5A;MAGEC2;UCHL1;SPOPL;PRKAR2B;YWHAZ;UBE2J2;TRAF3;CDKN1A;BLZF1;GPR37;NKD2;PRKAR2A;NEK6;SLF2;UBE2G1;DET1;PRKAR1A;AXIN2;OTUB1;SPOP;NLK;GPI;APC;RB1;TRAF6;TANK;TRAF2
prerank,adenylyltransferase activity (GO:0070566),-0.2834420169923757,-0.7556600756519873,0.7886497064579256,0.9647927873259525,1.0,10/21,32.35%,OAS2;KARS1;MTPAP;NMNAT1;PAPOLB;TENT4B;ABL1;GPHN;OASL;FICD
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2541220689971394,-0.755217764730523,0.8218029350104822,0.9621814282988639,1.0,19/34,40.43%,SMYD3;SETD7;KMT5A;EHMT1;EZH2;SETDB1;ETFBKMT;SETD6;SETD4;CAMKMT;DOT1L;EEF1AKMT3;EEF2KMT;METTL21C;KMT2E;EEF1AKMT4;VCPKMT;SMYD2;N6AMT1
prerank,kinase inhibitor activity (GO:0019210),0.29777615365724447,0.7550484295224202,0.7422303473491774,0.9322234082674461,1.0,6/33,10.49%,SPRY4;HEXIM1;SNCA;TAOK3;CDKN1A;PRKRIP1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.3315904278810512,0.7542128648662417,0.7164835164835165,0.9301496702829737,1.0,7/15,22.40%,KMT2B;SETMAR;SETD3;KMT2A;KMT2D;WDR5;SETD1A
prerank,damaged DNA binding (GO:0003684),0.2787131417433331,0.7540697801498497,0.7901234567901234,0.9271653262800589,1.0,17/44,23.20%,DCLRE1B;FANCG;ERCC4;RAD1;AUNIP;EP300;XPC;SMC6;RPA2;APEX1;MPG;SDE2;CREBBP;DDB2;XRCC1;PNKP;RAD18
prerank,lysine N-methyltransferase activity (GO:0016278),-0.29165364109667047,-0.7535555929694333,0.7887323943661971,0.9612071911495409,1.0,12/20,40.08%,SETD7;KMT5A;EHMT1;ETFBKMT;SETD6;SETD4;EEF1AKMT3;EEF2KMT;METTL21C;EEF1AKMT4;VCPKMT;SMYD2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2934140146240897,0.7522807353316904,0.7737881508078994,0.9266102257284098,1.0,7/34,11.10%,UBE2QL1;UBE2E3;UBE2J2;UBE2E1;UBE2G1;BIRC6;AKTIP
prerank,hydro-lyase activity (GO:0016836),-0.24502800408097838,-0.7515484496643917,0.8782051282051282,0.9606268943522979,1.0,14/41,23.34%,GMDS;HACD4;HACD3;ACO1;TBXAS1;AUH;ENO1;ECHDC2;CBS;PARK7;ECHDC3;FAHD2A;L3HYPDH;TGDS
prerank,RNA cap binding (GO:0000339),-0.30084851177497735,-0.750319372024941,0.7802607076350093,0.959114203353325,1.0,5/16,18.22%,CYFIP2;EIF4A1;LARP1;GEMIN5;EIF4E2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.2744126878948715,-0.7496707307966535,0.8254901960784313,0.9566892852545664,1.0,2/25,1.63%,EFEMP1;TGFA
prerank,vitamin D receptor binding (GO:0042809),0.3344221238676072,0.7491228958694535,0.715203426124197,0.9282583916247531,1.0,9/14,28.57%,MED13;MED1;MED4;MED30;TAF7;MED16;MED14;SNW1;MED17
prerank,ubiquitin-protein transferase activity (GO:0004842),0.21295518170166441,0.7476481848201373,0.9526123936816525,0.9272636614635891,1.0,68/346,16.92%,NEDD4L;TNFAIP1;DTX3;UBR1;HECW2;BTRC;TRIM9;RNF150;CUL3;RBX1;TRAF5;PELI2;MYLIP;SIAH2;TRIM62;TRIM43;UBE2QL1;CBLL1;UBE2E3;NEURL1B;NEURL3;UBR3;RCHY1;HACE1;UBE2J2;VPS18;TRAF3;UBE2E1;SIAH3;RNF25;MIB2;KCTD13;FBXO24;RNF112;UBE2G1;HECW1;BIRC6;CBLB;CNOT4;VPS11;RLIM;TSPAN17;AKTIP;TRIM2;PPIL2;RNF121;UBR2;UBE3A;PPP1R11;RNF114;TRAF6;KLHL13;TRAF2;RMND5B;ARIH1;TRIM45;LMO7;RNF103-CHMP3;PEX12;ZFP91;RNF138;ZNRF2;NFX1;ERCC8;RNF166;MSL2;RNF6;TRIM37
prerank,phosphotyrosine residue binding (GO:0001784),0.2908310286097278,0.7469545013687279,0.7648148148148148,0.925075647092969,1.0,3/37,2.28%,PIK3R1;NCK2;LDLRAP1
prerank,single-stranded DNA helicase activity (GO:0017116),0.32191486422267857,0.7468181942598415,0.7288135593220338,0.9220976296118563,1.0,4/19,10.77%,MCM6;WRNIP1;MCM7;MCM2
prerank,CoA-ligase activity (GO:0016405),-0.3120898086798998,-0.7457024826447847,0.78,0.9585474625336866,1.0,1/14,2.19%,ACSS3
prerank,Hsp90 protein binding (GO:0051879),0.2897992332116348,0.743793085327188,0.7827715355805244,0.9234659073312392,1.0,1/33,0.67%,SLC12A2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3231647232013244,0.7431683633707896,0.7412008281573499,0.9212935971022321,1.0,4/17,10.98%,BAAT;ACOT12;PPT1;ACOT2
prerank,N-methyltransferase activity (GO:0008170),0.31170610377678765,0.7428382445121788,0.7535934291581109,0.9186133800583984,1.0,9/20,22.90%,TRMT1;RNMT;TRMT11;PRMT1;SETD3;METTL18;TFB2M;DIMT1;TRMT1L
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.33748618027286226,-0.7415308700591015,0.7788104089219331,0.9608176537662614,1.0,1/10,1.05%,B4GALT1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.29089429803161126,-0.7355501889954761,0.8015564202334631,0.9650506122777537,1.0,1/15,2.48%,AGPAT4
prerank,lipoprotein particle receptor binding (GO:0070325),-0.25341013631147025,-0.7351203582235901,0.8244897959183674,0.9623290430008418,1.0,4/27,12.56%,APOE;HSPG2;MESD;AP2A1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.2894487404400047,0.7332598219039431,0.8033088235294118,0.9295987567114559,1.0,9/33,14.41%,NCOA3;CCAR2;TBP;DRAP1;RPRD1B;CTR9;HNRNPU;UVSSA;URI1
prerank,four-way junction DNA binding (GO:0000400),-0.2835876215585065,-0.7297978184564283,0.8040816326530612,0.9658703025536413,1.0,7/17,29.53%,RAD51B;HMGB2;RAD51C;MSH6;FANCM;ABL1;WRN
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2818410465228318,-0.7278627037261606,0.8200371057513914,0.964843125792912,1.0,6/17,24.75%,LBR;DPYD;BDH2;DECR1;PTGR2;PTGR1
prerank,acid-thiol ligase activity (GO:0016878),-0.30948544189503785,-0.7266600910488541,0.8011811023622047,0.9631060460433121,1.0,1/13,2.19%,ACSS3
prerank,histone methyltransferase binding (GO:1990226),-0.32343725389769584,-0.7253264293775137,0.8018181818181818,0.9614185765419514,1.0,1/11,1.73%,LCOR
prerank,RNA polymerase binding (GO:0070063),0.30171537759021927,0.7180400647261825,0.7633744855967078,0.9479248806318666,1.0,4/18,11.41%,BIN1;PHRF1;TCERG1;YTHDC2
prerank,GABA receptor binding (GO:0050811),0.34081779746860225,0.7174344809405443,0.7536231884057971,0.9455944444916196,1.0,6/11,22.09%,PLCL2;TRAK1;TRAK2;JAKMIP1;GABARAP;GABARAPL2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2680008195849013,-0.7129249230905568,0.8551587301587301,0.9728172542826947,1.0,3/21,9.75%,FGF1;KL;FRS2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3342539702466888,0.7122622939332782,0.7655913978494624,0.9494605804587638,1.0,11/11,66.60%,HCN2;CNGB1;HCN1;CNGA1;KCNA10;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4
prerank,protein phosphorylated amino acid binding (GO:0045309),0.27528502202365773,0.71090986813561,0.8210332103321033,0.9481080618448631,1.0,3/42,2.28%,PIK3R1;NCK2;LDLRAP1
prerank,ligand-gated calcium channel activity (GO:0099604),0.3093586582927146,0.7084277250262908,0.771255060728745,0.9482916214178285,1.0,6/19,15.28%,ITPR1;RYR2;RYR3;GRIN2B;RASA3;GRIN2A
prerank,endoribonuclease activity (GO:0004521),-0.24239754850608927,-0.7076822739035765,0.8957446808510638,0.9757355533466805,1.0,18/32,39.36%,NYNRIN;SMG6;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;ZC3H12B;RNASEK;AGO2;ENDOU;RIDA;EXOG;ENDOG;ZC3H12D;CPSF3;PIWIL4
prerank,Notch binding (GO:0005112),0.303812488606997,0.7038279027764485,0.7862903225806451,0.9512565731380528,1.0,4/22,4.43%,DLL3;CHAC1;CUL3;DNER
prerank,RNA polymerase core enzyme binding (GO:0043175),0.2740316123940644,0.7034029145554508,0.8142076502732241,0.9486205673319724,1.0,9/33,17.09%,NCOA3;CCAR2;RPRD1B;CTR9;MAF1;HNRNPU;UVSSA;URI1;RRN3
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.30038947522416914,-0.7016704724742703,0.8208092485549133,0.9788030285725026,1.0,4/12,18.22%,CYFIP2;LARP1;GEMIN5;EIF4E2
prerank,Hsp70 protein binding (GO:0030544),-0.2373620077988976,-0.6989601769313594,0.9081632653061225,0.9786607603978221,1.0,13/31,28.23%,HDAC8;ERN1;DNAJB2;PPEF2;PPID;DNAJC10;DNAJB12;PRKN;DNAJC2;DNAJC8;RPS3;MVD;IQCG
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.20292765809866803,0.6965177320958014,0.9725490196078431,0.954163431370579,1.0,41/269,13.27%,GLMN;VCL;FZD6;USP25;PTPN22;PRR5L;CUL3;RBX1;ABI2;JAK1;TRAF5;TRIB2;FAF2;SCN5A;MAGEC2;UCHL1;SPOPL;PRKAR2B;YWHAZ;UBE2J2;TRAF3;CDKN1A;BLZF1;GPR37;NKD2;PRKAR2A;NEK6;SLF2;UBE2G1;DET1;PRKAR1A;AXIN2;OTUB1;SPOP;NLK;GPI;APC;RB1;TRAF6;TANK;TRAF2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.33606585027530933,0.6957724311188108,0.7750556792873051,0.9519470491386305,1.0,3/10,17.25%,NAA11;NAA30;NAA15
prerank,endonuclease activity (GO:0004519),-0.22172897169850758,-0.6952217838050615,0.9360189573459715,0.9794643675075386,1.0,18/49,29.31%,N4BP2;NYNRIN;ERCC5;SMG6;REXO4;ZC3H12A;ERN1;INTS11;RNASEL;AGO1;DICER1;RPS3;ZC3H12B;RNASEK;APLF;NTHL1;AGO2;ENDOU
prerank,mRNA 3'-UTR binding (GO:0003730),0.23516006567812997,0.6935150160276907,0.9015025041736227,0.9515646005308915,1.0,23/79,17.47%,RBMS3;CPEB1;RBM24;ELAVL4;DAZL;BOLL;DND1;RBMS1;RNPS1;SECISBP2;CPEB4;PABPC4;CELF1;DAZAP1;HNRNPU;HNRNPC;DHX36;RSL1D1;FMR1;ELAVL2;KHSRP;IGF2BP3;RC3H1
prerank,MHC protein binding (GO:0042287),-0.2636287106023105,-0.688954693088905,0.8951612903225806,0.9825954045100639,1.0,6/20,28.33%,TAPBP;CD81;TUBB4B;TAP2;LAG3;TAP1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3205527757549367,0.6846423627446059,0.7958333333333333,0.9595271364841602,1.0,4/12,18.25%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,protein phosphatase regulator activity (GO:0019888),0.2484824764238925,0.67941082206814,0.8581560283687943,0.9627720594985321,1.0,18/53,22.36%,PTN;PPP2R2A;ANKLE2;PPP1R16A;PPP2R5D;SET;MGAT5;PPP6R2;PPP4R4;CABIN1;SAG;PPP1R15A;CALM3;PPP2R1A;PPP2R5B;LMTK2;BOD1L1;STYXL1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.23503020396579405,0.6765573980557094,0.8946488294314381,0.9628542964624014,1.0,20/69,19.08%,ZDHHC14;BAAT;PLAAT1;ZDHHC1;ZDHHC2;PLA2G4E;ZDHHC16;CERS4;KAT6A;GLYAT;EP300;ZDHHC17;ZDHHC21;HHAT;AWAT2;ZDHHC9;NAA15;SOAT2;CERS6;CERS5
prerank,3'-5' DNA helicase activity (GO:0043138),-0.26728041830295024,-0.6733118327697525,0.8947368421052632,0.9947456863847294,1.0,9/16,35.00%,ASCC3;NAV2;RECQL;ERCC3;FANCM;WRN;MCM5;HELQ;RECQL5
prerank,ion channel inhibitor activity (GO:0008200),0.2629799387857976,0.6718535508149076,0.8654205607476636,0.9650452622597222,1.0,2/35,3.68%,NEDD4L;ITPR1
prerank,myosin V binding (GO:0031489),0.2910569567115501,0.6712649334595978,0.8217391304347826,0.9626223968505448,1.0,2/15,6.00%,RAB39B;RAB3B
prerank,CoA hydrolase activity (GO:0016289),0.29482070290903184,0.6709937115597354,0.8353909465020576,0.9598702922810808,1.0,4/16,16.39%,BAAT;ACOT12;ACOT2;ACOT7
prerank,solute:proton symporter activity (GO:0015295),-0.26428217499429674,-0.6708353778490824,0.88,0.9938478852398165,1.0,2/16,10.17%,SLC2A13;SLC39A8
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.283630940052981,-0.6688513495473811,0.8917431192660551,0.9925550898888514,1.0,7/13,44.83%,DNASE1L1;DICER1;SLX4;EXO1;FEN1;GEN1;FAN1
prerank,serotonin receptor activity (GO:0099589),0.2829906162625637,0.6625091575139536,0.8541666666666666,0.9601912355043233,1.0,5/22,18.63%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.2829906162625637,0.6625091575139536,0.8541666666666666,0.9601912355043233,1.0,5/22,18.63%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,G protein-coupled amine receptor activity (GO:0008227),0.2829906162625637,0.6625091575139536,0.8541666666666666,0.9601912355043233,1.0,5/22,18.63%,HTR1B;HTR2C;HTR4;CHRM3;CHRM2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3048313061079333,0.6612065423641272,0.820627802690583,0.9586442101191625,1.0,3/11,12.77%,RDH14;DHRS13;RDH12
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.3166432687586356,0.6611734367279588,0.8034934497816594,0.9556506243055166,1.0,4/10,18.69%,FUOM;RPE;GALE;GALM
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.23704308290782033,-0.6610762736373867,0.9246861924686193,0.9963327337012371,1.0,6/26,20.19%,CSGALNACT1;CHSY1;B3GALNT1;EXTL2;CHPF2;B3GALNT2
prerank,glycine binding (GO:0016594),0.3118207919033584,0.6610044843938921,0.8042553191489362,0.952831455918266,1.0,4/11,20.94%,GRIN2B;SRR;GLRB;GRIN1
prerank,miRNA binding (GO:0035198),-0.23108971407499032,-0.6590468779960698,0.9189765458422174,0.9948361414990532,1.0,8/30,19.36%,TUT4;TUT7;ZC3H12A;RBM10;PUM1;ELAVL1;PNPT1;AGO1
prerank,chemokine receptor binding (GO:0042379),0.2541787893916281,0.6585433245653276,0.8763837638376384,0.9524558127270837,1.0,3/35,5.43%,CCRL2;CXCL5;CXCL10
prerank,RNA polymerase II complex binding (GO:0000993),0.2577292997874035,0.657704754692645,0.8682745825602969,0.9503185734640097,1.0,7/32,14.41%,NCOA3;CCAR2;RPRD1B;CTR9;HNRNPU;UVSSA;URI1
prerank,ATP hydrolysis activity (GO:0140603),-0.2131760746184026,-0.656126353574973,0.9619047619047619,0.9940595276132426,1.0,5/41,7.69%,RNF213;MYO18A;CHD3;ABCA3;ABCA4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.2925154151340891,0.6531202913786874,0.828693790149893,0.9519932351047504,1.0,4/14,15.66%,AK8;AK7;AK5;AK4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.2659039714297947,0.6523783547451464,0.8565400843881856,0.949805625705756,1.0,6/24,15.67%,ITPKB;AK8;AK7;AK5;AK4;AK3
prerank,methyltransferase activity (GO:0008168),0.23735746195256188,0.6508309143708656,0.9140350877192982,0.948344707446751,1.0,12/46,18.35%,NSUN3;AS3MT;TRMT11;EEF1AKMT1;PRMT1;GCSH;PRMT3;PRMT7;SUV39H1;GAMT;NSUN2;METTL4
prerank,dynactin binding (GO:0034452),0.2985017319945326,0.6491920596912766,0.8434237995824635,0.9470514307746185,1.0,4/12,17.60%,HOOK3;BICD2;HTT;GSK3B
prerank,single-stranded DNA binding (GO:0003697),-0.18000923923143491,-0.6463815971970704,0.9910179640718563,0.9987574756406815,1.0,24/93,24.41%,SSBP2;SSBP1;ERCC5;RTF1;REXO4;RAD51B;PCBP2;SAMHD1;BRCA2;NABP1;RPA1;HMGB2;PARK7;MCMDC2;TOP3A;RAD52;NEIL3;MCM8;WBP11;ERCC1;CDC45;RAD51;POLR2G;RPA3
prerank,growth factor activity (GO:0008083),0.2213707771438179,0.6461514862363762,0.9243421052631579,0.9471427066537185,1.0,8/74,9.32%,PTN;NRG1;FGF2;NRG3;IL4;FGF10;JAG1;PDGFB
prerank,tRNA methyltransferase activity (GO:0008175),0.2800744413552839,0.6448160361890554,0.8458333333333333,0.9455339737493554,1.0,2/16,9.62%,TRMT5;THUMPD2
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3017871680879331,0.6427453476379273,0.8294736842105264,0.9447064958216066,1.0,7/11,28.38%,RBX1;PPIL2;STUB1;UBE4A;UBE2K;UBOX5;ANAPC11
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.21716657024973818,-0.6415793712664902,0.927400468384075,0.9991566765099634,1.0,11/34,26.02%,CNOT7;NOCT;ERI3;CNOT8;EXOSC5;PNPT1;TOE1;PNLDC1;PAN3;EXOSC7;ANGEL2
prerank,ribonuclease P activity (GO:0004526),-0.281488366630022,-0.640590287524003,0.9083820662768031,0.9967647053367841,1.0,5/11,37.40%,PRORP;RPP38;POP1;RPP21;RPP40
prerank,tRNA binding (GO:0000049),-0.20609052874275938,-0.6404418623782013,0.9679633867276888,0.9937223946739823,1.0,9/43,16.47%,EEF1A1;KARS1;CARS1;ELP1;SARS1;TYW5;XPOT;TRMT10B;TRNAU1AP
prerank,nuclear import signal receptor activity (GO:0061608),0.2787409181457134,0.6321526872394266,0.8510204081632653,0.9521874346366183,1.0,4/15,19.72%,KPNA4;KPNA1;TNPO1;KPNA3
prerank,MHC class I protein binding (GO:0042288),-0.26726940387510345,-0.6267123040252317,0.939453125,1.0,1.0,4/13,28.33%,TAPBP;TUBB4B;TAP2;TAP1
prerank,ribosomal small subunit binding (GO:0043024),-0.24403811523021193,-0.6240301142115079,0.9198542805100182,0.999360401000664,1.0,5/17,18.95%,CPEB2;NME1;MTIF3;LARP1;EIF1B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.20274493765386736,-0.6227325568640315,0.9625779625779626,0.9971443486076939,1.0,9/35,23.67%,MTFMT;TARS2;FTO;ELAC2;TRIT1;PTRH2;TRMT13;FTSJ1;TRMT12
prerank,neuropeptide binding (GO:0042923),0.27100759285382886,0.6221882046246922,0.8701825557809331,0.958283356680091,1.0,2/18,8.13%,OPRK1;GPR37
prerank,NADPH binding (GO:0070402),-0.26138510901414136,-0.6192272699123761,0.922365988909427,0.9961911522541527,1.0,4/13,27.41%,LBR;DECR1;GRHPR;MTRR
prerank,telomeric DNA binding (GO:0042162),-0.2094860289680986,-0.6189485080291518,0.9741935483870968,0.993236476024283,1.0,7/32,22.17%,SMG6;UPF3A;RPA1;RAD50;SMG5;UPF2;ACD
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2909534872833526,0.6162416737254901,0.8839103869653768,0.960445173979192,1.0,5/11,21.67%,HNRNPA1;TERF1;RPA2;HNRNPA2B1;CTC1
prerank,carboxy-lyase activity (GO:0016831),-0.21908464457603605,-0.6059004168801195,0.9470468431771895,0.9980299320705347,1.0,5/23,21.94%,CSAD;ODC1;DDC;BCKDHA;AZIN1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2509054034551095,-0.6045140803023971,0.916504854368932,0.9958612667919283,1.0,6/14,26.17%,ACO1;ISCA2;RSAD2;EXO5;NDUFS1;SDHB
prerank,endodeoxyribonuclease activity (GO:0004520),-0.23465730955105418,-0.6037143503099771,0.951171875,0.9933427781522083,1.0,11/20,36.92%,ERCC5;DCLRE1C;RAD50;ERCC1;RPS3;APLF;EXO1;EXOG;ENDOG;FEN1;ZRANB3
prerank,pyridoxal phosphate binding (GO:0030170),-0.22883039157259133,-0.5965518526526825,0.9421965317919075,0.9944370265387099,1.0,10/20,34.00%,PYGB;OAT;CBS;AGXT;ABAT;PDXK;PNPO;PYGL;SHMT1;GLDC
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.27289273182666596,0.5904148865061837,0.9042553191489362,0.9778369903620786,1.0,2/14,6.70%,OTUD5;DESI2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.2533954644626599,-0.5785414825452214,0.9408602150537635,1.0,1.0,1/11,6.39%,DDAH1
prerank,RNA methyltransferase activity (GO:0008173),0.24659360612519113,0.5784028279721013,0.9294605809128631,0.9831357305037484,1.0,2/19,6.16%,FBLL1;TRMT5
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.20937696912307113,-0.577986223651085,0.9620758483033932,0.9972901775639751,1.0,2/23,5.85%,SESTD1;WIPI2
prerank,signal sequence binding (GO:0005048),-0.1923844123591681,-0.570454556908865,0.9829059829059829,0.9976959727258357,1.0,8/35,21.86%,CEMIP;BRAP;KPNA6;NFKBIA;SEC61A1;BABAM2;NUP214;AP2M1
prerank,N-acyltransferase activity (GO:0016410),0.2231601384208237,0.5694256723483754,0.943609022556391,0.9860899562064804,1.0,12/32,23.86%,BAAT;PLAAT1;PLA2G4E;CERS4;GLYAT;EP300;CERS6;CERS5;NAT8L;CERS1;ESCO1;CERS2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",-0.20301216804306643,-0.564229717642283,0.9837067209775967,0.9972416702472386,1.0,13/28,39.20%,EDC3;PRORP;ELAC2;RPP38;DICER1;NUDT16;POP1;AGO2;EXO1;RPP21;FEN1;RPP40;MRPL44
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.22853795962008913,0.5634559287615543,0.9445544554455445,0.9866950105452427,1.0,8/27,18.93%,POLR2C;POLR3H;MED20;POLR1A;PRIM1;POLR1B;POLR3F;POLR2D
prerank,CCR chemokine receptor binding (GO:0048020),-0.19650812927222616,-0.5600761916689613,0.9915433403805497,0.995843515991229,1.0,20/28,52.38%,CCL15;CCL14;CCL25;CCL13;CCL19;CCR2;CCL2;NARS1;CX3CL1;CCL5;CCL4;CCL8;MSMP;CCL7;DEFB130A;CCL1;CCL3;CCL11;DEFB1;CXCL13
prerank,single-stranded RNA binding (GO:0003727),0.20766952679164266,0.5584047657591952,0.96875,0.9866826338556128,1.0,14/43,21.42%,AGO3;DDX3X;ADARB2;HNRNPA1;RBM7;HNRNPU;FMR1;DDX11;ZFR;LACTB2;ENDOV;POLR2D;EIF4H;PTBP1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21044201575513347,0.5569272930008933,0.9633699633699634,0.9846303037451283,1.0,9/40,15.03%,FBLL1;AS3MT;PCMTD2;THUMPD2;PRMT7;SETD3;METTL18;SUV39H1;GAMT
prerank,histone acetyltransferase binding (GO:0035035),-0.21638599524293783,-0.5539921001495431,0.9613152804642167,0.9950073983818928,1.0,8/21,25.59%,STAT1;HIF1A;MEF2A;GLI3;SIRT2;EGR1;TP53;TRIP4
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.2598038119292829,0.5437646863085918,0.9424778761061947,0.9887598911811423,1.0,3/11,17.25%,NAA11;NAA30;NAA15
prerank,3'-5' exonuclease activity (GO:0008408),0.20209632497704239,0.5347917092259856,0.975736568457539,0.9900991604464603,1.0,12/45,17.66%,REXO2;PAN2;XRN2;RAD1;TRIR;REV3L;DIS3L2;EXD1;ERI2;TATDN1;USB1;APEX1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.2117069314683025,0.5328466808321992,0.9574861367837338,0.9881756504475367,1.0,6/28,16.92%,TRAF5;TRAF3;TRAF6;TRAF2;MADD;TRIM37
prerank,carbohydrate kinase activity (GO:0019200),-0.23238408923507164,-0.527344579285883,0.9692028985507246,1.0,1.0,7/11,43.24%,HK2;GNE;HK1;KHK;GALK2;POMK;HK3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.20893827311270988,-0.5263736462040237,0.9709302325581395,0.9979969580490785,1.0,2/18,8.31%,GAS6;BIRC3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.2422473320778405,0.5247438036483851,0.934322033898305,0.9888815479182788,1.0,12/12,75.79%,DHRS4;CRYZL1;CBR1;CRYZ;NQO1;CBR4;NQO2;ADH4;AKR1C1;AIFM2;DCXR;NDUFS7
prerank,pseudouridine synthase activity (GO:0009982),0.241697532801808,0.5237408498466694,0.9520833333333333,0.9864312090471757,1.0,13/13,75.85%,TRUB1;PUS7;DKC1;RPUSD1;PUS10;PUS1;PUSL1;PUS3;RPUSD3;RPUSD2;RPUSD4;TRUB2;PUS7L
prerank,gamma-tubulin binding (GO:0043015),0.2205507674288616,0.5228233506179721,0.9611650485436893,0.983919995068593,1.0,6/21,18.98%,DDX3X;BRSK1;ARHGEF7;PAK1;MARK4;NDRG1
prerank,transaminase activity (GO:0008483),0.24596160004452094,0.5202959167167884,0.9550321199143469,0.9821311884602542,1.0,2/11,10.55%,GOT1;PSAT1
prerank,regulatory RNA binding (GO:0061980),0.19751960540302987,0.5122967289244713,0.9798534798534798,0.9823427059780389,1.0,11/38,19.90%,DND1;AGO3;TARBP2;ZC3H10;ZNF346;HNRNPA1;FMR1;MATR3;RC3H1;HNRNPA2B1;DDX21
prerank,ubiquitin binding (GO:0043130),-0.14948025799858353,-0.5086586631990476,1.0,0.9996655002264884,1.0,21/73,31.53%,SMAD3;TOM1L1;RNF185;USP5;DNAJB2;MDM2;SIRT2;NPLOC4;IKBKG;VPS28;UBE2L6;UBXN1;TOP2A;PRKN;RNF19B;NUP62;OTUB2;HSPB1;NEDD4;CXCR4;AUP1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.20370144136300233,0.5068920721998903,0.96875,0.9815374421940014,1.0,7/27,18.93%,POLR2C;POLR3H;MED20;POLR1A;POLR1B;POLR3F;POLR2D
prerank,aspartic-type peptidase activity (GO:0070001),-0.22548218323541924,-0.5052904528920789,0.97632058287796,0.9976187274972467,1.0,3/10,31.46%,BACE2;CTSD;CTSE
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.1660388765685219,-0.5011172989257138,0.9954128440366973,0.9955809307010501,1.0,6/42,16.09%,KAT2B;CCND2;CCND3;CCNG1;CCND1;CDKN1B
prerank,snoRNA binding (GO:0030515),-0.16638567027930448,-0.48548689777806436,0.9978021978021978,0.9955792715985305,1.0,11/30,36.20%,NUDT4;NOP58;UTP6;BYSL;NUDT16;NUDT1;NHP2;NUDT5;IMP4;ISG20;BMS1
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.19454385945704067,-0.4644777288247567,0.996031746031746,0.9959504527338272,1.0,3/13,24.49%,ARHGDIA;SH3BP4;RANBP1
prerank,neuropeptide hormone activity (GO:0005184),0.188505025125628,0.45607410523302244,0.98989898989899,0.9932323680676908,1.0,22/22,81.18%,CCK;SPX;NPY;PNOC;OXT;QRFP;CORT;HCRT;GHRH;NPPA;UCN;CALCB;NPFF;GAL;CRH;VIP;NMB;ADCYAP1;GRP;PENK;AGRP;PPY
prerank,ribonuclease P RNA binding (GO:0033204),0.2093271403464725,0.44372465167793423,0.9895833333333334,0.9927242096946405,1.0,10/10,79.08%,POP7;POP5;RPP30;POP4;RPP25;RPP14;RPP40;RPP21;POP1;RPP38
prerank,nuclear localization sequence binding (GO:0008139),-0.16524197731985363,-0.42690188994685535,0.9960861056751468,0.9969554157347555,1.0,4/18,21.04%,BRAP;KPNA6;NFKBIA;NUP214
prerank,aspartic-type endopeptidase activity (GO:0004190),0.16415568110483375,0.3459760699783799,0.9977064220183486,0.999198367186132,1.0,12/12,83.60%,PSEN1;HM13;SPPL3;SPPL2A;BACE1;PGC;DDI2;ASPRV1;NAPSA;SPPL2B;CTSE;BACE2
